"#",Jurisdiction,Kind,Display Key,Lens ID,Publication Date,Publication Year,Application Number,Application Date,Priority Numbers,Earliest Priority Date,Title,Abstract,Applicants,Inventors,Owners,URL,Document Type,Has Full Text,Cites Patent Count,Cited by Patent Count,Simple Family Size,Extended Family Size,Sequence Count,CPC Classifications,IPCR Classifications,US Classifications,NPL Citation Count,NPL Resolved Citation Count,NPL Resolved Lens ID(s),NPL Resolved External ID(s),NPL Citations,Legal Status
1,US,A1,US 2007/0043954 A1,115-540-038-761-348,2007-02-22,2007,US 20627505 A,2005-08-17,US 20627505 A,2005-08-17,Legacy access control security system modernization apparatus,"A system is provided for upgrading a legacy security system having a legacy control panel and a legacy card reader, without interfering with legacy system operation. A new control panel is installed between the legacy card reader and the legacy control panel. Also, a new token reader is installed next to the legacy card reader and connected to the new control panel. The new control panel passes credentials it receives from the legacy card reader to the legacy control panel, avoiding interference with legacy system operation. When the new control panel receives credentials from the new token reader, it evaluates them against an access rights list administered independently of the legacy access rights list. When the new control panel determines that an access request should be granted, it sends a memorized legacy credential associated with full access rights to the legacy control panel, causing it to open the door.",FOX CHRISTOPHER W,FOX CHRISTOPHER W,COMMON CREDENTIAL SYSTEMS L.L.C (2005-08-16),https://lens.org/115-540-038-761-348,Patent Application,yes,6,210,2,2,0,G06F21/34;;G06F21/34;;H04L9/3271;;H04L9/3271;;H04L9/3236;;H04L9/3236;;H04L63/0853;;H04L63/0853;;H04L63/101;;H04L63/101;;H04L2209/805;;H04L2209/805,H04L9/00,713/185,0,0,,,,ACTIVE
2,US,A,US 5926780 A,167-447-843-922-423,1999-07-20,1999,US 94788797 A,1997-10-09,US 94788797 A,1997-10-09,System for measuring the initial velocity vector of a ball and method of use,"A system 20 for measuring the initial velocity vector of a ball 500 includes a first light sensing array 24, a first light source 28, a second light sensing array 30, and a second light source 32. The ball 500 has an initial position 22. When the ball 500 is struck, at time T1 it casts a first shadow position 36 on first light sensing array 24, and at time T2 it casts a second shadow position 42 on second light sensing array 30. A first plane 38 is formed by initial position 22, first light source 28, and first shadow position 36. A second plane 44 is formed by initial position 22, second light source 32, and second shadow position 42. The line of flight 37 of ball 500 is defined by the intersection of planes 38 and 44. A slant distance D.sub.s is determined, whereby the speed S.sub.b of ball 500 is defined as S.sub.b =D.sub.s /(T2-T1). The velocity vector is then S.sub.b in the direction of line of flight 37.",FOX TWEED,FOX TWEED;;COYLE CHRISTOPHER W,FOX TWEED (1997-09-23),https://lens.org/167-447-843-922-423,Granted Patent,yes,12,111,1,1,0,A63B24/0021;;A63B24/0021;;A63B69/3658;;A63B69/3658;;A63B2024/0034;;A63B2024/0034,A63B69/36,702/142;;702/150;;473/140;;473/152,0,0,,,,EXPIRED
3,US,E,US RE036530 E,130-913-692-161-761,2000-01-25,2000,US 79753497 A,1997-02-07,US 79753497 A;;US 8372593 A,1993-06-25,Method for receiving and transmitting optical data and control information to and from remotely located receivers and transmitters in an optical locator system,"The method for receiving and transmitting optical data and control information to and from remotely located receivers and transmitters in an optical location system. Wherein, the locator system tracks and locates the position of a main object having an attached transceiver. This transceiver has stored in memory selected identifying information about the object to which the transceiver is attached. The selected identifying information was received by the transceiver over it's 1-wire interface from a touch memory.",PRECISION TRACKING FM INC,HELLER ALAN C;;FOX CHRISTOPHER W,,https://lens.org/130-913-692-161-761,Amended Patent,yes,20,39,4,4,0,G06K7/1097;;G06K7/1097;;G06K7/0008;;G06K7/0008;;G07C9/28;;G07C9/28;;G08B3/1083;;G08B3/1083,G06K7/00;;G06K7/10;;G07C9/00;;G08B3/10,359/155;;359/144;;359/167;;359/172;;340/572;;340/825.49,0,0,,,,PENDING
4,US,A,US 5387993 A,148-795-589-744-36X,1995-02-07,1995,US 8372593 A,1993-06-25,US 8372593 A,1993-06-25,Method for receiving and transmitting optical data and control information to and from remotely located receivers and transmitters in an optical locator system,"The method for receiving and transmitting optical data and control information to and from remotely located receivers and transmitters in an optical location system. Wherein, the locator system tracks and locates the position of a main object having an attached transceiver. This transceiver has stored in memory selected identifying information about the object to which the transceiver is attached. The selected identifying information was received by the transceiver over it's 1-wire interface from a touch memory.",PRECISION TRACKING FM INC,HELLER ALAN C;;FOX CHRISTOPHER W,PRECISION TRACKING FM INC (1985-01-01);;FRESHLOC TECHNOLOGIES INC (2000-03-09),https://lens.org/148-795-589-744-36X,Granted Patent,yes,17,525,4,4,0,G06K7/1097;;G06K7/1097;;G06K7/0008;;G06K7/0008;;G07C9/28;;G07C9/28;;G08B3/1083;;G08B3/1083,G06K7/00;;G06K7/10;;G07C9/00;;G08B3/10,359/155;;319/144;;319/167;;319/172;;340/972;;340/825.49,0,0,,,,EXPIRED
5,US,S,US D0530680 S,076-808-158-108-628,2006-10-24,2006,US 23254105 F,2005-06-21,US 23254105 F,2005-06-21,Control module for heat and light therapy device,,BIOCARE SYSTEMS INC,FOX SHERRY;;WRIGHT DAVID W;;ANDREWS CHRISTOPHER,BIOCARE SYSTEMS INC (2005-06-21),https://lens.org/076-808-158-108-628,Design Right,no,0,14,1,1,0,,,1303;;D13/168,0,0,,,,EXPIRED
6,WO,A2,WO 1997/012344 A2,077-591-681-899-200,1997-04-03,1997,US 9615471 W,1996-09-26,US 451095 P;;US 59498396 A,1995-09-29,"METHOD, APPARATUS, SYSTEM AND FIRMWARE FOR SECURE TRANSACTIONS","The present invention relates to an electronic module used for secure transactions. More specifically, the electronic module is capable of passing information back and forth between a service provider's equipment via a secure, encrypted technique so that money and other valuable data can be securely passed electronically. The module is capable of being programmed, keeping track of real time, recording transactions for later review, and creating encryption key pairs.",DALLAS SEMICONDUCTOR,CURRY STEPHEN M;;LOOMIS DONALD W;;FOX CHRISTOPHER W,,https://lens.org/077-591-681-899-200,Patent Application,no,0,12,15,19,0,G06Q20/341;;G06Q20/367;;G06Q20/3823;;G06Q20/401;;G06Q20/4093;;G06Q20/40975;;G07F7/0826;;G07F7/1008;;G07F7/1016;;H04L9/3263;;H04L9/3297;;H04L2209/34;;H04L2209/56;;G07F7/10;;G06Q20/401;;G06Q20/341;;G07F7/1008;;G06Q20/40975;;G06Q20/401;;G07F7/1016;;G06Q20/367;;G06Q20/4093;;G06Q20/3823;;G07F7/0826;;H04L2209/34;;H04L2209/56;;H04L9/3297;;H04L9/3263,G06Q20/34;;G06Q20/36;;G06Q20/38;;G06Q20/40;;G07F7/08;;G07F7/10;;G09C1/00,,0,0,,,,PENDING
7,WO,A3,WO 1997/012344 A3,155-946-325-987-703,1997-05-15,1997,US 9615471 W,1996-09-26,US 451095 P;;US 59498396 A,1995-09-29,"METHOD, APPARATUS, SYSTEM AND FIRMWARE FOR SECURE TRANSACTIONS","The present invention relates to an electronic module used for secure transactions. More specifically, the electronic module is capable of passing information back and forth between a service provider's equipment via a secure, encrypted technique so that money and other valuable data can be securely passed electronically. The module is capable of being programmed, keeping track of real time, recording transactions for later review, and creating encryption key pairs.",DALLAS SEMICONDUCTOR,CURRY STEPHEN M;;LOOMIS DONALD W;;FOX CHRISTOPHER W,,https://lens.org/155-946-325-987-703,Search Report,yes,9,0,15,19,0,G06Q20/341;;G06Q20/367;;G06Q20/3823;;G06Q20/401;;G06Q20/4093;;G06Q20/40975;;G07F7/0826;;G07F7/1008;;G07F7/1016;;H04L9/3263;;H04L9/3297;;H04L2209/34;;H04L2209/56;;G07F7/10;;G06Q20/401;;G06Q20/341;;G07F7/1008;;G06Q20/40975;;G06Q20/401;;G07F7/1016;;G06Q20/367;;G06Q20/4093;;G06Q20/3823;;G07F7/0826;;H04L2209/34;;H04L2209/56;;H04L9/3297;;H04L9/3263,G06Q20/34;;G06Q20/36;;G06Q20/38;;G06Q20/40;;G07F7/08;;G07F7/10;;G09C1/00,,0,0,,,,PENDING
8,AU,A,AU 1996/073745 A,139-283-671-558-843,1997-04-17,1997,AU 1996/073745 A,1996-09-26,US 451095 P;;US 59498396 A;;US 9615471 W,1995-09-29,"Method, apparatus, system and firmware for secure transactions",,DALLAS SEMICONDUCTOR,CURRY STEPHEN M;;LOOMIS DONALD W;;FOX CHRISTOPHER W,,https://lens.org/139-283-671-558-843,Patent Application,no,0,0,15,19,0,G06Q20/341;;G06Q20/367;;G06Q20/3823;;G06Q20/401;;G06Q20/4093;;G06Q20/40975;;G07F7/0826;;G07F7/1008;;G07F7/1016;;H04L9/3263;;H04L9/3297;;H04L2209/34;;H04L2209/56;;G07F7/10;;G06Q20/401;;G06Q20/341;;G07F7/1008;;G06Q20/40975;;G06Q20/401;;G07F7/1016;;G06Q20/367;;G06Q20/4093;;G06Q20/3823;;G07F7/0826;;H04L2209/34;;H04L2209/56;;H04L9/3297;;H04L9/3263,G06Q20/34;;G06Q20/36;;G06Q20/38;;G06Q20/40;;G07F7/08;;G07F7/10;;G09C1/00,,0,0,,,,EXPIRED
9,MX,A,MX 9802375 A,165-371-597-556-964,1998-11-30,1998,MX 9802375 A,1998-03-26,US 451095 P;;US 59498396 A,1995-09-29,"METHOD, APPARATUS, SYSTEM AND FIRMWARE FOR SECURE TRANSACTIONS.","The present invention relates to an electronic module used for secure transactions. More specifically, the electronic module is capable of passing information back and forth between a service provider's equipment via a secure, encrypted technique so that money and other valuable data can be securely passed electronically. The module is capable of being programmed, keeping track of real time, recording transactions for later review, and creating encryption key pairs.",DALLAS SEMICONDUCTOR,CURRY STEPHEN M;;LOOMIS DONALD W;;FOX CHRISTOPHER W,,https://lens.org/165-371-597-556-964,Patent Application,no,0,0,15,19,0,G06Q20/341;;G06Q20/367;;G06Q20/3823;;G06Q20/401;;G06Q20/4093;;G06Q20/40975;;G07F7/0826;;G07F7/1008;;G07F7/1016;;H04L9/3263;;H04L9/3297;;H04L2209/34;;H04L2209/56;;G07F7/10;;G06Q20/401;;G06Q20/341;;G07F7/1008;;G06Q20/40975;;G06Q20/401;;G07F7/1016;;G06Q20/367;;G06Q20/4093;;G06Q20/3823;;G07F7/0826;;H04L2209/34;;H04L2209/56;;H04L9/3297;;H04L9/3263,G06Q20/34;;G06Q20/36;;G06Q20/38;;G06Q20/40;;G07F7/08;;G07F7/10;;G09C1/00,,0,0,,,,EXPIRED
10,CA,A1,CA 2232791 A1,027-002-709-762-571,1997-04-03,1997,CA 2232791 A,1996-09-26,US 451095 P;;US 59498396 A,1995-09-29,"METHOD, APPARATUS, SYSTEM AND FIRMWARE FOR SECURE TRANSACTIONS","The present invention relates to an electronic module used for secure transactions. More specifically, the electronic module is capable of passing information back and forth between a service provider's equipment via a secure, encrypted technique so that money and other valuable data can be securely passed electronically. The module is capable of being programmed, keeping track of real time, recording transactions for later review, and creating encryption key pairs.",DALLAS SEMICONDUCTOR,FOX CHRISTOPHER W;;LOOMIS DONALD W;;CURRY STEPHEN M,,https://lens.org/027-002-709-762-571,Patent Application,no,0,0,15,19,0,G06Q20/341;;G06Q20/367;;G06Q20/3823;;G06Q20/401;;G06Q20/4093;;G06Q20/40975;;G07F7/0826;;G07F7/1008;;G07F7/1016;;H04L9/3263;;H04L9/3297;;H04L2209/34;;H04L2209/56;;G07F7/10;;G06Q20/401;;G06Q20/341;;G07F7/1008;;G06Q20/40975;;G06Q20/401;;G07F7/1016;;G06Q20/367;;G06Q20/4093;;G06Q20/3823;;G07F7/0826;;H04L2209/34;;H04L2209/56;;H04L9/3297;;H04L9/3263,G06Q20/34;;G06Q20/36;;G06Q20/38;;G06Q20/40;;G07F7/08;;G07F7/10;;G09C1/00,,0,0,,,,DISCONTINUED
11,WO,A3,WO 1997/012344 A3,080-515-331-267-469,1997-04-03,1997,US US9615471,1996-09-26,"US 60/0/004,510;;US 8/594,983",1995-09-29,"METHOD, APPARATUS, SYSTEM AND FIRMWARE FOR SECURE TRANSACTIONS","The present invention relates to an electronic module used for secure transactions. More specifically, the electronic module is capable of passing information back and forth between a service provider's equipment via a secure, encrypted technique so that money and other valuable data can be securely passed electronically. The module is capable of being programmed, keeping track of real time, recording transactions for later review, and creating encryption key pairs.",DALLAS SEMICONDUCTOR CORPORATION,"CURRY, Stephen, M.;;LOOMIS, Donald, W.;;FOX, Christopher, W.",,https://lens.org/080-515-331-267-469,Search Report,yes,0,0,1,1,0,,G07F7/08;;G07F7/10,,0,0,,,,UNKNOWN
12,US,B1,US 6237095 B1,129-282-467-707-541,2001-05-22,2001,US 354198 A,1998-01-06,US 354198 A;;US 59501496 A;;US 451095 P,1995-09-29,Apparatus for transfer of secure information between a data carrying module and an electronic device,"The present invention relates to an electronic module used for secure transactions. More specifically, the electronic module is capable of passing encrypted information back and forth between a service provider's equipment via a secure, encrypted technique so that money and other valuable data can be securely passed electronically. The module is capable of being programmed, keeping track of real time, recording transactions for later review, and creating encryption key pairs.",DALLAS SEMICONDUCTOR,CURRY STEPHEN M;;LOOMIS DONALD W;;FOX CHRISTOPHER W,DALLAS SEMICONDUCTOR CORPORATION (1999-07-15),https://lens.org/129-282-467-707-541,Granted Patent,yes,8,177,2,19,0,G06Q20/06;;G06Q20/06;;G06Q20/341;;G06Q20/341;;G06Q20/3672;;G06Q20/3672;;G06Q20/3823;;G06Q20/3823;;G06Q20/4093;;G06Q20/4093;;G06Q20/40975;;G06Q20/40975;;G07F7/1008;;G07F7/1008;;G07F7/1016;;G07F7/1016;;H04L9/3249;;H04L9/3249;;H04L9/3263;;H04L9/3263;;H04L2209/34;;H04L2209/34;;H04L2209/56;;H04L2209/56,G06Q20/06;;G06Q20/34;;G06Q20/36;;G06Q20/38;;G06Q20/40;;G07F7/08;;G07F7/10;;H04L9/32,713/178,0,0,,,,EXPIRED
13,CN,A,CN 1198233 A,124-058-264-900-140,1998-11-04,1998,CN 96197307 A,1996-09-26,US 451095 P;;US 59498396 A,1995-09-29,"Method, apparatus, system and firmware for secure transactions",,DALLAS SEMICONDUCTOR,CURRY STEPHEN M;;LOOMIS DONALD W;;FOX CHRISTOPHER W,,https://lens.org/124-058-264-900-140,Patent Application,no,0,4,15,19,0,G06Q20/341;;G06Q20/367;;G06Q20/3823;;G06Q20/401;;G06Q20/4093;;G06Q20/40975;;G07F7/0826;;G07F7/1008;;G07F7/1016;;H04L9/3263;;H04L9/3297;;H04L2209/34;;H04L2209/56;;G07F7/10;;G06Q20/401;;G06Q20/341;;G07F7/1008;;G06Q20/40975;;G06Q20/401;;G07F7/1016;;G06Q20/367;;G06Q20/4093;;G06Q20/3823;;G07F7/0826;;H04L2209/34;;H04L2209/56;;H04L9/3297;;H04L9/3263,G06Q20/34;;G06Q20/36;;G06Q20/38;;G06Q20/40;;G07F7/08;;G07F7/10;;G09C1/00,,0,0,,,,DISCONTINUED
14,EP,A2,EP 1020821 A2,154-233-118-600-864,2000-07-19,2000,EP 00109707 A,1996-09-26,EP 96935993 A;;US 451095 P;;US 59498396 A,1995-09-29,"Method, apparatus, system and firmware for secure transactions","The present invention relates to an electronic module used for secure transactions. More specifically, the electronic module is capable of passing information back and forth between a service provider's equipment via a secure, encrypted technique so that money and other valuable data can be securely passed electronically. The module is capable of being programmed, keeping track of real time, recording transactions for later review, and creating encryption key pairs.",DALLAS SEMICONDUCTOR,CURRY STEPHEN M;;LOOMIS DONALD W;;FOX CHRISTOPHER W,,https://lens.org/154-233-118-600-864,Patent Application,yes,0,0,2,19,0,G06Q20/341;;G06Q20/3823;;G06Q20/4093;;G06Q20/40975;;G07F7/1008;;G07F7/1016;;H04L9/3249;;H04L9/3263;;H04L9/3297;;H04L2209/34;;H04L2209/56,G07F7/10,,0,0,,,,DISCONTINUED
15,US,A,US 6105013 A,171-981-095-359-78X,2000-08-15,2000,US 4119098 A,1998-03-10,US 4119098 A;;US 59498396 A;;US 451095 P,1995-09-29,"Method, apparatus, system and firmware for secure transactions","The present invention relates to an electronic module used for secure transactions. More specifically, the electronic module is capable of passing information back and forth between a service provider's equipment via a secure, encrypted technique so that money and other valuable data can be securely passed electronically. The module is capable of being programmed, keeping track of real time, recording transactions for later review, and creating encryption key pairs.",DALLAS SEMICONDUCTOR,CURRY STEPHEN M;;LOOMIS DONALD W;;FOX CHRISTOPHER W,DALLAS SEMICONDUCTOR CORPORATION (1996-04-12),https://lens.org/171-981-095-359-78X,Granted Patent,yes,12,329,15,19,0,G06Q20/341;;G06Q20/367;;G06Q20/3823;;G06Q20/401;;G06Q20/4093;;G06Q20/40975;;G07F7/0826;;G07F7/1008;;G07F7/1016;;H04L9/3263;;H04L9/3297;;H04L2209/34;;H04L2209/56;;G07F7/10;;G06Q20/401;;G06Q20/341;;G07F7/1008;;G06Q20/40975;;G06Q20/401;;G07F7/1016;;G06Q20/367;;G06Q20/4093;;G06Q20/3823;;G07F7/0826;;H04L2209/34;;H04L2209/56;;H04L9/3297;;H04L9/3263,G06Q20/34;;G06Q20/36;;G06Q20/38;;G06Q20/40;;G07F7/08;;G07F7/10;;G09C1/00,705/65;;235/379;;380/30;;705/75;;713/156;;713/173;;713/174,13,0,,,"Federal Information Processing Standards Publication, (FIPS PUB) 186, Digital Signatur Standard (DDS), Issued: May 19, 1994.;;Federal Information Processing Standards Publication, (FIPS PUB) 190 1, Secure Hash Standard, Issued: May 31, 1994.;;Microsoft Corporation s Secure Transaction Technology, STT Wire Formats and Protoc version 0.902, Oct. 5, 1995.;;Matonis, Jon W., Digital Cash and Monetary Freedom, http://www.info.isoc.org/HMP/PAPER/136/html/paper.html, as of Apr. 1995.;;MasterCard, Secure Electronic Payment Protocol, Draft Version 1.1, Sep. 29, 1995.;;MasterCard, Secure Electronic Payment Protocol, Part 2; Functional Specifications, Draft Version 1.1, Sep. 29, 1995.;;MasterCard, Secure Electronic Payment Protocol, Part 3; Payment System Specification, Draft Version 1.1, Sep. 29, 1995.;;MasterCard, Secure Electronic Payment Protocol, Part 4; Certificate Management Specification, Draft Version 1.1, Sep. 29, 1995.;;SGS Thomson Microelectronics, CMOS Crypto Computer Family, Advance Datasheet ST16xF74, Oct., 1993.;;SGS Thomson Microelectronics, CMOS MCU Based Safeguarded Smartcard IC with Modular Aritmetic Processor, Advanced Data Sheet, ST16CF54, Sep. 1994.;;Micro Card, CP8 Products Crypto Card, Jan. 25, 1995.;;Wayner, Peter, Digital Ca$h, Commerce on the Net, Chpt. 3 & 10 and Appendix B, Jun. 1995.;;Schneier, Bruce, Applied Cryptography, Chpt. 19, pp. 461 482, 1996.",EXPIRED
16,US,A,US 5748740 A,078-951-544-711-075,1998-05-05,1998,US 59498396 A,1996-01-31,US 59498396 A;;US 451095 P,1995-09-29,"Method, apparatus, system and firmware for secure transactions","The present invention relates to an electronic module used for secure transactions. More specifically, the electronic module is capable of passing information back and forth between a service provider's equipment via a secure, encrypted technique so that money and other valuable data can be securely passed electronically. The module is capable of being programmed, keeping track of real time, recording transactions for later review, and creating encryption key pairs.",DALLAS SEMICONDUCTOR,CURRY STEPHEN M;;LOOMIS DONALD W;;FOX CHRISTOPHER W,DALLAS SEMICONDUCTOR CORPORATION (1996-04-12);;MAXIM INTEGRATED PRODUCTS INC (2008-06-09),https://lens.org/078-951-544-711-075,Granted Patent,yes,11,200,15,19,0,G06Q20/341;;G06Q20/367;;G06Q20/3823;;G06Q20/401;;G06Q20/4093;;G06Q20/40975;;G07F7/0826;;G07F7/1008;;G07F7/1016;;H04L9/3263;;H04L9/3297;;H04L2209/34;;H04L2209/56;;G07F7/10;;G06Q20/401;;G06Q20/341;;G07F7/1008;;G06Q20/40975;;G06Q20/401;;G07F7/1016;;G06Q20/367;;G06Q20/4093;;G06Q20/3823;;G07F7/0826;;H04L2209/34;;H04L2209/56;;H04L9/3297;;H04L9/3263,G06Q20/34;;G06Q20/36;;G06Q20/38;;G06Q20/40;;G07F7/08;;G07F7/10;;G09C1/00,380/25;;380/9;;380/21;;380/23;;380/24;;380/30;;380/49;;380/50;;235/379,13,0,,,"Federal Information Processing Standards Publication, (FIPS PUB) 186, Digital Signature Standard ( DDS ), Issued: May 19, 1994.;;Federal Information Processing Standards Publication, (FIPS PUB) 190 1, Secure Hash Standard , Issued: May 31, 1994.;;Microsoft Corporation s Secure Transaction Technology, STT Wire Formats and Protocols , version 0.902, Oct. 5, 1995.;;Matonis, Jon W., Digital Cash and Monetary Freedom , http://www.info.isoc.org/HMP/PAPER/136/html/paper.html, as of Apr. 1995.;;MasterCard, Secure Electronic Payment Protocol , Draft Version 1.1, Sep. 29, 1995.;;MasterCard, Secure Electronic Payment Protocol, Part 2; Functional Specifications , Draft Version 1.1, Sep. 29, 1995.;;MasterCard, Secure Electronic Payment Protocol, Part 3: Payment System Specification , Draft Version 1.1, Sep. 29, 1995.;;MasterCard, Secure Electronic Payment Protocol, Part 4: Certificate Management Specification , Draft Version 1.1, Sep. 29, 1995.;;SGS Thomson Microelectronics, CMOS Crypto Computer Family , Advance Datasheet, ST16xF74, Oct. 1993.;;SGS Thomson Microelectronics, CMOS MCU Based Safeguarded Smartcard IC with Modular Aritmetic Processor , Advanced Data Sheet, ST16CF54, Sep. 1994.;;Micro Card, CP8 Products Crypto Card , January 25, 1995.;;Wayner, Peter, Digital Ca$h, Commerce on the Net , Chpt. 3 & 10 and Appendix B, Jun., 1995.;;Schneier, Bruce, Applied Cryptography , Chpt. 19, pp. 461 482, 1996.",EXPIRED
17,AU,B2,AU 702508 B2,011-479-298-693-862,1999-02-25,1999,AU 1996/073745 A,1996-09-26,US 451095 P;;US 59498396 A;;US 9615471 W,1995-09-29,"Method, apparatus, system and firmware for secure transactions",,DALLAS SEMICONDUCTOR,CURRY STEPHEN M;;LOOMIS DONALD W;;FOX CHRISTOPHER W,,https://lens.org/011-479-298-693-862,Granted Patent,no,3,0,15,19,0,G06Q20/341;;G06Q20/367;;G06Q20/3823;;G06Q20/401;;G06Q20/4093;;G06Q20/40975;;G07F7/0826;;G07F7/1008;;G07F7/1016;;H04L9/3263;;H04L9/3297;;H04L2209/34;;H04L2209/56;;G07F7/10;;G06Q20/401;;G06Q20/341;;G07F7/1008;;G06Q20/40975;;G06Q20/401;;G07F7/1016;;G06Q20/367;;G06Q20/4093;;G06Q20/3823;;G07F7/0826;;H04L2209/34;;H04L2209/56;;H04L9/3297;;H04L9/3263,G06Q20/34;;G06Q20/36;;G06Q20/38;;G06Q20/40;;G07F7/08;;G07F7/10;;G09C1/00,,0,0,,,,EXPIRED
18,ID,A,ID 22323 A,056-558-994-161-155,1999-09-30,1999,ID 980458 A,1998-03-30,ID 980458 A,1998-03-30,METODE ALAT SISTIM DAN PERANGKAT KERAS UNTUK MENJAMIN PELAKSANAAN TRANSAKSI,,DALLAS SEMICONDUCTOR,CURRY STEPHEN M;;LOOMIS DONALD W;;FOX CHRISTOPHER W,,https://lens.org/056-558-994-161-155,Patent Application,no,0,0,1,1,0,,G06F17/30,,0,0,,,,PENDING
19,US,A,US 5805702 A,197-994-506-015-727,1998-09-08,1998,US 59501496 A,1996-01-31,US 59501496 A;;US 451095 P,1995-09-29,"Method, apparatus, and system for transferring units of value","The present invention relates to an electronic module used for secure transactions. More specifically, the electronic module is capable of passing encrypted information back and forth between a service provider's equipment via a secure, encrypted technique so that money and other valuable data can be securely passed electronically. The module is capable of being programmed, keeping track of real time, recording transactions for later review, and creating encryption key pairs.",DALLAS SEMICONDUCTOR,CURRY STEPHEN M;;LOOMIS DONALD W;;FOX CHRISTOPHER W,DALLAS SEMICONDUCTOR CORPORATION (1996-04-12),https://lens.org/197-994-506-015-727,Granted Patent,yes,3,171,2,19,0,G06Q20/06;;G06Q20/06;;G06Q20/341;;G06Q20/341;;G06Q20/3672;;G06Q20/3672;;G06Q20/3823;;G06Q20/3823;;G06Q20/4093;;G06Q20/4093;;G06Q20/40975;;G06Q20/40975;;G07F7/1008;;G07F7/1008;;G07F7/1016;;G07F7/1016;;H04L9/3249;;H04L9/3249;;H04L9/3263;;H04L9/3263;;H04L2209/34;;H04L2209/34;;H04L2209/56;;H04L2209/56,G06Q20/06;;G06Q20/34;;G06Q20/36;;G06Q20/38;;G06Q20/40;;G07F7/08;;G07F7/10;;H04L9/32,380/24,0,0,,,,EXPIRED
20,TR,T1,TR 199800565 T1,045-308-933-574-705,1998-06-22,1998,TR 9800565 T,1996-09-26,US 451095 P;;US 59498396 A,1995-09-29,"Güvenli parasal islemleri gerçeklestirmeye mahsus yöntem, cihaz, sistem ve bellenim.","Bulus parasal islemleri güvenli bir sekilde gerçeklestirmekte kullanilan bir elektronik modül ile ilgilidir. Daha özgül olarak bu elektronik modül, paranin ve diger degerli verilerin elektronik olarak güvenli bir sekilde aktarilabilmesi için sifrelenmis, güvenli bir teknik yoluyla enformasyonun bir servis saglayicisinin ekipmaninda alinip verilmesini saglamaktadir. Modül programlanabilmekte, gerçek zamanda çalismakta, islemleri daha sonra gözden geçirilebilecek sekilde kayda geçirmekte ve sifre anahtar çiftleri meydana getirmektedir.",DALLAS SEMICONDUCTOR,CURRY STEPHEN M;;LOOMIS DONALD W;;FOX CHRISTOPHER W,,https://lens.org/045-308-933-574-705,Patent Application,no,0,0,15,19,0,G06Q20/341;;G06Q20/367;;G06Q20/3823;;G06Q20/401;;G06Q20/4093;;G06Q20/40975;;G07F7/0826;;G07F7/1008;;G07F7/1016;;H04L9/3263;;H04L9/3297;;H04L2209/34;;H04L2209/56;;G07F7/10;;G06Q20/401;;G06Q20/341;;G07F7/1008;;G06Q20/40975;;G06Q20/401;;G07F7/1016;;G06Q20/367;;G06Q20/4093;;G06Q20/3823;;G07F7/0826;;H04L2209/34;;H04L2209/56;;H04L9/3297;;H04L9/3263,G06Q20/34;;G06Q20/36;;G06Q20/38;;G06Q20/40;;G07F7/08;;G07F7/10;;G09C1/00,,0,0,,,,PENDING
21,EP,A3,EP 1020821 A3,078-285-528-705-722,2000-08-02,2000,EP 00109707 A,1996-09-26,EP 96935993 A;;US 451095 P;;US 59498396 A,1995-09-29,"Method, apparatus, system and firmware for secure transactions","The present invention relates to an electronic module used for secure transactions. More specifically, the electronic module is capable of passing information back and forth between a service provider's equipment via a secure, encrypted technique so that money and other valuable data can be securely passed electronically. The module is capable of being programmed, keeping track of real time, recording transactions for later review, and creating encryption key pairs.",DALLAS SEMICONDUCTOR,CURRY STEPHEN M;;LOOMIS DONALD W;;FOX CHRISTOPHER W,,https://lens.org/078-285-528-705-722,Search Report,yes,5,0,2,19,0,G06Q20/341;;G06Q20/3823;;G06Q20/4093;;G06Q20/40975;;G07F7/1008;;G07F7/1016;;H04L9/3249;;H04L9/3263;;H04L9/3297;;H04L2209/34;;H04L2209/56,G07F7/10,,0,0,,,,DISCONTINUED
22,EP,A2,EP 0862769 A2,171-450-547-778-131,1998-09-09,1998,EP 96935993 A,1996-09-26,US 451095 P;;US 59498396 A;;US 9615471 W,1995-09-29,"METHOD, APPARATUS, SYSTEM AND FIRMWARE FOR SECURE TRANSACTIONS",,DALLAS SEMICONDUCTOR,CURRY STEPHEN M;;LOOMIS DONALD W;;FOX CHRISTOPHER W,,https://lens.org/171-450-547-778-131,Patent Application,yes,0,0,15,19,0,G06Q20/341;;G06Q20/367;;G06Q20/3823;;G06Q20/401;;G06Q20/4093;;G06Q20/40975;;G07F7/0826;;G07F7/1008;;G07F7/1016;;H04L9/3263;;H04L9/3297;;H04L2209/34;;H04L2209/56;;G07F7/10;;G06Q20/401;;G06Q20/341;;G07F7/1008;;G06Q20/40975;;G06Q20/401;;G07F7/1016;;G06Q20/367;;G06Q20/4093;;G06Q20/3823;;G07F7/0826;;H04L2209/34;;H04L2209/56;;H04L9/3297;;H04L9/3263,G06Q20/34;;G06Q20/36;;G06Q20/38;;G06Q20/40;;G07F7/08;;G07F7/10;;G09C1/00,,0,0,,,,DISCONTINUED
23,US,A,US 5572195 A,132-492-891-091-356,1996-11-05,1996,US 28383294 A,1994-08-01,US 28383294 A,1994-08-01,Sensory and control system for local area networks,"An object location, control, and tracking system is implemented using an object identifier variable-based protocol such as SNMP. Infrared sensors, touch memory ports, passive infrared sensors, and external device controllers are all accessed using object identifier variables and in this way stimuli events are reported to a computer on the network, and the external devices are controlled responsive to the stimuli.",PRECISION TRACKING FM INC,HELLER ALAN C;;SPRINGMEYER STEVEN;;FOX CHRISTOPHER W,PRECISION TRACKING FM INC (1994-11-22);;FRESHLOC TECHNOLOGIES INC (2000-03-09),https://lens.org/132-492-891-091-356,Granted Patent,yes,6,242,1,1,0,H04L41/0213;;H04L41/0213;;H04L41/26;;H04L41/26,H04L12/24,340/825.35;;340/825.44;;342/451,0,0,,,,EXPIRED
24,US,S,US D0535401 S,125-303-796-913-543,2007-01-16,2007,US 23254205 F,2005-06-21,US 23254205 F,2005-06-21,Heat and light therapy device,,BIOCARE SYSTEMS INC,TRAVIS LEE W;;WRIGHT DAVID W;;ANDREWS CHRISTOPHER;;FOX SHERRY,BIOCARE SYSTEMS INC (2005-06-21),https://lens.org/125-303-796-913-543,Design Right,yes,9,39,1,1,0,,,2803;;D24/210;;D24/206,0,0,,,,EXPIRED
25,US,S,US D0530821 S,186-183-810-021-55X,2006-10-24,2006,US 23256905 F,2005-06-21,US 23256905 F,2005-06-21,Heat and light therapy device,,BIOCARE SYSTEMS INC,TRAVIS LEE W;;WRIGHT DAVID W;;FOX SHERRY;;ANDREWS CHRISTOPHER,BIOCARE SYSTEMS INC (2005-06-21),https://lens.org/186-183-810-021-55X,Design Right,no,0,2,1,1,0,,,2803;;D24/210;;D24/206,0,0,,,,EXPIRED
26,US,S,US D0529618 S,109-110-221-429-688,2006-10-03,2006,US 23256805 F,2005-06-21,US 23256805 F,2005-06-21,Heat and light therapy device,,BIOCARE SYSTEMS INC,TRAVIS LEE W;;ANDREWS CHRISTOPHER;;WRIGHT DAVID W;;FOX SHERRY,BIOCARE SYSTEMS INC (2005-06-21),https://lens.org/109-110-221-429-688,Design Right,no,0,3,1,1,0,,,2803;;D24/210;;D24/206,0,0,,,,EXPIRED
27,US,S,US D0536457 S,175-946-682-414-669,2007-02-06,2007,US 23255205 F,2005-06-21,US 23255205 F,2005-06-21,Heat and light therapy device,,BIOCARE SYSTEMS INC,ANDREWS CHRISTOPHER;;TRAVIS LEE W;;WRIGHT DAVID W;;FOX SHERRY,BIOCARE SYSTEMS INC (2005-06-21),https://lens.org/175-946-682-414-669,Design Right,yes,9,0,1,1,0,,,2803;;D24/210;;D24/206,0,0,,,,EXPIRED
28,US,A,US 5355222 A,145-532-622-213-437,1994-10-11,1994,US 88407692 A,1992-05-15,US 88407692 A,1992-05-15,Optical receiver for area location system,"An optical location system for locating the position of a moving object in a defined area. An optical transmitter is attached to the moving object. A stationary receiver has a number of sensors for receiving a signal from the transmitter. One sensor has a field of view of the entire area. Other sensors have partially blocked fields of view, with the blocking being accomplished with nonopaque strips of decreasing width. These strips are arranged so that the detection or nondetection of light by the sensors can be digitally coded in a manner that corresponds to sections of the area.",PRECISION TRACKING FM INC,HELLER ALAN C;;FOX CHRISTOPHER W;;OLIVIER PHILIP D,FRESHLOC TECHNOLOGIES INC (2000-03-09);;PRECISION TRACKING FM INC. A TX CORP (1992-05-12),https://lens.org/145-532-622-213-437,Granted Patent,yes,18,97,7,7,0,G01B1/00;;G01S3/7835;;G01S3/7835;;G01S3/784;;G01S3/784,G01C1/00;;G01B11/00;;G01C15/00;;G01S3/783;;G01S3/784,356/375;;250/561,0,0,,,,EXPIRED
29,US,A1,US 2006/0049833 A1,014-341-200-889-38X,2006-03-09,2006,US 94365504 A,2004-09-08,US 94365504 A,2004-09-08,System and method for monitoring piezoelectric material performance,A system and method are provided for monitoring performance capacity of a piezoelectric material that may form part of an actuator or sensor device. A switch is used to selectively electrically couple an inductor to the piezoelectric material to form an inductor-capacitor circuit. Resonance is induced in the inductor-capacitor circuit when the switch is operated to create the circuit. The resonance of the inductor-capacitor circuit is monitored with the frequency of the resonance being indicative of performance capacity of the device's piezoelectric material.,NASA,MOSES ROBERT W;;FOX ROBERT L;;CHATTIN RICHARD L;;SHAMS QAMAR A;;FOX CHRISTOPHER L;;FOX MELANIE L,UNITED STATES OF AMERICA AS REPRESENTED BY THE ADMINISTRATOR OF THE NATIONAL AERONAUTICS AND SPACE ADMINISTRATION (2005-01-05),https://lens.org/014-341-200-889-38X,Patent Application,yes,9,4,4,4,0,G01H13/00;;G01R29/22;;G01R29/22;;G01H13/00,G01N27/00,324/633;;324/71.1,0,0,,,,INACTIVE
30,WO,A1,WO 2023/168010 A1,109-762-038-338-183,2023-09-07,2023,US 2023/0014393 W,2023-03-02,US 202263315798 P,2022-03-02,AUTHENTICATION OF CONSUMER PREMISE EQUIPMENT,In one embodiment a distribution system includes customer premise equipment that is authenticated to a network that includes a cable modem termination system based upon a DOCSIS authentication. The customer premise equipment receives data from a supplicant device that is interconnected to the network through the customer premise equipment where the supplicant device is authenticated to the network based upon an 802.1X authentication.,ARRIS ENTPR LLC,BEAN JANET T;;FOX CHRISTOPHER W;;LANE BRIAN W;;TOMOMATSU KAZUHIKO;;BARAN DAVID FRANKLIN,,https://lens.org/109-762-038-338-183,Patent Application,yes,3,0,2,2,0,H04L63/0869;;H04L63/0892;;H04L63/0876;;H04L63/162;;G06F21/45;;H04W12/69;;H04W12/06;;H04N21/6118;;H04N21/6168;;H04N21/25816;;H04H20/78;;H04L63/0876,H04L9/40;;G06F21/45;;H04N21/61;;H04W12/06;;H04W12/69,,1,0,,,"""Data-Over-Cable Service Interface Specifications DCA - MHAv2"", 17 February 2020 (2020-02-17), pages 1 - 445, XP044289252, Retrieved from the Internet <URL:www.itu.int/ifa/t/2017/sg9/docs/c/ties/T17-SG09-C-0113!!ZIP-E.zip DOCSIS%20MHAv2/CM-SP-R-PHY-I13-190912.pdf> [retrieved on 20200217]",PENDING
31,US,A1,US 2023/0283605 A1,148-350-506-423-527,2023-09-07,2023,US 202318116767 A,2023-03-02,US 202318116767 A;;US 202263315798 P,2022-03-02,AUTHENTICATION OF CONSUMER PREMISE EQUIPMENT,In one embodiment a distribution system includes customer premise equipment that is authenticated to a network that includes a cable modem termination system based upon a DOCSIS authentication. The customer premise equipment receives data from a supplicant device that is interconnected to the network through the customer premise equipment where the supplicant device is authenticated to the network based upon an 802.1X authentication.,ARRIS ENTPR LLC,BEAN JANET T;;FOX CHRISTOPHER W;;LANE BRIAN W;;TOMOMATSU KAZUHIKO;;BARAN DAVID FRANKLIN,ARRIS ENTERPRISES LLC (2023-03-07),https://lens.org/148-350-506-423-527,Patent Application,yes,0,0,2,2,0,H04L63/0869;;H04L63/0892;;H04L63/0876;;H04L63/162;;G06F21/45;;H04W12/69;;H04W12/06;;H04N21/6118;;H04N21/6168;;H04N21/25816;;H04H20/78;;H04L63/0876,H04L9/40;;H04H20/78,,0,0,,,,PENDING
32,WO,A3,WO 2006/091470 A3,024-762-810-950-553,2008-11-27,2008,US 2006/0005487 W,2006-02-15,US 6732305 A;;US 26674705 A,2005-02-23,IMPROVED HALOHYDRIN DEHALOGENASES AND RELATED POLYNUCLEOTIDES,"The present invention relates to novel halohydrin dehalogenase polypeptides and the polynucleotides that encode them. These polypeptides are useful in the production of 4-substituted-3-butyric acid derivatives and vicinal cyano, hydroxyl substituted carboxylic acid esters. The invention also provides related vectors, host cells and methods.",CODEXIS INC;;GAVRILOVIC VESNA;;DAVIS S CHRISTOPHER;;FOX RICHARD JOHN;;HUISMAN GJALT W;;MUNDORFF EMILY C;;NEWMAN LISA M;;FOX RICHARD,DAVIS S CHRISTOPHER;;FOX RICHARD JOHN;;HUISMAN GJALT W;;MUNDORFF EMILY C;;NEWMAN LISA M;;FOX RICHARD,,https://lens.org/024-762-810-950-553,Search Report,yes,1,0,9,29,2848,C12N9/14;;C12N9/14;;C12N9/88;;C12N9/88,C12N9/88;;C07H21/04;;C12N1/21;;C12N9/04;;C12N9/14;;C12N15/60;;C12N15/74;;C12P21/06;;C12Q1/68,,2,1,166-958-105-502-652,10.1016/s0957-4166(02)00222-7,"SPELLBERG J. ET AL.: ""Exploration of biocatalytic potential of halohydrin dehydrogenase using chromogenic substrates"", TETRAHEDRON ASYMMETRY, vol. 13, no. 10, 2002, pages 1083 - 1089, XP004368411;;See also references of EP 1859057A4",PENDING
33,EP,A2,EP 1859057 A2,067-723-037-397-911,2007-11-28,2007,EP 06735244 A,2006-02-15,US 2006/0005487 W;;US 6732305 A;;US 26674705 A,2005-02-23,IMPROVED HALOHYDRIN DEHALOGENASES AND RELATED POLYNUCLEOTIDES,,CODEXIS INC,DAVIS S CHRISTOPHER;;FOX RICHARD JOHN;;HUISMAN GJALT W;;MUNDORFF EMILY C;;NEWMAN LISA M;;FOX RICHARD,,https://lens.org/067-723-037-397-911,Patent Application,yes,0,0,9,29,2848,C12N9/14;;C12N9/14;;C12N9/88;;C12N9/88,C12N9/88;;C07H21/04;;C12N1/21;;C12N9/04;;C12N9/14;;C12N15/60;;C12N15/74;;C12P21/06;;C12Q1/68,,0,0,,,,DISCONTINUED
34,EP,A4,EP 1859057 A4,138-441-256-788-312,2009-08-19,2009,EP 06735244 A,2006-02-15,US 2006/0005487 W;;US 6732305 A;;US 26674705 A,2005-02-23,IMPROVED HALOHYDRIN DEHALOGENASES AND RELATED POLYNUCLEOTIDES,,CODEXIS INC,DAVIS S CHRISTOPHER;;FOX RICHARD JOHN;;HUISMAN GJALT W;;MUNDORFF EMILY C;;NEWMAN LISA M;;FOX RICHARD,,https://lens.org/138-441-256-788-312,Search Report,no,4,1,9,29,0,C12N9/14;;C12N9/88;;C12N9/14;;C12N9/88,C12N9/88;;C07H21/04;;C12N1/21;;C12N9/04;;C12N9/14;;C12N15/60;;C12N15/74;;C12P21/06;;C12Q1/68,,1,1,016-450-308-736-102,17322872;;10.1038/nbt1286,"FOX RICHARD J ET AL: ""Improving catalytic function by ProSAR-driven enzyme evolution"", NATURE BIOTECHNOLOGY, NATURE PUBLISHING GROUP, NEW YORK, NY, US, vol. 25, no. 3, 1 March 2007 (2007-03-01), pages 338 - 344, XP002566179, ISSN: 1087-0156, [retrieved on 20070218], DOI: 10.1038/NBT1286",DISCONTINUED
35,WO,A8,WO 2006/091470 A8,008-936-508-490-012,2012-11-29,2012,US 2006/0005487 W,2006-02-15,US 6732305 A;;US 26674705 A,2005-02-23,IMPROVED HALOHYDRIN DEHALOGENASES AND RELATED POLYNUCLEOTIDES,"The present invention relates to novel halohydrin dehalogenase polypeptides and the polynucleotides that encode them. These polypeptides are useful in the production of 4-substituted-3-butyric acid derivatives and vicinal cyano, hydroxyl substituted carboxylic acid esters. The invention also provides related vectors, host cells and methods.",CODEXIS INC;;DAVIS S CHRISTOPHER;;FOX RICHARD JOHN;;HUISMAN GJALT W;;GAVRILOVIC VESNA;;MUNDORFF EMILY C;;NEWMAN LISA M;;FOX RICHARD,DAVIS S CHRISTOPHER;;FOX RICHARD JOHN;;HUISMAN GJALT W;;MUNDORFF EMILY C;;NEWMAN LISA M;;FOX RICHARD,,https://lens.org/008-936-508-490-012,Amended Application,yes,0,0,9,29,2848,C12N9/14;;C12N9/14;;C12N9/88;;C12N9/88,C12N9/88;;C07H21/04;;C12N1/21;;C12N9/04;;C12N9/14;;C12N15/60;;C12N15/74;;C12P21/06;;C12Q1/68,,0,0,,,,PENDING
36,WO,A2,WO 2006/091470 A2,147-269-544-045-85X,2006-08-31,2006,US 2006/0005487 W,2006-02-15,US 6732305 A;;US 26674705 A,2005-02-23,IMPROVED HALOHYDRIN DEHALOGENASES AND RELATED POLYNUCLEOTIDES,"The present invention relates to novel halohydrin dehalogenase polypeptides and the polynucleotides that encode them. These polypeptides are useful in the production of 4-substituted-3-butyric acid derivatives and vicinal cyano, hydroxyl substituted carboxylic acid esters. The invention also provides related vectors, host cells and methods.",CODEXIS INC;;GAVRILOVIC VESNA;;DAVIS S CHRISTOPHER;;FOX RICHARD JOHN;;HUISMAN GJALT W;;MUNDORFF EMILY C;;NEWMAN LISA M;;FOX RICHARD,DAVIS S CHRISTOPHER;;FOX RICHARD JOHN;;HUISMAN GJALT W;;MUNDORFF EMILY C;;NEWMAN LISA M;;FOX RICHARD,,https://lens.org/147-269-544-045-85X,Patent Application,yes,0,5,9,29,2848,C12N9/14;;C12N9/88;;C12N9/14;;C12N9/88,C12Q1/68;;C07H21/04;;C12N1/21;;C12N9/04;;C12N9/14;;C12N9/88;;C12N15/60;;C12N15/74,,0,0,,,,PENDING
37,US,A1,US 2012/0054099 A1,010-202-761-366-76X,2012-03-01,2012,US 80692010 A,2010-08-24,US 80692010 A,2010-08-24,Method and system for virtual processing of checks deposited in automated teller machines,"A system and method enable receipt of check deposits, and other transactions, at a remote terminal such as an automated teller machine (ATM). The ATM images the checks and sends the images and associated account and transaction information to a manager server. The manager server creates a virtual deposit slip for each transaction, and batches one or more transactions for further processing at a work station. The manager server sends the batches, which may include images, transaction data, and virtual deposit slips, to a work station. A teller may view the batches, perform verification and correction activities, and scan the batches using an emulated scanner that is part of the work station software. The virtually scanned batches may be sent to an additional processing system or to a clearing center.",FOX JAMES H;;ALLEN JEFFREY B;;DEBRECHT CHRISTOPHER K;;SIMMS JAMES W;;ABC COIN SORTING COUNTING SUPPLY INC,FOX JAMES H;;ALLEN JEFFREY B;;DEBRECHT CHRISTOPHER K;;SIMMS JAMES W,ABC COIN SORTING COUNTING SUPLLY INC (2010-08-17),https://lens.org/010-202-761-366-76X,Patent Application,yes,2,15,1,1,0,G06Q20/1085;;G06Q20/1085;;G06Q40/02;;G06Q40/02,G06Q40/00,705/43,0,0,,,,DISCONTINUED
38,SG,A1,SG 127837 A1,108-438-745-468-568,2006-12-29,2006,SG 200603352 A,2006-05-23,US 14122905 A,2005-05-31,System and method for information handling system custom application ordering and installation,Replacement of legacy information handling systems at a deployment site is automatically managed in cooperation with an information handling system manufacture site by coordinating the building of replacement information handling systems with appropriate configurations. An asset discovery tool interfaces with the legacy information handling systems through a deployment site network to discover the configurations of the legacy systems and communicates the legacy configurations to the manufacture site. An asset translation engine translates the legacy configurations to replacement configurations for building the replacement information handling systems. The ordering of replacement systems and the translation to the replacement configuration is managed by rules defined through an order tool of the deployment site and may include applications packaged at the deployment site and communicated to the manufacture site for installation on the replacement systems.,DELL PRODUCTS LP,RALEY JEFFERSON;;COX TIM W;;FOX STACEY;;HANES KEVIN;;HARDING CHRISTOPHER;;RONES CRAIG,,https://lens.org/108-438-745-468-568,Patent Application,no,0,0,13,13,0,H04L41/022;;H04L41/0816;;H04L67/1095;;G06F16/40;;G16Z99/00;;G06F17/00;;G06F30/18;;H04L41/0816;;H04L41/12;;H04L41/022;;H04L67/1095,,,0,0,,,,PENDING
39,US,A1,US 2006/0288093 A1,109-015-735-863-70X,2006-12-21,2006,US 14122905 A,2005-05-31,US 14122905 A,2005-05-31,System and method for information handling system custom application ordering and installation,Replacement of legacy information handling systems at a deployment site is automatically managed in cooperation with an information handling system manufacture site by coordinating the building of replacement information handling systems with appropriate configurations. An asset discovery tool interfaces with the legacy information handling systems through a deployment site network to discover the configurations of the legacy systems and communicates the legacy configurations to the manufacture site. An asset translation engine translates the legacy configurations to replacement configurations for building the replacement information handling systems. The ordering of replacement systems and the translation to the replacement configuration is managed by rules defined through an order tool of the deployment site and may include applications packaged at the deployment site and communicated to the manufacture site for installation on the replacement systems.,RALEY JEFFERSON;;COX TIM W;;FOX STACEY;;HANES KEVIN;;HARDING CHRISTOPHER;;RONES CRAIG,RALEY JEFFERSON;;COX TIM W;;FOX STACEY;;HANES KEVIN;;HARDING CHRISTOPHER;;RONES CRAIG,DELL PRODUCTS L.P (2005-05-05),https://lens.org/109-015-735-863-70X,Patent Application,yes,6,19,13,13,0,H04L41/022;;H04L41/0816;;H04L67/1095;;G06F16/40;;G16Z99/00;;G06F17/00;;G06F30/18;;H04L41/0816;;H04L41/12;;H04L41/022;;H04L67/1095,G06F15/173,709/223,0,0,,,,DISCONTINUED
40,TW,A,TW 200709610 A,122-894-024-184-238,2007-03-01,2007,TW 95118427 A,2006-05-24,US 14122905 A,2005-05-31,System and method for information handling system custom application ordering and installation,Replacement of legacy information handling systems at a deployment site is automatically managed in cooperation with an information handling system manufacture site by coordinating the building of replacement information handling systems with appropriate configurations. An asset discovery tool interfaces with the legacy information handling systems through a deployment site network to discover the configurations of the legacy systems and communicates the legacy configurations to the manufacture site. An asset translation engine translates the legacy configurations to replacement configurations for building the replacement information handling systems. The ordering of replacement systems and the translation to the replacement configuration is managed by rules defined through an order tool of the deployment site and may include applications packaged at the deployment site and communicated to the manufacture site for installation on the replacement systems.,DELL PRODUCTS LP,RALEY JEFFERSON;;COX TIM W;;FOX STACEY;;HANES KEVIN;;HARDING CHRISTOPHER;;RONES CRAIG,,https://lens.org/122-894-024-184-238,Patent of Addition,no,0,1,13,13,0,H04L41/022;;H04L41/0816;;H04L67/1095;;G06F16/40;;G16Z99/00;;G06F17/00;;G06F30/18;;H04L41/0816;;H04L41/12;;H04L41/022;;H04L67/1095,H04L12/24;;G06F15/173;;G06F15/177,,0,0,,,,ACTIVE
41,DE,A1,DE 102006023974 A1,142-182-224-062-219,2007-01-04,2007,DE 102006023974 A,2006-05-22,US 14122905 A,2005-05-31,System und Verfahren für maßgeschneiderte Anwendungsbestellung und Installation für Informationsverarbeitungssysteme,"Der Ersatz von Altinformationsverarbeitungssystemen an einem Einsatzort wird automatisch in Zusammenarbeit mit einem Herstellungsort von Informationsverarbeitungssystemen verwaltet, indem das Herstellen von Ersatzinformationsverarbeitungssystemen mit geeigneten Konfigurationen koordiniert wird. Ein Bestandserfassungswerkzeug ist mit den Altinformationsverarbeitungssystemen über ein Netzwerk des Einsatzorts verbunden, um die Konfigurationen der Altsysteme zu ermitteln, und übermittelt die Altkonfigurationen an den Herstellungsort. Eine Bestandsübersetzungsengine übersetzt die Altkonfigurationen in Ersatzkonfigurationen zum Herstellen der Ersatzinformationsverarbeitungssysteme. Das Bestellen von Ersatzinformationsverarbeitungssystemen und die Übersetzung der Ersatzkonfiguration wird durch Regeln gesteuert, die durch ein Bestellwerkzeug des Einsatzorts festgelegt sind, und kann Anwendungen enthalten, die an dem Einsatzort verpackt und an den Herstellungsort zur Installation auf den Ersatzsystemen übermittelt werden.",DELL PRODUCTS LP,RALEY JEFFERSON;;COX TIM W;;FOX STACEY;;HANES KEVIN;;HARDING CHRISTOPHER;;RONES CRAIG,,https://lens.org/142-182-224-062-219,Patent Application,no,0,0,13,13,0,H04L41/022;;H04L41/0816;;H04L67/1095;;G06F16/40;;G16Z99/00;;G06F17/00;;G06F30/18;;H04L41/0816;;H04L41/12;;H04L41/022;;H04L67/1095,G06Q30/00;;G06F17/30,,0,0,,,,ACTIVE
42,DE,B4,DE 102006023974 B4,037-082-495-978-443,2015-10-29,2015,DE 102006023974 A,2006-05-22,US 14122905 A,2005-05-31,System und Verfahren für maßgeschneiderte Anwendungsbestellung und Installation für Informationsverarbeitungssysteme,"Ein System zum Herstellen von Ersatzinformationsverarbeitungssystemen, wobei das System aufweist: ein Bestandserfassungswerkzeug, das einem Einsatzort zugeordnet ist, wobei der Einsatzort mehrere Altinformationsverarbeitungssysteme aufweist, die mit einem Netzwerk des Einsatzortes verbunden sind, wobei jedes Altinformationsverarbeitungssystem eine Konfiguration aufweist, und wobei das Bestandserfassungswerkzeug ausgebildet ist, automatisch die Konfiguration der Altinformationsverarbeitungssysteme durch das Netzwerk zu ermitteln, um eine ermittelte Bestandstabelle zu erzeugen; wobei die Bestandstabelle eine Liste von Hardwarekomponenten und Softwareanwendungen umfasst, die auf den Altinformationsverarbeitungssystemen vorhanden sind; ein Anwendungspaketwerkzeug, das ausgebildet ist, ausgewählte Anwendungen zu verpacken, die durch das Bestandserfassungswerkzeug erfasst wurden, und um die verpackten Anwendungen an den Herstellungsort zu übermitteln; ein Bestellwerkzeug, das dem Einsatzort zugeordnet ist, und geeignet ist, die ermittelte Bestandstabelle an einen Herstellungsort zu übermitteln, wobei das Bestellwerkzeug weiterhin ausgebildet ist, ein Ersatzinformationsverarbeitungssystem für ein oder mehrere der Altinformationsverarbeitungssysteme in der ermittelten Bestandstabelle zu bestellen; eine Kundenanwendungsdatenbank, die die verpackten Software-Anwendungen speichert; eine Herstelleranwendungsdatenbank, die die vorbestimmten Software-Anwendungen speichert; ...",DELL PRODUCTS LP,RALEY JEFFERSON;;COX TIM W;;FOX STACEY;;HANES KEVIN;;HARDING CHRISTOPHER;;RONES CRAIG,,https://lens.org/037-082-495-978-443,Granted Patent,no,4,0,13,13,0,H04L41/022;;H04L41/0816;;H04L67/1095;;G06F16/40;;G16Z99/00;;G06F17/00;;G06F30/18;;H04L41/0816;;H04L41/12;;H04L41/022;;H04L67/1095,G06Q30/00;;G06F15/177;;G06F17/30;;G06Q50/04,,1,0,,,"""ASSETMETRIX"", http://web.archive.org/web/20050507 094037www.assetmetrix.com/solutions/default.asp 7. Mai 2005",ACTIVE
43,TW,B,TW I434550 B,015-508-356-203-119,2014-04-11,2014,TW 95118427 A,2006-05-24,US 14122905 A,2005-05-31,System and method for information handling system custom application ordering and installation,,DELL PRODUCTS LP,RALEY JEFFERSON;;COX TIM W;;FOX STACEY;;HANES KEVIN;;HARDING CHRISTOPHER;;RONES CRAIG,,https://lens.org/015-508-356-203-119,Granted Patent,no,0,0,13,13,0,H04L41/022;;H04L41/0816;;H04L67/1095;;G06F16/40;;G16Z99/00;;G06F17/00;;G06F30/18;;H04L41/0816;;H04L41/12;;H04L41/022;;H04L67/1095,,,0,0,,,,ACTIVE
44,WO,A1,WO 1997/004395 A1,126-040-637-957-092,1997-02-06,1997,US 9611915 W,1996-07-19,US 127795 P;;US 127895 P;;US 127995 P,1995-07-20,METHOD AND APPARATUS FOR ENCRYPTION KEY CREATION,"A portable electronic data module for secure transactions, the electronic data module having a random number generator and an optimized co-processor for producing unbreakable key sets for a two-key cryptosystem. A real-time clock is sampled depending upon an external random event series such as power-ups of the data module by a host apparatus, and based upon the contents of the sample thus obtained, the entropy of a previously-loaded accumulator is further enhanced to achieve a pool of true random numbers. By repeatedly requesting randon bytes of information from said pool of random numbers, large random numbers are created which are then rendered prime and used for key set creation.",DALLAS SEMICONDUCTOR,LITTLE WENDELL L;;CURRY STEPHEN M;;ARMSTRONG BRYAN M;;FOX CHRISTOPHER W;;LOOMIS DONALD W;;SCHWEITZER PETER,,https://lens.org/126-040-637-957-092,Patent Application,yes,5,1,17,17,0,G06F7/588;;G06F7/588;;G06F9/30134;;G06F9/30134;;G06F11/1004;;G06F11/1004;;G06F21/602;;G06F21/602;;G06F21/72;;G06F21/72;;G06F21/73;;G06F21/73;;G06F21/81;;G06F21/81;;G06F21/86;;G06F21/86;;G06F21/87;;G06F21/87;;G06F2211/007;;G06F2211/007;;G06F2221/2143;;G06F2221/2143;;G06F2221/2153;;G06F2221/2153;;G06Q20/341;;G06Q20/341;;G06Q20/40975;;G06Q20/40975;;G07F7/082;;G07F7/082;;G07F7/1008;;G07F7/1008;;G11C5/06;;G11C5/06;;G11C5/143;;G11C5/143;;G11C7/24;;G11C7/24;;G11C8/20;;G11C8/20;;H01L23/57;;H01L23/57;;H01L2224/16225;;H01L2224/16225;;H01L2924/16152;;H01L2924/16152;;H01L2924/3011;;H01L2924/3011;;H04L25/026;;H04L25/026;;Y10S257/922;;Y10S257/922,G06F1/00;;G06F7/58;;G06F7/72;;G06F21/00;;G07F7/10;;G11C5/00;;G11C5/14;;G11C7/24;;G11C8/20;;H01L23/58;;H04L9/08;;H04L9/30;;H04L25/02,,1,0,,,"""SOFT MICROCONTROLLER DATA BOOK"", 6 October 1993, DALLAS SEMICONDUCTOR, DALLAS, US, XP002020287",PENDING
45,AU,A,AU 1996/067619 A,196-240-353-173-443,1997-02-18,1997,AU 1996/067619 A,1996-07-19,US 127795 P;;US 127895 P;;US 127995 P;;US 9611915 W,1995-07-20,Method and apparatus for encryption key creation,,DALLAS SEMICONDUCTOR,LITTLE WENDELL L;;CURRY STEPHEN M;;ARMSTRONG BRYAN M;;FOX CHRISTOPHER W;;LOOMIS DONALD W;;SCHWEITZER PETER,,https://lens.org/196-240-353-173-443,Patent Application,no,0,0,17,17,0,G06F7/588;;G06F7/588;;G06F9/30134;;G06F9/30134;;G06F11/1004;;G06F11/1004;;G06F21/602;;G06F21/602;;G06F21/72;;G06F21/72;;G06F21/73;;G06F21/73;;G06F21/81;;G06F21/81;;G06F21/86;;G06F21/86;;G06F21/87;;G06F21/87;;G06F2211/007;;G06F2211/007;;G06F2221/2143;;G06F2221/2143;;G06F2221/2153;;G06F2221/2153;;G06Q20/341;;G06Q20/341;;G06Q20/40975;;G06Q20/40975;;G07F7/082;;G07F7/082;;G07F7/1008;;G07F7/1008;;G11C5/06;;G11C5/06;;G11C5/143;;G11C5/143;;G11C7/24;;G11C7/24;;G11C8/20;;G11C8/20;;H01L23/57;;H01L23/57;;H01L2224/16225;;H01L2224/16225;;H01L2924/16152;;H01L2924/16152;;H01L2924/3011;;H01L2924/3011;;H04L25/026;;H04L25/026;;Y10S257/922;;Y10S257/922,G06F1/00;;G06F7/58;;G06F7/72;;G06F21/00;;G07F7/10;;G11C5/00;;G11C5/14;;G11C7/24;;G11C8/20;;H01L23/58;;H04L9/08;;H04L9/30;;H04L25/02,,0,0,,,,PENDING
46,US,A,US 5850450 A,111-960-434-768-301,1998-12-15,1998,US 69027296 A,1996-07-19,US 69027296 A;;US 127795 P;;US 127895 P;;US 127995 P,1995-07-20,Method and apparatus for encryption key creation,"A portable electronic data module for secure transactions, the electronic data module having a random number generator and an optimized co-processor for producing unbreakable key sets for a two-key cryptosystem. A real-time clock is sampled depending upon an external random event series such as power-ups of the data module by a host apparatus, and based upon the contents of the sample thus obtained, the entropy of a previously-loaded accumulator is further enhanced to achieve a pool of true random numbers. By repeatedly requesting random bytes of information from said pool of random numbers, large random numbers are created which are then rendered prime and used for key set creation.",DALLAS SEMICONDUCTOR,SCHWEITZER PETER;;CURRY STEPHEN M;;LITTLE WENDELL L;;ARMSTRONG BRYAN M;;FOX CHRISTOPHER W;;LOOMIS DONALD W,DALLAS SEMICONDUCTOR CORPORATION (1996-07-17),https://lens.org/111-960-434-768-301,Granted Patent,yes,15,137,17,17,0,G06F7/588;;G06F7/588;;G06F9/30134;;G06F9/30134;;G06F11/1004;;G06F11/1004;;G06F21/602;;G06F21/602;;G06F21/72;;G06F21/72;;G06F21/73;;G06F21/73;;G06F21/81;;G06F21/81;;G06F21/86;;G06F21/86;;G06F21/87;;G06F21/87;;G06F2211/007;;G06F2211/007;;G06F2221/2143;;G06F2221/2143;;G06F2221/2153;;G06F2221/2153;;G06Q20/341;;G06Q20/341;;G06Q20/40975;;G06Q20/40975;;G07F7/082;;G07F7/082;;G07F7/1008;;G07F7/1008;;G11C5/06;;G11C5/06;;G11C5/143;;G11C5/143;;G11C7/24;;G11C7/24;;G11C8/20;;G11C8/20;;H01L23/57;;H01L23/57;;H01L2224/16225;;H01L2224/16225;;H01L2924/16152;;H01L2924/16152;;H01L2924/3011;;H01L2924/3011;;H04L25/026;;H04L25/026;;Y10S257/922;;Y10S257/922,G06F1/00;;G06F7/58;;G06F7/72;;G06F21/00;;G07F7/10;;G11C5/00;;G11C5/14;;G11C7/24;;G11C8/20;;H01L23/58;;H04L9/08;;H04L9/30;;H04L25/02,380/30,4,1,043-166-564-692-138,10.1007/bf03295797,"Soft Microcontroller Data Book ; Oct. 6, 1993; Dallas Semiconductor; Dallas, US, *see pp. 1 through 3*, *see p. 7*, *see p. 8*, see p. 73*, *see pp. 77 through 80*, *see p. 82*, *see p. 229*, *see pp. 290 through 292*.;;Bill Morton, The Beginner s Guide To Pretty Good Privacy, Version 1.1 (Apr. 13, 1995).;;How PGP Works and the Maths Behind RSA, Internet article http://rschp2.anu.edu.au:8080/howpgp.html.;;James Nechvatal, Public Key Cryptography, Security Technology Group, National Computer Systems Laboratory, National Institute of Standards and Technology, Gaithersnburg, MD 20899, Dec. 1990.",EXPIRED
47,US,A1,US 2010/0167345 A1,174-358-154-297-713,2010-07-01,2010,US 57382409 A,2009-10-05,US 57382409 A;;US 91717904 A;;US 49438203 P;;US 54603304 P,2003-08-11,HALOHYDRIN DEHALOGENASES AND RELATED POLYNUCLEOTIDES,"The present invention relates to novel halohydrin dehalogenase polypeptides and the polynucleotides that encode them. These polypeptides are useful in the production of 4-substituted-3-butyric acid derivatives and vicinal cyano, hydroxyl substituted carboxylic acid esters. The invention also provides related vectors, host cells and methods.",CODEXIS INC,DAVIS S CHRISTOPHER;;FOX RICHARD JOHN;;HUISMAN GJALT W;;GAVRILOVIC VESNA;;NEWMAN LISA MARIE,,https://lens.org/174-358-154-297-713,Patent Application,yes,16,0,17,29,742,C12N9/14;;C12N9/88;;C12N9/14;;C12N15/52;;C12N9/88;;C12N9/88;;C12N9/14,C12P21/00;;C07H21/00;;C07H21/04;;C12N1/21;;C12N5/10;;C12N9/04;;C12N9/14;;C12N9/88;;C12N15/60;;C12N15/74;;C12Q1/68,435/69.1;;435/232;;536/23.2;;435/320.1;;435/419,0,0,,,,ACTIVE
48,BR,A,BR PI0413501 A,190-651-111-798-975,2006-10-10,2006,BR PI0413501 A,2004-08-11,US 49438203 P;;US 54603304 P;;US 2004/0026654 W,2003-08-11,"polipetìdeo, polinucleotìdeo isolado ou recombinante, vetor de expressão, célula hospedeira, e, método de preparar um polipetìdeo de hhdh","""POLIPEPTìDEO, POLINUCLEOTìDEO ISOLADO OU RECOMBINANTE, VETOR DE EXPRESSãO , CéLULA HOSPEDEIRA, E, MéTODO DE PREPARAR UM POLIPEPTìDEO DE HHDH"". A presente invenção refere-se aos novos polipeptídeos de haloidrina-desalogenase e aos polinucleotídeos que os codificam. Estes polipeptídeos são úteis na produção de derivados de ácido 4-substituído-3-butírico e de ésteres de ácido carboxílico vicinal-ciano, hidroxil-substituídos. A invenção também proporciona vetores, células hospedeiras e métodos relacionados.",CODEXIS INC,DAVIS S CHRISTOPHER;;FOX RICHARD JOHN;;GAVRILOVIC VESNA;;HUISMAN GJALT W;;NEWMAN LISA MARIE,,https://lens.org/190-651-111-798-975,Patent Application,no,0,0,17,29,0,C12N9/14;;C12N9/88;;C12N9/14;;C12N15/52;;C12N9/88;;C12N9/88;;C12N9/14,C07H21/04;;C12N1/21;;C12N9/04;;C12N9/14;;C12N9/88;;C12N15/60;;C12N15/74;;C12Q1/68,,0,0,,,,DISCONTINUED
49,US,B2,US 8101395 B2,141-662-366-548-317,2012-01-24,2012,US 57382409 A,2009-10-05,US 57382409 A;;US 91717904 A;;US 49438203 P;;US 54603304 P,2003-08-11,Halohydrin dehalogenases and related polynucleotides,"The present invention relates to novel halohydrin dehalogenase polypeptides and the polynucleotides that encode them. These polypeptides are useful in the production of 4-substituted-3-butyric acid derivatives and vicinal cyano, hydroxyl substituted carboxylic acid esters. The invention also provides related vectors, host cells and methods.",DAVIS S CHRISTOPHER;;FOX RICHARD J;;HUISMAN GJALT W;;GAVRILOVIC VESNA;;NEWMAN LISA MARIE;;CODEXIS INC,DAVIS S CHRISTOPHER;;FOX RICHARD J;;HUISMAN GJALT W;;GAVRILOVIC VESNA;;NEWMAN LISA MARIE,,https://lens.org/141-662-366-548-317,Granted Patent,yes,25,2,17,29,742,C12N9/14;;C12N9/88;;C12N9/14;;C12N15/52;;C12N9/88;;C12N9/88;;C12N9/14,C12N9/88;;C07H21/04;;C07K14/00;;C12N1/21;;C12N9/04;;C12N9/14;;C12N15/60;;C12N15/74;;C12Q1/68,435/232;;530/350,32,21,088-273-242-424-372;;017-976-846-535-343;;025-769-853-797-657;;012-706-634-231-645;;052-328-795-035-042;;179-801-653-878-016;;133-245-607-243-913;;052-549-921-761-790;;166-958-105-502-652;;043-043-968-709-186;;038-382-938-657-069;;061-583-917-506-24X;;008-782-851-804-219;;047-978-243-986-580;;017-390-715-015-286;;001-514-332-046-617;;038-043-510-052-572;;054-399-907-114-548;;135-456-794-183-356;;005-222-568-120-407;;124-335-592-847-062,10.1016/s0040-4020(97)00843-0;;10.1016/s0141-0229(97)00255-x;;10.1093/emboj/cdg479;;pmc204463;;14517233;;10.3109/10242429508998161;;10.1016/s1381-1177(97)00034-9;;10.1016/s0957-4166(98)00003-2;;10.1016/s0957-4166(99)00308-0;;10.1021/ol0067540;;11429866;;10.1016/s0957-4166(02)00222-7;;10.1016/0040-4039(94)88167-7;;10.1007/bf00170187;;1656964;;10.1016/s0006-291x(05)81264-1;;10.1016/s0040-4020(01)89297-8;;10.1128/aem.60.4.1297-1301.1994;;8017917;;pmc201473;;10094681;;10.1128/jb.181.7.2050-2058.1999;;pmc93616;;9169427;;10.1074/jbc.272.23.14650;;10.1016/s0958-1669(99)80066-4;;10449315;;14636074;;10.1021/bi034941a;;10.1016/s0141-0229(01)00488-4;;1846134;;10.1128/jb.173.1.124-129.1991;;pmc207165;;11489858;;10.1128/jb.183.17.5058-5066.2001;;pmc95381,"Archer 1997, ""Epoxide Hydrolases as Asymmetric Catalysts,"" Tetrahedron, Elsevier Science, 53(46):15617-15662.;;Assis et al., 1998, ""Synthesis of Chiral Epihalohydrins Using Haloalcohol Dehalogenase a from Arthrobacter erithii H10a,""Enzyme Microb. Technol. 22:545-551.;;De Jong et al., 2003, ""Structure and Mechanism of a Bacterial Haloalcohol Dehalogenase: A New Variation of the Short-Chain Dehydrogenase/Reductase Fold Without an NAD(P)H Binding Site,"" EMBO Journal, 22(19):4933-4944, XP002305279, ISSN: 0261-4189.;;Hallinan et al., 1995, ""Yeast Catalysed Reduction of beta-keto Esters (2): Optimisation of the Stereospecific Reduction by Zygosaccharomyces rouxii,"" Biocatal. Biotransform. 12:179-191.;;Kasai et al., 1998, ""Chiral C3 Epoxides and Halohydrins: Their Preparation and Synthetic Application,"" J. Molec. Cat. B: Enzymatic, 4:237-252.;;Lewis et al., 1999, ""Cloning and Nucleotide Sequence of the Haloalcohol Dehalogenase B Gene from Agrobacterium tumefaciens,"" Database Accession No. Q9WWB6, XP002152213.;;Lewis, 1999, ""Agrobacterium tumefaciens Haloalcohol Dehalogenase B Gene, Complete CDS,"" Database EMBL Online!, XP002305665, retrieved from EBI accession No. EM-PRO: AF149769, database accession No. AF149769.;;Lutje Spelberg et al., 1998, ""Enantioselectivity of a Recombinant Epoxide Hydrolase from Agrobacterium radiobacter,"" Tetrahedron: Asymmetry, Elsevier Science, 9(3):459-466.;;Lutje Spelberg et al., 1999, ""A Tandem Enzyme Reaction to Produce Optically Active Halohydrins, Epoxides and Diols,"" Tetrahedron: Asymmetry, 10:2863-2870.;;Lutje Spelberg, et al., 2000, ""Highly Enantioselective and Regioselective Biocatalytic Azidolysis of Aromatic Epoxides,"" Org. Lett., 3(1):41-43.;;Lutje Spelberg, et al., 2002, ""Exploration of the Biocatalytic Potential of a Halohydrin Dehalogenase using Chromogenic Substrates,"" Tetrahedron: Asymmetry, 13:1083-1089.;;Mischitz et al., 1994 ""Asymmetric Opening of an Epoxide by Azide Catalyzed by an Immobilized Enzyme Preparation from Rhodococcus sp.,"" Tetrahedron Letters, 35(1):81-84.;;Nagasawa, et al., 1992, ""Purification and Characterization of Halohydrin Hydrogen-halide Lyase from a Recombinant Escherichia coli Containing the Gene from a Corynebacterium sp.,"" Appl. Microbiol. Biotechnol., 36:478-482.;;Nakamura et al., 1991, ""A New Catalytic Function of Halohydrin Hydrogen-Halide-Lyase, Synthesis of beta-Hydroxynitriles from Epoxides and Cyanide,"" Biochem Biophys Res Commun., 180(1):124-30.;;Nakamura et al., 1994, ""A New Enzymatic Synthesis of (R)-gamma-Chloro-beta-Hydroxybutyronitrile,"" Tetrahedron, Elsevier Science, 50(41):11821-11826.;;Nakamura, et al., 1994, ""Characterization of a Novel Enantioselective Halohydrin Hydrogen-Halide-Lyase,"" Appl. Environ. Microbiol., 60(4):1297-1301.;;Office Action from U.S. Appl. No. 10/917,179 dated Aug. 6, 2007.;;Office Action from U.S. Appl. No. 11/067,323 dated Aug. 8, 2007.;;Office Action from U.S. Appl. No. 11/266,747 dated Aug. 8, 2007.;;Office Action from U.S. Appl. No. 11/266,747 dated May 15, 2008.;;PCT International Search Report from PCT/US06/05487 dated Sep. 25, 2008.;;PCT International Search Report from PCT/USO4/26654 dated Nov. 29, 2004.;;Poelarends et al., 1999, ""Degradation of 1,2-Dibromoethane by Mycobacterium sp. Strain GP1,"" J. Bacteriol., 181(7):2050-2058.;;Rink et al., Jun. 1997, ""Primary Structure and Catalytic Mechanism of the Epoxide Hydrolase from Agrobacterium radiobacter AD1,"" J. Biol. Chem., 272(23):14650-14657.;;SEQ Id No: 2 Comparison to Accession No. AAW69435 in JP1020981 A1.;;Swanson, P. E., 1999, ""Dehalogenases Applied to Industrial-Scale Biocatalysis,"" Curr. Opin. Biotechnol., 10:365-369.;;Tang et al., 2003, ""Steady-State Kinetics and Tryptophan Fluorescence Properties of Halohydrin Dehalogenase from Agrobacterium radiobacter. Roles of W139 and W249 in the Active Site and Halide-Induced Conformational Change,"" Biochemistry, 42(47):14057-14065, XP002305278, ISSNL 0006-2960.;;Tang et al., 2002, ""Improved Stability of Halohydrin Dehalogenase from Agrobacterium radiobacter AD1 by Replacement of Cysteine Residues,"" Enzyme Microb. Technol., 30:251-258.;;Van Den Wijngaard et al., 1991, ""Purification and Characterization of Haloalcohol Dehalogenase from Arthrobacter sp. Strain AD2,"" J. Bacteriol., 173(1):124-129.;;Van Hylckama et al., 2001, ""Halohydrin Dehalogenases are Structurally and Mechanistically Related to Short-Chain Dehydrogenases/Reductases,"" Journal of Bacteriology, 183(17):5058-5066, XP002305277, ISSN: 0021-9193.;;Supplementary European Search Report from EP06735244.3 dated Jul. 9, 2009.;;Search Report from SG200808477-4 dated Apr. 13, 2010.",ACTIVE
50,CA,A1,CA 2535255 A1,046-533-994-983-542,2005-02-24,2005,CA 2535255 A,2004-08-11,US 49438203 P;;US 54603304 P;;US 2004/0026654 W,2003-08-11,IMPROVED HALOHYDRIN DEHALOGENASES AND RELATED POLYNUCLEOTIDES,"The present invention relates to novel halohydrin dehalogenase polypeptides and the polynucleotides that encode them. These polypeptides are useful in t he production of 4-substituted-3-butyric acid derivatives and vicinal cyano, hydroxyl substituted carboxylic acid esters. The invention also provides related vectors, host cells and methods.",CODEXIS INC,HUISMAN GJALT W;;GAVRILOVIC VESNA;;DAVIS S CHRISTOPHER;;FOX RICHARD JOHN;;NEWMAN LISA MARIE,,https://lens.org/046-533-994-983-542,Patent Application,no,0,0,17,29,744,C12N9/14;;C12N9/88;;C12N9/14;;C12N15/52;;C12N9/88;;C12N9/88;;C12N9/14,C12N9/88;;C07H21/04;;C12N1/21;;C12N9/04;;C12N9/14;;C12N15/60;;C12N15/74;;C12Q1/68,,0,0,,,,DISCONTINUED
51,US,B2,US 7824898 B2,077-728-362-893-738,2010-11-02,2010,US 91717904 A,2004-08-11,US 91717904 A;;US 49438203 P;;US 54603304 P,2003-08-11,Halohydrin dehalogenases and related polynucleotides,"The present invention relates to novel halohydrin dehalogenase polypeptides and the polynucleotides that encode them. These polypeptides are useful in the production of 4-substituted-3-butyric acid derivatives and vicinal cyano, hydroxyl substituted carboxylic acid esters. The invention also provides related vectors, host cells and methods.",CODEXIS INC,DAVIS S CHRISTOPHER;;FOX RICHARD JOHN;;HUISMAN GJALT W;;GAVRILOVIC VESNA;;NEWMAN LISA MARIE,CODEXIS INC (2004-11-03),https://lens.org/077-728-362-893-738,Granted Patent,yes,26,1,17,29,742,C12N9/14;;C12N9/88;;C12N9/14;;C12N15/52;;C12N9/88;;C12N9/88;;C12N9/14,C12N9/88;;C07H21/04;;C07K14/00;;C12N1/21;;C12N9/04;;C12N9/14;;C12N15/60;;C12N15/74;;C12Q1/68,435/232;;530/350,31,21,124-335-592-847-062;;054-399-907-114-548;;025-769-853-797-657;;135-456-794-183-356;;088-273-242-424-372;;017-976-846-535-343;;012-706-634-231-645;;052-328-795-035-042;;179-801-653-878-016;;133-245-607-243-913;;052-549-921-761-790;;166-958-105-502-652;;043-043-968-709-186;;038-382-938-657-069;;061-583-917-506-24X;;008-782-851-804-219;;047-978-243-986-580;;017-390-715-015-286;;001-514-332-046-617;;038-043-510-052-572;;005-222-568-120-407,11489858;;10.1128/jb.183.17.5058-5066.2001;;pmc95381;;14636074;;10.1021/bi034941a;;10.1093/emboj/cdg479;;pmc204463;;14517233;;10.1016/s0141-0229(01)00488-4;;10.1016/s0040-4020(97)00843-0;;10.1016/s0141-0229(97)00255-x;;10.3109/10242429508998161;;10.1016/s1381-1177(97)00034-9;;10.1016/s0957-4166(98)00003-2;;10.1016/s0957-4166(99)00308-0;;10.1021/ol0067540;;11429866;;10.1016/s0957-4166(02)00222-7;;10.1016/0040-4039(94)88167-7;;10.1007/bf00170187;;1656964;;10.1016/s0006-291x(05)81264-1;;10.1016/s0040-4020(01)89297-8;;10.1128/aem.60.4.1297-1301.1994;;8017917;;pmc201473;;10094681;;10.1128/jb.181.7.2050-2058.1999;;pmc93616;;9169427;;10.1074/jbc.272.23.14650;;10.1016/s0958-1669(99)80066-4;;10449315;;1846134;;10.1128/jb.173.1.124-129.1991;;pmc207165,"Van Hylckama et al, << Halohydrin Dehalogenases Are Structurally and Mechanistically Related To Short-Chain Dehydrogenases/Reductases, Journal of Bacteriology, vol. 183 No. 17, Sep. 2001, pp. 5058-5066, XP002305277, ISSN: 0021-9193.;;Tang et al, ""Steady-State Kinetics and Tryptophan Fluorescence Properties of Halohydrin Dehalogenase From Agrobacterium Radiobacter. Roles of W139 and W249 In The Active Site and Halide-Induced Conformational Change"", Biochemistry, vol. 42 No. 47, Dec. 2003, pp. 14057-14065, XP002305278, ISSNL 0006-2960.;;De Jong et al, ""Structure and Mechanism Of A Bacterial Haloalcohol Dehalogenase: A New Variation Of The Short-Chain Dehydrogenase/Reductase Fold Without An NAD(P)H Binding Site"", EMBO (European Molecular Biology Organization) Journal, vol. 22 No. 19, Oct. 2003, pp. 4933-4944, XP002305279, ISSN: 0261-4189.;;Lewis M., ""Agrobacterium Tumefaciens Haloalcohol Dehalogenase B Gene, Complete CDS"", Database EMBL 'Online!, Jun. 1999, XP002305665, retrieved from EBI accession No. EM-PRO: AF149769, database accession No. AF149769.;;Supplementary European Search Report for 06735244.3 dated Jul. 9, 2009.;;Tang et al., 2002, ""Improved Stability of Halohydrin Dehalogenase from Agrobacterium Radiobacter AD1 by Replacement of Cysteine Residues,"" Enzyme Microb. Technol., 30:251-258.;;Archer, 1997, ""Epoxide Hydrolases as Asymmetric Catalysts,"" Tetrahedron, Elsevier Science, 53(46):15617-15662.;;Assis et al., 1998, ""Synthesis of Chiral Epihalohydrins Using Haloalcohol Dehalogenase A from Arthrobacter Erithii H10a,"" Enzyme Microb. Technol. 22:545-551.;;Hallinan et al., 1995, ""Yeast Catalysed Reduction of beta-keto Esters (2): Optimisation of the Stereospecific Reduction by Zygosaccharomyces rouxii,"" Biocatal. Biotransform. 12:179-191.;;Kasai et al., 1998, ""Chiral C3 Epoxides and Halohydrins: Their Preparation and Synthetic Application,"" J. Molec. Cat. B: Enzymatic, 4:237-252.;;Lewis et al., 1999, ""Cloning and Nucleotide Sequence of the Haloalcohol Dehalogenase B Gene from Agrobacterium Tumefaciens,"" Database Accession No. Q9WWB6, XP002152213.;;Lutje Spelberg et al., 1998, ""Enantioselectivity of a Recombinant Epoxide Hydrolase from Agrobacterium Radiobacter,"" Tetrahedron: Asymmetry, Elsevier Science, 9(3):459-466.;;Lutje Spelberg et al., 1999, ""A Tandem Enzyme Reaction to Produce Optically Active Halohydrins, Epoxides and Diols,"" Tetrahedron: Asymmetry, 10:2863-2870.;;Lutje Spelberg et al., 2001, ""Highly Enantioselective and Regioselective Biocatalytic Azidolysis of Aromatic Epoxides,"" Org. Lett., 3(1):41-43.;;Lutje Spelberg et al., 2002, ""Exploration of the Biocatalytic Potential of a Halohydrin Dehalogenase using Chromogenic Substrates,"" Tetrahedron: Asymmetry, 13:1083-1089.;;Mischitz et al., 1994 ""Asymmetric Opening of an Epoxide by Azide Catalyzed by an Immobilized Enzyme Preparation from Rhodococcus sp.,"" Tetrahedron Letters, 35(1):81-84.;;Nagasawa et al., 1992, ""Purification and Characterization of Halohydrin Hydrogen-halide Lyase from a Recombinant Escherichia coli Containing the Gene from a Corynebacterium sp.,"" Appl. Microbiol. Biotechnol., 36:478-482.;;Nakamura et al., 1991, ""A New Catalytic Function of Halohydrin Hydrogen-Halide-Lyase, Synthesis of beta-Hydroxynitriles from Epoxides and Cyanide,"" Biochem Biophys Res Commun., 180(1):124-30.;;Nakamura et al., 1994, ""A New Enzymatic Synthesis of (R)-gamma-Chloro-beta-Hydroxybutyronitrile,"" Tetrahedron, Elsevier Science, 50(41):11821-11826.;;Nakamura, et al., 1994, ""Characterization of a Novel Enantioselective Halohydrin Hydrogen-Halide-Lyase,"" Appl. Environ. Microbiol., 60(4):1297-1301.;;Office Action from U.S. Appl. No. 11/067,323 dated Aug. 8, 2007.;;Office Action from U.S. Appl. No. 11/266,747 dated May 15, 2008.;;Office Action from U.S. Appl. No. 11/266,747 dated Aug. 8, 2007.;;PCT International Search Report from PCT/US06/05487 dated Sep. 25, 2008.;;PCT International Search Report from PCT/US04/26654 dated Nov. 29, 2004.;;Poelarends et al., 1999, ""Degradation of 1,2-Dibromoethane by Mycobacterium sp. Strain GP1,"" J. Bacteriol., 181(7):2050-2058.;;Rink et al., 1997, ""Primary Structure and Catalytic Mechanism of the Epoxide Hydrolase from Agrobacterium Radiobacter AD1,"" J. Biol. Chem., 272(23):14650-14657.;;SEQ ID No. 2 Comparison to Accession No. AAW69435 in JP1020981 A1.;;Swanson, P. E., 1999, ""Dehalogenases Applied to Industrial-Scale Biocatalysis,"" Curr. Opin. Biotechnol., 10:365-369.;;Van Den Wijngaard et al., 1991, ""Purification and Characterization of Haloalcohol Dehalogenase from Arthrobacter sp. Strain AD2,"" J. Bacteriol., 173(1):124-129.;;Search Report from SG200808477-4 dated Jun. 3, 2010.",ACTIVE
52,US,A1,US 2012/0208259 A1,080-483-172-480-831,2012-08-16,2012,US 201213349514 A,2012-01-12,US 201213349514 A;;US 57382409 A;;US 91717904 A;;US 49438203 P;;US 54603304 P,2003-08-11,Halohydrin Dehalogenases and Related Polynucleotides,"The present invention relates to novel halohydrin dehalogenase polypeptides and the polynucleotides that encode them. These polypeptides are useful in the production of 4-substituted-3-butyric acid derivatives and vicinal cyano, hydroxyl substituted carboxylic acid esters. The invention also provides related vectors, host cells and methods.",DAVIS S CHRISTOPHER;;FOX RICHARD JOHN;;HUISMAN GJALT W;;GAVRILOVIC VESNA;;NEWMAN LISA MARIE;;CODEXIS INC,DAVIS S CHRISTOPHER;;FOX RICHARD JOHN;;HUISMAN GJALT W;;GAVRILOVIC VESNA;;NEWMAN LISA MARIE,,https://lens.org/080-483-172-480-831,Patent Application,yes,0,0,17,29,742,C12N9/14;;C12N9/88;;C12N9/14;;C12N15/52;;C12N9/88;;C12N9/88;;C12N9/14,C12N9/88;;C07H21/04;;C12N1/15;;C12N1/19;;C12N1/21;;C12N5/10;;C12N9/04;;C12N9/14;;C12N15/60;;C12N15/63;;C12N15/74;;C12Q1/68,435/232;;435/320.1;;435/419;;435/252.3;;435/254.11;;536/23.2;;435/254.2,0,0,,,,ACTIVE
53,SG,A1,SG 148180 A1,046-624-316-935-529,2008-12-31,2008,SG 2008084774 A,2004-08-11,US 49438203 P;;US 54603304 P,2003-08-11,IMPROVED HALOHYDRIN DEHALOGENASES AND RELATED POLYNUCLEOTIDES,"IMPROVED HALOHYDRIN DEHALOGENASES AND RELATED POLYNUCLEOTIDES The present invention relates to novel halohydrin debalogenase polypeptides and the polynucleotides that encode them. These polypeptides are useful in the production of 4-substituted-3-butyric acid derivatives and vicinal cyano, hydroxyl substituted carboxylic acid esters. The invention also provides related vectors, host cells and methods.",CODEXIS INC,DAVIS S CHRISTOPHER;;FOX RICHARD JOHN;;GAVRILOVIC VESNA;;HUISMAN GJALT W;;NEWMAN LISA MARIE,,https://lens.org/046-624-316-935-529,Patent Application,no,0,0,17,29,0,C12N9/14;;C12N9/88;;C12N9/14;;C12N15/52;;C12N9/88;;C12N9/88;;C12N9/14,C07H21/04;;C12N1/21;;C12N9/04;;C12N9/14;;C12N9/88;;C12N15/60;;C12N15/74;;C12Q1/68,,0,0,,,,PENDING
54,EP,A1,EP 1654356 A1,169-636-497-678-67X,2006-05-10,2006,EP 04781364 A,2004-08-11,US 2004/0026654 W;;US 49438203 P;;US 54603304 P,2003-08-11,IMPROVED HALOHYDRIN DEHALOGENASES AND RELATED POLYNUCLEOTIDES,,CODEXIS INC,DAVIS S CHRISTOPHER;;FOX RICHARD JOHN;;GAVRILOVIC VESNA;;HUISMAN GJALT W;;NEWMAN LISA MARIE,,https://lens.org/169-636-497-678-67X,Patent Application,yes,0,0,17,29,0,C12N9/14;;C12N9/88;;C12N9/14;;C12N15/52;;C12N9/88;;C12N9/88;;C12N9/14,C07H21/04;;C12N1/21;;C12N9/04;;C12N9/14;;C12N9/88;;C12N15/60;;C12N15/74;;C12Q1/68,,0,0,,,,DISCONTINUED
55,NO,L,NO 20060405 L,175-547-093-456-950,2006-03-10,2006,NO 20060405 A,2006-01-25,US 49438203 P;;US 54603304 P;;US 2004/0026654 W,2003-08-11,Forbedrede halohydrindehalogenaser og relaterte polynukleotider,"Det beskrives nye halohydrindehalogenasepolypeptider og polynukleotidene som koder for dem. Disse polypeptidene er anvendelige ved fremstilling av 4-substituert-3-smørsyre-derivater og vicinal cyano, hydroksylsubstituerte karboksylsyreestere. Det beskrives også relaterte vektorer, vertsceller og fremgangsmåter. 0 200 400 600 800 tid av reaksjon (min) 1000",CODEXIS INC,DAVIS CHRISTOPHER S;;HUISMAN GJALR W;;NEWMAN LISA MARIE;;FOX RICHARD JOHN;;GAVRILOVIC VESNA,,https://lens.org/175-547-093-456-950,Abstract,no,0,0,17,29,0,C12N9/14;;C12N9/88;;C12N9/14;;C12N15/52;;C12N9/88;;C12N9/88;;C12N9/14,C12N9/14;;C07H21/04;;C12N1/21;;C12N9/04;;C12N9/88;;C12N15/55;;C12N15/60;;C12N15/74;;C12Q1/68,,0,0,,,,DISCONTINUED
56,WO,A1,WO 2005/017141 A1,076-678-773-969-363,2005-02-24,2005,US 2004/0026654 W,2004-08-11,US 49438203 P;;US 54603304 P,2003-08-11,IMPROVED HALOHYDRIN DEHALOGENASES AND RELATED POLYNUCLEOTIDES,"The present invention relates to novel halohydrin dehalogenase polypeptides and the polynucleotides that encode them. These polypeptides are useful in the production of 4-substituted-3-butyric acid derivatives and vicinal cyano, hydroxyl substituted carboxylic acid esters. The invention also provides related vectors, host cells and methods.",CODEXIS INC,DAVIS S CHRISTOPHER;;FOX RICHARD JOHN;;GAVRILOVIC VESNA;;HUISMAN GJALT W;;NEWMAN LISA MARIE,,https://lens.org/076-678-773-969-363,Patent Application,yes,1,24,17,29,742,C12N9/14;;C12N9/88;;C12N9/14;;C12N15/52;;C12N9/88;;C12N9/88;;C12N9/14,C07H21/04;;C12N1/21;;C12N9/04;;C12N9/14;;C12N9/88;;C12N15/60;;C12N15/74;;C12Q1/68,,5,4,135-456-794-183-356;;124-335-592-847-062;;054-399-907-114-548;;025-769-853-797-657,10.1016/s0141-0229(01)00488-4;;11489858;;10.1128/jb.183.17.5058-5066.2001;;pmc95381;;14636074;;10.1021/bi034941a;;10.1093/emboj/cdg479;;pmc204463;;14517233,"TANG LIXIA ET AL: ""Improved stability of halohydrin dehalogenase from Agrobacterium radiobacter AD1 by replacement of cysteine residues"", ENZYME AND MICROBIAL TECHNOLOGY, vol. 30, no. 2, 14 February 2002 (2002-02-14), pages 251 - 258, XP002305276, ISSN: 0141-0229;;DATABASE EMBL [online] 3 June 1999 (1999-06-03), LEWIS M.: ""Agrobacterium tumefaciens haloalcohol dehalogenase B gene, complete cds."", XP002305665, retrieved from EBI accession no. EM_PRO:AF149769 Database accession no. AF149769;;VAN HYLCKAMA VLIEG JOHAN E T ET AL: ""Halohydrin dehalogenases are structurally and mechanistically related to short-chain dehydrogenases/reductases"", JOURNAL OF BACTERIOLOGY, vol. 183, no. 17, September 2001 (2001-09-01), pages 5058 - 5066, XP002305277, ISSN: 0021-9193;;TANG LIXIA ET AL: ""Steady-state kinetics and tryptophan fluorescence properties of halohydrin dehalogenase from Agrobacterium radiobacter. Roles of W139 and W249 in the active site and halide-induced conformational change."", BIOCHEMISTRY, vol. 42, no. 47, 2 December 2003 (2003-12-02), pages 14057 - 14065, XP002305278, ISSN: 0006-2960;;DE JONG R M ET AL: ""Structure and mechanism of a bacterial haloalcohol dehalogenase: A new variation of the short-chain dehydrogenase/reductase fold without an NAD(P)H binding site."", EMBO (EUROPEAN MOLECULAR BIOLOGY ORGANIZATION) JOURNAL, vol. 22, no. 19, 1 October 2003 (2003-10-01), pages 4933 - 4944, XP002305279, ISSN: 0261-4189",PENDING
57,KR,A,KR 20060064617 A,097-359-818-236-651,2006-06-13,2006,KR 20067002876 A,2006-02-10,US 49438203 P;;US 54603304 P,2003-08-11,IMPROVED HALOHYDRIN DEHALOGENASES AND RELATED POLYNUCLEOTIDES,"The present invention relates to novel halohydrin dehalogenase polypeptides and the polynucleotides that encode them. These polypeptides are useful in the production of 4-substituted-3- butyric acid derivatives and vicinal cyano, hydroxyl substituted carboxylic acid esters. The invention also provides related vectors, host cells and methods.",CODEXIS INC,DAVIS S CHRISTOPHER;;FOX RICHARD JOHN;;GAVRILOVIC VESNA;;HUISMAN GJALT W;;NEWMAN LISA MARIE,,https://lens.org/097-359-818-236-651,Patent Application,no,0,0,17,29,1488,C12N9/14;;C12N9/88;;C12N9/14;;C12N15/52;;C12N9/88;;C12N9/88;;C12N9/14,C12N9/14;;C07H21/04;;C12N1/21;;C12N9/04;;C12N9/88;;C12N15/60;;C12N15/74;;C12Q1/68,,0,0,,,,DISCONTINUED
58,US,B2,US 7541171 B2,093-890-226-321-503,2009-06-02,2009,US 6732305 A,2005-02-23,US 6732305 A;;US 91717904 A;;US 49438203 P;;US 54603304 P,2003-08-11,Halohydrin dehalogenases and related polynucleotides,"The present invention relates to novel halohydrin dehalogenase polypeptides and the polynucleotides that encode them. These polypeptides are useful in the production of 4-substituted-3-butyric acid derivatives and vicinal cyano, hydroxyl substituted carboxylic acid esters. The invention also provides related vectors, host cells and methods.",CODEXIS INC,DAVIS S CHRISTOPHER;;FOX RICHARD JOHN;;HUISMAN GJALT W;;GAVRILOVIC VESNA;;NEWMAN LISA MARIE,CODEXIS INC (2006-05-19),https://lens.org/093-890-226-321-503,Granted Patent,yes,24,11,2,29,1144,C12N9/14;;C12N9/88;;C12N9/14;;C12N9/88,C07H21/04;;C12N9/88;;C12N1/21;;C12N9/04;;C12N9/14;;C12N15/74;;C12Q1/68,435/232,29,21,124-335-592-847-062;;054-399-907-114-548;;025-769-853-797-657;;135-456-794-183-356;;088-273-242-424-372;;017-976-846-535-343;;012-706-634-231-645;;052-328-795-035-042;;179-801-653-878-016;;133-245-607-243-913;;052-549-921-761-790;;166-958-105-502-652;;043-043-968-709-186;;038-382-938-657-069;;061-583-917-506-24X;;008-782-851-804-219;;047-978-243-986-580;;017-390-715-015-286;;001-514-332-046-617;;038-043-510-052-572;;005-222-568-120-407,11489858;;10.1128/jb.183.17.5058-5066.2001;;pmc95381;;14636074;;10.1021/bi034941a;;10.1093/emboj/cdg479;;pmc204463;;14517233;;10.1016/s0141-0229(01)00488-4;;10.1016/s0040-4020(97)00843-0;;10.1016/s0141-0229(97)00255-x;;10.3109/10242429508998161;;10.1016/s1381-1177(97)00034-9;;10.1016/s0957-4166(98)00003-2;;10.1016/s0957-4166(99)00308-0;;10.1021/ol0067540;;11429866;;10.1016/s0957-4166(02)00222-7;;10.1016/0040-4039(94)88167-7;;10.1007/bf00170187;;1656964;;10.1016/s0006-291x(05)81264-1;;10.1016/s0040-4020(01)89297-8;;10.1128/aem.60.4.1297-1301.1994;;8017917;;pmc201473;;10094681;;10.1128/jb.181.7.2050-2058.1999;;pmc93616;;9169427;;10.1074/jbc.272.23.14650;;10.1016/s0958-1669(99)80066-4;;10449315;;1846134;;10.1128/jb.173.1.124-129.1991;;pmc207165,"Van Hylckama et al, ""Halohydrin Dehalogenases Are Structurally and Mechanistically Related To Short-Chain Dehydrogenases/Reductases"", Journal of Bacteriology, vol. 183 No. 17, Sep. 2001, pp. 5058-5066, XP002305277, ISSN: 0021-9193.;;Tang et al, ""Steady-State Kinetics and Tryptophan Fluorescence Properties of Halohydrin Dehalogenase From Agrobacterium Radiobacter. Roles of W139 and W249 In The Active Site and Halide-Induced Conformational Change"", Biochemistry, vol. 42 No. 47, Dec. 2003, pp. 14057-14065, XP002305278, ISSNL 0006-2960.;;De Jong et al, ""Structure and Mechanism Of A Bacterial Haloalcohol Dehalogenase: A New Variation Of The Short-Chain Dehydrogenase/Reductase Fold Without An NAD(P)H Binding Site"", EMBO (European Molecular Biology Organization) Journal, vol. 22 No. 19, Oct. 2003, pp. 4933-4944, XP002305279, ISSN: 0261-4189.;;Lewis M., ""Agrobacterium Tumefaciens Haloalcohol Dehalogenase B Gene, Complete CDS"", Database EMBL 'Online!, Jun. 1999, XP002305665, retrieved from EBI accession No. EM-PRO: AF149769, database accession No. AF149769.;;Tang, et al., 2002, ""Improved Stability of Halohydrin Dehalogenase from Agrobacterium radiobacter AD1 by Replacement of Cysteine Residues,"" Enzyme Microb. Technol., 30:251-258.;;Archer, 1997, ""Epoxide Hydrolases as Asymmetric Catalysts,"" Tetrahedron, Elsevier Science, 53(46):15617-15662.;;Assis, et al., May 1998, ""Synthesis of Chiral Epihalohydrins Using Haloalcohol Dehalogenase A from Arthrobacter Erithii H10a."" Enzyme Microb. Technol. 22:545-551.;;Hallinan, et al., 1995, ""Yeast Catalysed Reduction of beta- keto Esters (2): Optimisation of the Stereospecific Reduction by Zygosaccharomyces Rouxii,"" Biocatal. Biotransform. 12:179-191.;;Kasai et al., 1998, ""Chiral C3 Epoxides and Halohydrins: Their Preparation and Synthetic Application,"" J. Molec. Cat. B: Enzymatic, 4:237-252.;;Lewis et al., 1999, ""Cloning and Nucleotide Sequence of the Haloalcohol Dehalogenase B Gene from Agrobacterium Tumefaciens,"" Database Accession No. Q9WWB6, XP002152213.;;Lutje Spelberg et al., 1998, ""Enantioselectivity of a Recombinant Epoxide Hydrolase from Agrobacterium Radiobacter,"" Tetrahedron: Asymmetry, Elsevier Science, 9(3):459-466.;;Lutje Spelberg et al., 1999, ""A Tandem Enzyme Reaction to Produce Optically Active Halohydrins, Epoxides and Diols,"" Tetrahedron: Asymmetry, 10:2863-2870.;;Lutje Spelberg, et al., 2000, ""Highly Enantioselective and Regioselective Biocatalytic Azidolysis of Aromatic Epoxides,"" Org. Lett., 3(1):41-43.;;Lutje Spelberg, et al., 2002, ""Exploration of the Biocatalytic Potential of a Halohydrin Dehalogenase using Chromogenic Substrates,"" Tetrahedron: Asymmetry, 13:1083-1089.;;Mischitz et al., 1994 ""Asymmetric Opening of an Epoxide by Azide Catalyzed by an Immobilized Enzyme Preparation from Rhodococcus sp.,"" Tetrahedron Letters, 35(1):81-84.;;Nagasawa, et al., 1992, ""Purification and Characterization of Halohydrin Hydrogen-halide Lyase from a Recombinant Escherichia coli Containing the Gene from a Corynebacterium sp.,"" Appl. Microbiol. Biotechnol., 36:478-482.;;Nakamura et al., 1991, ""A New Catalytic Function of Halohydrin Hydrogen-Halide-Lyase, Synthesis of beta-Hydroxynitriles from Epoxides and Cyanide,"" Biochem Biophys Res Commun., 180(1):124-30.;;Nakamura et al., 1994, ""A New Enzymatic Synthesis of (R)-gamma-Chloro-beta-Hydroxybutyronitrile,"" Tetrahedron, Elsevier Science, 50(41):11821-11826.;;Nakamura, et al., 1994, ""Characterization of a Novel Enantioselective Halohydrin Hydrogen-Halide-Lyase,"" Appl. Environ. Microbiol., 60(4):1297-1301.;;Office Action from U.S. Appl. No. 10/917,179 dated Aug. 6, 2007.;;Office Action from U.S. Appl. No. 11/266,747 dated Aug. 8, 2007.;;Office Action from U.S. Appl. No. 11/266,747 dated May 15, 2008.;;PCT International Search Report from PCT/US06/05487 dated Sep. 25, 2008.;;PCT International Search Report from PCT/US04/26654 dated Nov. 29, 2004.;;Poelarends et al., Apr. 1999, ""Degradation of 1,2-Dibromoethane by Mycobacterium sp. Strain GP1,"" J. Bacteriol., 181(7):2050-2058.;;Rink et al., Jun. 1997, ""Primary Structure and Catalytic Mechanism of the Epoxide Hydrolase from Agrobacterium Radiobacter AD1,"" J. Biol. Chem., 272(23):14650-14657.;;SEQ ID No. 2 Comparison to Accession No. AAW69435 in JP1020981 A1.;;Swanson, P. E., 1999, ""Dehalogenases Applied to Industrial-Scale Biocatalysis,"" Curr. Opin. Biotechnol., 10:365-369.;;Van Den Wijngaard et al., Jan. 1991, ""Purification and Characterization of Haloalcohol Dehalogenase from Arthrobacter sp. Strain AD2,"" J. Bacteriol., 173(1):124-129.",ACTIVE
59,AU,A1,AU 2004/265693 A1,128-681-098-382-818,2005-02-24,2005,AU 2004/265693 A,2004-08-11,US 49438203 P;;US 54603304 P;;US 2004/0026654 W,2003-08-11,Improved halohydrin dehalogenases and related polynucleotides,,CODEXIS INC,FOX RICHARD JOHN;;DAVIS S CHRISTOPHER;;HUISMAN GJALT W;;GAVRILOVIC VESNA;;NEWMAN LISA MARIE,,https://lens.org/128-681-098-382-818,Patent Application,no,0,0,17,29,0,C12N9/14;;C12N9/88;;C12N9/14;;C12N15/52;;C12N9/88;;C12N9/88;;C12N9/14,C12N9/88;;C07H21/04;;C12N1/21;;C12N9/04;;C12N9/14;;C12N15/60;;C12N15/74;;C12Q1/68,,0,0,,,,DISCONTINUED
60,US,B2,US 8535910 B2,023-446-377-916-678,2013-09-17,2013,US 201213349514 A,2012-01-12,US 201213349514 A;;US 57382409 A;;US 91717904 A;;US 49438203 P;;US 54603304 P,2003-08-11,Halohydrin dehalogenases and related polynucleotides,"The present invention relates to novel halohydrin dehalogenase polypeptides and the polynucleotides that encode them. These polypeptides are useful in the production of 4-substituted-3-butyric acid derivatives and vicinal cyano, hydroxyl substituted carboxylic acid esters. The invention also provides related vectors, host cells and methods.",DAVIS S CHRISTOPHER;;FOX RICHARD J;;MITCHELL VESNA;;HUISMAN GJALT W;;NEWMAN LISA M;;CODEXIS INC,DAVIS S CHRISTOPHER;;FOX RICHARD J;;MITCHELL VESNA;;HUISMAN GJALT W;;NEWMAN LISA M,,https://lens.org/023-446-377-916-678,Granted Patent,yes,25,2,17,29,742,C12N9/14;;C12N9/88;;C12N9/14;;C12N15/52;;C12N9/88;;C12N9/88;;C12N9/14,C12P21/06;;C07H21/04;;C12N1/21;;C12N9/00;;C12N9/04;;C12N9/14;;C12N9/88;;C12N15/60;;C12N15/74;;C12Q1/68,435/69.1;;435/254.2;;435/320.1;;435/183;;536/23.2,32,21,088-273-242-424-372;;017-976-846-535-343;;025-769-853-797-657;;012-706-634-231-645;;052-328-795-035-042;;179-801-653-878-016;;133-245-607-243-913;;052-549-921-761-790;;166-958-105-502-652;;043-043-968-709-186;;038-382-938-657-069;;061-583-917-506-24X;;008-782-851-804-219;;047-978-243-986-580;;017-390-715-015-286;;001-514-332-046-617;;038-043-510-052-572;;054-399-907-114-548;;135-456-794-183-356;;005-222-568-120-407;;124-335-592-847-062,10.1016/s0040-4020(97)00843-0;;10.1016/s0141-0229(97)00255-x;;10.1093/emboj/cdg479;;pmc204463;;14517233;;10.3109/10242429508998161;;10.1016/s1381-1177(97)00034-9;;10.1016/s0957-4166(98)00003-2;;10.1016/s0957-4166(99)00308-0;;10.1021/ol0067540;;11429866;;10.1016/s0957-4166(02)00222-7;;10.1016/0040-4039(94)88167-7;;10.1007/bf00170187;;1656964;;10.1016/s0006-291x(05)81264-1;;10.1016/s0040-4020(01)89297-8;;10.1128/aem.60.4.1297-1301.1994;;8017917;;pmc201473;;10094681;;10.1128/jb.181.7.2050-2058.1999;;pmc93616;;9169427;;10.1074/jbc.272.23.14650;;10.1016/s0958-1669(99)80066-4;;10449315;;14636074;;10.1021/bi034941a;;10.1016/s0141-0229(01)00488-4;;1846134;;10.1128/jb.173.1.124-129.1991;;pmc207165;;11489858;;10.1128/jb.183.17.5058-5066.2001;;pmc95381,"Archer 1997, ""Epoxide Hydrolases as Asymmetric Catalysts,"" Tetrahedron, Elsevier Science, 53(46):15617-15662.;;Assis et al., 1998, ""Synthesis of Chiral Epihalohydrins Using Haloalcohol Dehalogenase A from Arthrobacter erithii H10a,"" Enzyme Microb. Technol. 22:545-551.;;De Jong et al., 2003, ""Structure and Mechanism of a Bacterial Haloalcohol Dehalogenase: A New Variation of the Short-Chain Dehydrogenase/Reductase Fold Without an NAD(P)H Binding Site,"" EMBO Journal, 22(19):4933-4944, XP002305279, ISSN: 0261-4189.;;Hallinan et al., 1995, ""Yeast Catalysed Reduction of beta-keto Esters (2); Optimisation of the Stereospecific Reduction by Zygosaccharontyces rouxii,"" Biocatal. Biotransform. 12:179-191.;;Kasai et al., 1998, ""Chiral C3 Epoxides and Halohydrins: Their Preparation and Synthetic Application,"" J. Molec. Cat. B: Enzymatic, 4:237-252.;;Lewis et al., 1999, ""Cloning and Nucleotide Sequence of the Haloalcohol Dehalogenase B Gene from Agrobacterium tumefaciens,"" Database Accession No. Q9WWB6, XP002152213.;;Lewis, 1999, ""Agrobacterium tumefaciens Haloalcohol Dehalogenase B Gene, Complete CDS,"" Database EMBL Online!, XP002305665, retrieved from EBI accession No. EM-PRO: AF149769, database accession No. AF149769.;;Lutje Spelberg et al., 1998, ""Enantioselectivity of a Recombinant Epoxide Hydrolase from Agrobacterium radiobacter,"" Tetrahedron: Asymmetry, Elsevier Science, 9(3):459-466.;;Lutje Spelberg et al., 1999, ""A Tandem Enzyme Reaction to Produce Optically Active Halohydrins, Epoxides and Diols,"" Tetrahedron: Asymmetry, 10:2863-2870.;;Lutje Spelberg, et al., 2000, ""Highly Enantioselective and Regioselective Biocatalytic Azidolysis of Aromatic Epoxides,"" Org. Lett., 3(1):41-43.;;Lutje Spelberg, et al., 2002, ""Exploration of the Biocatalytic Potential of a Halohydrin Dehalogenase using Chromogenic Substrates,"" Tetrahedron: Asymmetry, 13:1083-1089.;;Mischitz et al., 1994 ""Asymmetric Opening of an Epoxide by Azide Catalyzed by an Immobilized Enzyme Preparation from Rhodococcus sp.,"" Tetrahedron Letters, 35(1):81-84.;;Nagasawa, at al., 1992, ""Purification and Characterization of Halohydrin Hydrogen-halide Lyase from a Recombinant Escherichla coli Containing the Gene from a Corynebacterium sp.,"" Appl. Microbiol. Btotechnol., 36:478-482.;;Nakamura et al., 1991, ""A New Catalytic Function of Halohydrin Hydrogen-Halide-Lyase, Synthesis of beta-Hydroxynitriles from Epoxides and Cyanide,"" Biochem Blophys Res Commun., 180(1):124-30.;;Nakamura et al., 1994, ""A New Enzymatic Synthesis of (R)-gamma-Chloro-beta-Hydroxybutyronitrile,"" Tetrahedron, Elsevier Science, 50(41):11821-11826.;;Nakamura, et al., 1994, ""Characterization of a Novel Enantioselective Halohydrin Hydrogen-Halide-Lyase,"" Appl. Environ. Microbiol., 60(4):1297-1301.;;Office Action from U.S. Appl. No. 10/917,179 dated Aug. 6, 2007.;;Office Action from U.S. Appl. No. 11/067,323 dated Aug. 8, 2007.;;Office Action from U.S. Appl. No. 11/266,747 dated Aug. 8, 2007.;;Office Action from U.S. Appl. No. 11/266,747 dated May 15, 2008.;;PCT International Search Report from PCT/US06/05487 dated Sep. 25, 2008.;;PCT International Search Report from PCT/US04/26654 dated Nov. 29, 2004.;;Poelarends et al., 1999, ""Degradation of 1,2-Dibromoethane by Mycobacterium sp. Strain GP1,"" J. Bacteriol., 181(7):2050-2058.;;Rink et al., Jun. 1997, ""Primary Structure and Catalytic Mechanism of the Epoxide Hydrolase from Agrobacterium radiobacter AD1,"" J. Biol. Chem., 272(23):14650-14657.;;SEQ ID No. 2 Comparison to Accession No. AAW69435 in JP1020981 A1.;;Swanson, P. B., 1999, ""Dehalogenases Applied to Industrial-Scale Biocatalysis,"" Curr. Opin. Biotechnol., 10:365-369.;;Tang et al., 2003, ""Steady-State Kinetics and Tryptophan Fluorescence Properties of Halohydrin Dehalogenase from Agrobacterium radiobacter. Roles of W139 and W249 in the Active Site and Halide-Induced Conformational Change,"" Biochemistry, 42(47):14057-14065, XP002305278, ISSNL 0006-2960.;;Tang et al., 2002, ""Improved Stability of Halohydrin Dehalogenase from Agrobacterium radiobacter AD1 by Replacement of Cysteine Residues,"" Enzyme Microb. Technol., 30:251-258.;;Van Den Wijngaard et al., 1991, ""Purification and Characterization of Haloalcohol Dehalogenase from Arthrobacter sp. Strain AD2,"" J. Bacteriol., 173(1):124-129.;;Van Hylckama et al., 2001, ""Halohydrin Dehalogenases are Structurally and Mechanistically Related to Short-Chain Dehydrogenases/Reductases,"" Journal of Bacteriology, 183(17):5058-5066, XP002305277, ISSN: 0021-9193.;;Supplementary European Search Report from BP06735244.3 dated Jul. 9, 2009.;;Search Report from SG200808477-4 dated Apr. 13, 2010.",ACTIVE
61,EP,B1,EP 0086556 B1,026-155-203-109-867,1986-05-07,1986,EP 83300191 A,1983-01-14,US 34489582 A,1982-02-01,PROCESS FOR PREPARING (3S)-3-(((2-AMINO-4-THIAZOLYL)((1-CARBOXY-1-METHYLETHOXY)IMINO)-ACETYL)AMINO)-2-OXO-1-AZETIDINESULFONIC ACID AND 4-SUBSTITUTED DERIVATIVES,"Disclosed herein is a process for preparing a compound having the formula <IMAGE> which comprises coupling a compound having the formula <IMAGE> or a salt thereof, with a compound having the formula <IMAGE> to obtain a compound having the formula <IMAGE> reacting that compound with 2-aminooxy-2-methylpropanoic acid, or a salt thereof, to obtain a compound having the formula <IMAGE> and, if R is an amino protecting group, deprotecting that compound to yield the desired product; wherein R is hydrogen or an amino protecting group; R1 is hydrogen, methyl or ethyl; M(+) is an inorganic cation or a substituted ammonium ion; and M1(+) is hydrogen, an inorganic cation or a substituted ammonium ion.","E.R. SQUIBB & SONS, INC.","CIMARUSTI, CHRISTOPHER M.;;FOX, RITA T.;;FRITZ, ALAN W.;;KOSTER, WILLIAM H.;;MONIOT, JEROME L.",,https://lens.org/026-155-203-109-867,Granted Patent,yes,0,0,10,10,0,C07D277/587;;C07D417/12;;Y02P20/55;;C07D277/587;;C07D417/12;;Y02P20/55,C07D205/085;;C07D205/08;;C07D277/20;;C07D417/12,,0,0,,,,EXPIRED
62,US,A1,US 2023/0114769 A1,083-506-638-989-620,2023-04-13,2023,US 202218080636 A,2022-12-13,US 202218080636 A;;US 202117517009 A;;US 202063108754 P,2020-11-02,REMOTE CONTROLLER SOURCE ADDRESS VERIFICATION AND RETENTION FOR ACCESS DEVICES,Systems and methods for source address verification and/or retention for access devices.,ARRIS ENTPR LLC,BEAN JANET T;;ANAND IMMANUEL E;;FOX CHRISTOPHER W;;BARAN DAVID F;;EMMENDORFER MICHAEL J,,https://lens.org/083-506-638-989-620,Patent Application,yes,4,0,3,3,0,H04L45/021;;H04L61/5014;;H04L45/021;;H04L61/5014;;H04L45/66;;H04L45/655,H04L61/5014;;H04L45/00;;H04L45/021;;H04L45/655,,0,0,,,,PENDING
63,CN,B,CN 1873675 B,112-808-496-281-830,2015-07-22,2015,CN 200610085076 A,2006-05-31,US 14122905 A,2005-05-31,System and method for customizing and installation communication processing system application,,DELL PRODUCTS LP,RONES CRAIG;;FOX STACEY;;RALEY JEFFERSON WATTS;;HARDING CHRISTOPHER;;HANES KEVIN LEE;;COX TIM W,,https://lens.org/112-808-496-281-830,Granted Patent,no,0,0,13,13,0,H04L41/022;;H04L41/0816;;H04L67/1095;;G06F16/40;;G16Z99/00;;G06F17/00;;G06F30/18;;H04L41/0816;;H04L41/12;;H04L41/022;;H04L67/1095,H04L12/24;;H04L29/08,,0,0,,,,ACTIVE
64,WO,A1,WO 2010/093773 A1,014-653-592-777-514,2010-08-19,2010,US 2010/0023866 W,2010-02-11,US 15160109 P,2009-02-11,CAST REMOVAL DEVICE,Apparatus and methods for cutting through a layer of material. Some embodiments pertain to the removal of an orthopedic cast in a manner that is quiet and generates little or no particulate matter. In yet other embodiments there are a pair of toothed wheels that press down and penetrate into the cast and then split the cast by moving it past a sharp edge. In some embodiments the cutting head is reversible for the cutting of material in either of two opposite directions.,ORTHOPEDIATRICS LLC;;DEETER NICK A;;SEGGERN ROBERT VON;;DANIELS DAVID W;;FOX MARK;;BROWN SCOTT;;BREMER CHRISTOPHER,DEETER NICK A;;SEGGERN ROBERT VON;;DANIELS DAVID W;;FOX MARK;;BROWN SCOTT;;BREMER CHRISTOPHER,,https://lens.org/014-653-592-777-514,Patent Application,yes,3,0,2,2,0,A61F5/05;;A61F5/05;;Y10T83/04;;Y10T83/04;;Y10T83/0405;;Y10T83/0405,A61F5/04,,0,0,,,,PENDING
65,US,A,US 4443374 A,188-276-997-652-428,1984-04-17,1984,US 34489582 A,1982-02-01,US 34489582 A,1982-02-01,"Process for preparing (3S)-3-[[(2-amino-4-thiazolyl)[(1-carboxy-1-methylethoxy)imino]-acetyl]amino]-2-oxo-1-azetidinesulfonic acid, and 4-substituted derivatives","Disclosed herein is a process for preparing a compound having the formula ##STR1## which comprises coupling a compound having the formula ##STR2## or a salt thereof, with a compound having the formula ##STR3## to obtain a compound having the formula ##STR4## reacting that compound with 2-aminooxy-2-methylpropanoic acid, or a salt thereof, to obtain a compound having the formula ##STR5## and, if R is an amino protecting group, deprotecting that compound to yield the desired product; wherein R is hydrogen or an amino protecting group; R.sub.1 is hydrogen, methyl or ethyl; M.sup..sym. is an inorganic cation or a substituted ammonium ion; and M.sub.1.sup..sym. is hydrogen, an inorganic cation or a substituted ammonium ion.",SQUIBB & SONS INC,CIMARUSTI CHRISTOPHER M;;FOX RITA T;;FRITZ ALAN W;;KOSTER WILLIAM H;;MONIOT JEROME L,E.R. SQUIBB & SONS INC. LAWRENCEVILLE-PRINCETON ROAD PRINCTON NJ 08540 A DE CORP (1982-05-19),https://lens.org/188-276-997-652-428,Granted Patent,yes,9,3,10,10,0,C07D277/587;;C07D417/12;;Y02P20/55;;C07D277/587;;C07D417/12;;Y02P20/55,C07D205/085;;C07D277/20;;C07D417/12;;C07D205/08,260/245.4;;X260239A,1,1,019-437-529-451-592,7106103;;10.1111/j.1432-1033.1982.tb06622.x,"Georgopapadakou et al., European J. Biochem. 124, 507, (1982).",EXPIRED
66,US,B2,US 9228223 B2,189-794-518-380-055,2016-01-05,2016,US 201313757554 A,2013-02-01,US 201313757554 A;;US 6986908 A;;US 90134907 P;;US 90993707 P,2007-02-12,Structure-activity relationships,The present disclosure relates to compositions and methods for screening a plurality of polypeptide variants.,CODEXIS INC,MUNDORFF EMILY;;DAVIS SIMON CHRISTOPHER;;HUISMAN GJALT W;;KREBBER ANKE;;GRATE JOHN H;;FOX RICHARD,,https://lens.org/189-794-518-380-055,Granted Patent,yes,42,1,9,9,0,C12N9/00;;C12N15/1093;;C40B10/00;;C40B30/04;;C40B40/02;;C40B40/10;;G16B20/00;;G16B20/50;;G16B20/30;;G16B20/00;;C12N9/00;;C12N15/1093;;C40B10/00;;C40B30/04;;C40B40/02;;C40B40/10;;G16B20/30;;G16B20/50;;C12Q1/26;;G01N33/6845;;C12Q1/25;;C12Q1/00;;G01N33/6803,C40B30/04;;C12N9/00;;C12N15/10;;C12Q1/00;;C12Q1/25;;C12Q1/26;;C40B10/00;;C40B30/08;;C40B40/02;;C40B40/10;;G01N33/68;;G16B20/30;;G16B20/50,,28,26,014-584-465-169-448;;052-172-855-558-614;;008-462-945-304-888;;011-686-095-284-884;;017-122-411-657-318;;016-590-136-897-288;;016-450-308-736-102;;092-496-127-267-968;;087-617-084-673-049;;013-988-646-246-259;;018-781-288-221-53X;;013-746-913-107-105;;004-794-542-070-525;;010-071-391-784-51X;;125-626-680-797-145;;062-058-464-640-155;;131-077-545-152-545;;000-131-434-792-181;;061-730-951-147-698;;072-967-973-861-539;;059-962-100-715-651;;035-910-384-330-626;;044-488-867-123-328;;060-207-248-889-056;;161-514-851-540-045;;003-957-099-086-043,11564557;;10.1016/s1074-5521(01)00061-8;;10.1016/s1359-6446(00)01910-2;;12546969;;10.1109/icec.1994.350037;;10.1016/s0167-7799(00)89015-0;;8595137;;10.1038/12884;;10471932;;10.1006/abio.1999.4363;;10660453;;17322872;;10.1038/nbt1286;;11875428;;10.1038/nbt0302-270;;10976071;;10.1126/science.289.5485.1760;;10.1016/s0958-1669(02)00350-6;;12482512;;12943855;;10.1016/s0958-1669(03)00099-5;;pmc556283;;15811944;;10.1073/pnas.0409206102;;14966663;;10.1007/s00253-004-1568-8;;10.1016/s1367-5931(98)80043-4;;9667912;;10.1016/s0958-1669(02)00328-2;;12323357;;15866000;;10.1016/j.tibtech.2005.03.005;;12943849;;10.1016/s0958-1669(03)00093-4;;10.1016/j.jmb.2005.10.082;;16325201;;12547427;;10.1016/s1367-5931(02)00005-4;;10.1038/ng1482;;15568024;;12714060;;10.1016/s1367-5931(03)00032-2;;10.1016/s0958-1669(03)00101-0;;12943844;;12878003;;10.1016/s0968-0004(03)00135-x;;10099128;;10.1016/s1074-5521(99)80033-7;;9770460;;pmc22805;;10.1073/pnas.95.21.12179;;10.1021/ar030250v;;15023082,"Raillard et al., ""Novel enzyme activities and functional plasticity revealed by recombining highly homologous enzymes,"" Chem. Biol. 2001, 8:891-898.;;Templin et al., ""Protein microarray technology,"" Drug Discov. Today 2002, 7:815-822.;;Horn, J., et al., ""A Niched Pareto Genetic Algorithm for Multiobjective Optimization,"" Evolutional Computation, IEEE World Congress on Computational Intelligence, Proceedings of the First IEEE Conference on Orlando, FL, USA, pp. 82-87, Jun. 1994.;;Willett, P., ""Genetic algorithms in molecular recognition and design,"" Trends in Biotechnology, 13(12):516-521, 1995.;;Ness, et al., ""DNA shuffling of subgenomic sequences of subtilisin,"" Nature Biotechnology, 17:893-896, 1999.;;Arenkov, et al., 2000, ""Protein Microchips: Use for Immunoassay and Enzymatic Reactions,"" Anal. Biochem., 278:123-131.;;Fox, et al., 2007, ""Improving catalytic function by ProSAR-driven enzyme evolution,"" Nat. Biotechnol., 25(3):338-344.;;Houseman, et al., 2002, ""Peptide chips for the quantitative evaluation of protein kinase activity,"" Nat. Biotechnol., 20:270-274.;;MacBeath et al., 2000, ""Printing Proteins as Microarrays for High-Throughput Function Determination,"" Science, 289:1760-1763.;;Bornscheuer, 2002, ""Methods to increase enantioselectivity of lipases and esterases,"" Curr. Opin. Biotechnol., 13(6):543-547.;;Cherry et al., 2003, ""Directed evolution of industrial enzymes: an update,"" Curr. Opin. Biotechnol., 14(4):438-443.;;Chockalingam et al., 2005, ""Directed evolution of specific receptor-ligand pairs for use in the creation of gene switches,"" Proc. Nat. Acad. Sci. U.S.A., 102(16)5691-5696.;;Gupta et al., 2004, ""Bacterial lipases: an oveniew of production, purification and biochemical properties,"" Appl. Microbiol. Biotechnol., 64(6)763-781.;;PCT International Search Report from PCT/US2008/001907, dated Jan. 13, 2009.;;Kazlauskas et al., 1998, ""Improving hydrolases for organic synthesis,"" Curr. Opin. Chem. Biol., 2(1):121-126.;;Kirk et al., 2002, ""Industrial enzyme applications,"" Curr. Opin. Chem. Biol., 13(4):345-351.;;Morley et al., 2005, ""Improving enzyme properties: when are closer mutations better?"", Trends Biotechnol., 23(5):231-237.;;Turner, 2003, ""Controlling Chirality,"" Curr. Opin. Chem. Biol., 14(4):401-406.;;Wong et al., 2006, ""A Statistical Analysis of Random Mutagenesis Methods Used for Directed Protein Evolution,"" J. Mol. Biol. , 355(4):858-871.;;Zhu et al., 2003, ""Protein chip technology,"" Curr. Opin. Chem. Biol. , 7(1)55-63).;;Aharoni et al., 2005, Nature Genetics 37(1):73-76.;;Copley, S.D., 2003, Curr.Opin.Chem. Biol. 7:265-272.;;Gustafsson et al., 2003, Curr. Opin. Biotech. 14:366-370.;;James, L.C. and Tawfik, D.D., Trends Biochem. Sci. 28(7):361-368, Jul. 2003.;;O'Brien, P.J. and Herschlag, D., 1999, Chem.& Biol. 6(4):R91-R105.;;Schneider et al., 1998, Proc. Natl. Acad. Sci. USA 95:12179-12184.;;Wise, E.L., and Rayment, I, 2004, Acc Chem. Res. 37:149-158.;;Yazbeck et al., 2003, Adv. Synth. Catal. 345(4):524-532.",ACTIVE
67,US,A1,US 2015/0191767 A1,022-142-501-550-759,2015-07-09,2015,US 201514662541 A,2015-03-19,US 201514662541 A;;US 201313764252 A;;US 6986908 A;;US 90134907 P;;US 90993707 P,2007-02-12,STRUCTURE-ACTIVITY RELATIONSHIPS,The present disclosure relates to compositions and methods for screening a plurality of polypeptide variants.,CODEXIS INC,MUNDORFF EMILY;;DAVIS SIMON CHRISTOPHER;;HUISMAN GJALT W;;KREBBER ANKE;;GRATE JOHN H;;FOX RICHARD,,https://lens.org/022-142-501-550-759,Patent Application,yes,0,0,9,9,0,C12N9/00;;C12N15/1093;;C40B10/00;;C40B30/04;;C40B40/02;;C40B40/10;;G16B20/00;;G16B20/50;;G16B20/30;;G16B20/00;;C12N9/00;;C12N15/1093;;C40B10/00;;C40B30/04;;C40B40/02;;C40B40/10;;G16B20/30;;G16B20/50;;C12Q1/26;;G01N33/6845;;C12Q1/25;;C12Q1/00;;G01N33/6803,C12Q1/25;;G16B20/30;;G16B20/50,,0,0,,,,DISCONTINUED
68,US,B2,US 11552928 B2,158-839-821-141-489,2023-01-10,2023,US 202117517009 A,2021-11-02,US 202117517009 A;;US 202063108754 P,2020-11-02,Remote controller source address verification and retention for access devices,Systems and methods for source address verification and/or retention for access devices.,ARRIS ENTPR LLC,BEAN JANET T;;ANAND IMMANUEL E;;FOX CHRISTOPHER W;;BARAN DAVID F;;EMMENDORFER MICHAEL J,ARRIS ENTERPRISES LLC (2021-11-04),https://lens.org/158-839-821-141-489,Granted Patent,yes,5,0,3,3,0,H04L45/021;;H04L61/5014;;H04L45/021;;H04L61/5014;;H04L45/66;;H04L45/655,H04L61/5014;;H04L45/00;;H04L45/021;;H04L45/655,,0,0,,,,ACTIVE
69,DE,D1,DE 3363312 D1,059-182-817-685-296,1986-06-12,1986,DE 3363312 T,1983-01-14,US 34489582 A,1982-02-01,PROCESS FOR PREPARING (3S)-3-(((2-AMINO-4-THIAZOLYL)((1-CARBOXY-1-METHYLETHOXY)IMINO)-ACETYL)AMINO)-2-OXO-1-AZETIDINESULFONIC ACID AND 4-SUBSTITUTED DERIVATIVES,"Disclosed herein is a process for preparing a compound having the formula <IMAGE> which comprises coupling a compound having the formula <IMAGE> or a salt thereof, with a compound having the formula <IMAGE> to obtain a compound having the formula <IMAGE> reacting that compound with 2-aminooxy-2-methylpropanoic acid, or a salt thereof, to obtain a compound having the formula <IMAGE> and, if R is an amino protecting group, deprotecting that compound to yield the desired product; wherein R is hydrogen or an amino protecting group; R1 is hydrogen, methyl or ethyl; M(+) is an inorganic cation or a substituted ammonium ion; and M1(+) is hydrogen, an inorganic cation or a substituted ammonium ion.",SQUIBB & SONS INC,CIMARUSTI CHRISTOPHER M;;FOX RITA T;;FRITZ ALAN W;;KOSTER WILLIAM H;;MONIOT JEROME L,,https://lens.org/059-182-817-685-296,Granted Patent,no,0,0,10,10,0,C07D277/587;;C07D417/12;;Y02P20/55;;C07D277/587;;C07D417/12;;Y02P20/55,C07D205/08;;C07D205/085;;C07D277/20;;C07D417/12,,0,0,,,,EXPIRED
70,US,A1,US 2012/0042524 A1,054-406-530-671-119,2012-02-23,2012,US 201013201090 A,2010-02-11,US 201013201090 A;;US 15160109 P;;US 2010/0023866 W,2009-02-11,CAST REMOVAL DEVICE,Apparatus and methods for cutting through a layer of material. Some embodiments pertain to the removal of an orthopedic cast in a manner that is quiet and generates little or no particulate matter. In yet other embodiments there are a pair of toothed wheels that press down and penetrate into the cast and then split the cast by moving it past a sharp edge. In some embodiments the cutting head is reversible for the cutting of material in either of two opposite directions.,DEETER NICK A;;VON SEGGERN ROBERT;;DANIELS DAVID W;;FOX MARK;;BROWN SCOTT;;BREMER CHRISTOPHER,DEETER NICK A;;VON SEGGERN ROBERT;;DANIELS DAVID W;;FOX MARK;;BROWN SCOTT;;BREMER CHRISTOPHER,ORTHOPEDIATRICS CORP (2011-11-01);;Z-CAST LLC (2009-08-07);;ORTHOPEDIATRICS CORPORATION (2009-08-07),https://lens.org/054-406-530-671-119,Patent Application,yes,29,5,2,2,0,A61F5/05;;A61F5/05;;Y10T83/04;;Y10T83/04;;Y10T83/0405;;Y10T83/0405,A61F15/02;;B26D7/06;;B26D7/14,30/278;;83/13;;83/14,0,0,,,,DISCONTINUED
71,FR,A1,FR 2886432 A1,093-223-382-773-983,2006-12-01,2006,FR 0604820 A,2006-05-31,US 14122905 A,2005-05-31,SYSTEME ET PROCEDE DE COMMANDE ET D'INSTALLATION DE SYSTEMES INFORMATIQUES A LA DEMANDE,Le remplacement d'anciens systèmes de traitement d'information (10) auprès d'un site de déploiement (14) est géré de façon automatisée en coopération avec un site de fabrication (28) de systèmes de traitement d'information en coordonnant la construction de systèmes de traitement d'information de remplacement (52) avec des configurations appropriées. Un outil de découverte de biens (16) s'interface avec les anciens systèmes de traitement d'information (10) à travers un réseau (12) du site de déploiement (14) afin de découvrir les configurations des anciens systèmes (10) et communique les anciennes configurations au site de fabrication (28). Un moteur de traduction de biens (34) traduit les anciennes configurations en des configurations de remplacement pour la construction de systèmes de traitement d'information de remplacement (52).,DELL PRODUCTS LP,RALEY JEFFERSON WATTS;;COX TIM W;;FOX STACEY;;HANES KEVIN LEE;;HARDING CHRISTOPHER;;RONES CRAIG,,https://lens.org/093-223-382-773-983,Patent Application,no,0,0,13,13,0,H04L41/022;;H04L41/0816;;H04L67/1095;;G06F16/40;;G16Z99/00;;G06F17/00;;G06F30/18;;H04L41/0816;;H04L41/12;;H04L41/022;;H04L67/1095,G06F19/00;;H04L12/24,,0,0,,,,PENDING
72,EP,A1,EP 0086556 A1,131-635-241-430-562,1983-08-24,1983,EP 83300191 A,1983-01-14,US 34489582 A,1982-02-01,Process for preparing (3S)-3-(((2-amino-4-thiazolyl)((1-carboxy-1-methylethoxy)imino)-acetyl)amino)-2-oxo-1-azetidinesulfonic acid and 4-substituted derivatives.,"Disclosed herein is a process for preparing a compound having the formula
  which comprises coupling a compound having the formula
  or a salt thereof, with a compound having the formula
  to obtain a compound having the formula
  reacting that compound with 2-aminooxy-2-methyl- propanoic acid, or a salt thereof, to obtain a compoung having the formula
  and, if R is an amino protecting group, deprotecting that compound to yield the desired product; wherein
 R is hydrogen or an amino protecting group; R 1  is hydrogen, methyl or ethyl; M⊕ is an inorganic cation or a substituted ammonium ion; and M 1 ⊕ is hydrogen, an inorganic cation or a substituted ion.",SQUIBB & SONS INC,CIMARUSTI CHRISTOPHER M;;FOX RITA T;;FRITZ ALAN W;;KOSTER WILLIAM H;;MONIOT JEROME L,,https://lens.org/131-635-241-430-562,Patent Application,yes,4,7,10,10,0,C07D277/587;;C07D417/12;;Y02P20/55;;C07D277/587;;C07D417/12;;Y02P20/55,C07D205/085;;C07D205/08;;C07D277/20;;C07D417/12,,0,0,,,,EXPIRED
73,CA,A,CA 1196335 A,173-426-028-536-598,1985-11-05,1985,CA 420362 A,1983-01-27,US 34489582 A,1982-02-01,"PROCESS FOR PREPARING (3S)-3-[[(2-AMINO-4- THIAZOLYL)[(1-CARBOXY-1- METHYLETHOXY)IMINO]ACETYL]AMINO]-2-OXO-1- AZETIDINESULFONIC ACID, AND 4-SUBSTITUTED DERIVATIVES","ABSTRACT PROCESS FOR PREPARING (3S)-3-[[(2-AMINO-4-THIAZOLYL)](1-CARBOXY-1-METHYLETHOXY)IMINO]-ACETYL)AMINO]-2-OXO-1-AZETIDINESULFONIC ACID, AND 4-SUBSTITUTED DERIVATIVES Disclosed herein is a process for preparing a compound having the formula , which comprises coupling a compound having the formula or a salt thereof, with a compound having the formula to obtain a compound having the formula reacting that compound with 2-aminooxy-2-methyl-propanoic acid, or a salt thereof, to obtain a compound having the formula and, if R is an amino protecting group, deprotecting that compound to yield the desired product; wherein R is hydrogen or an amino protecting group; R1 is hydrogen, methyl or ethyl; M? is an inorganic cation or a substituted am-monium ion; and M? is hydrogen, an inorganc cation or a substi-tuted ammonium ion. The compounds thus prepared are .beta.-lactam anti-biotics which are useful for combating bacterial in-fections.",SQUIBB & SONS INC,CIMARUSTI CHRISTOPHER M;;FOX RITA T;;FRITZ ALAN W;;KOSTER WILLIAM H;;MONIOT JEROME L,,https://lens.org/173-426-028-536-598,Granted Patent,no,0,0,10,10,0,C07D277/587;;C07D417/12;;Y02P20/55;;C07D277/587;;C07D417/12;;Y02P20/55,C07D205/08;;C07D205/085;;C07D277/20;;C07D417/12,260-302,0,0,,,,EXPIRED
74,GB,A,GB 2426844 A,175-908-251-044-064,2006-12-06,2006,GB 0610518 A,2006-05-26,US 14122905 A,2005-05-31,An automated method for replacing legacy systems with a package of current applications including repackaging and integrating unique legacy applications.,Replacement of legacy information handling systems at a deployment site is automatically managed in cooperation with an information handling system manufacture site by coordinating the building of replacement information handling systems with appropriate configurations. An asset discovery tool interfaces with the legacy information handling systems through a deployment site network to discover the configurations of the legacy systems and communicates the legacy configurations to the manufacture site. An asset translation engine translates the legacy configurations to replacement configurations for building the replacement information handling systems. The ordering of replacement systems and the translation to the replacement configuration is managed by rules defined through an order tool of the deployment site and may include applications packaged at the deployment site and communicated to the manufacture site for installation on the replacement systems.,DELL PRODUCTS LP,RALEY JEFFERSON WATTS;;COX TIM W;;FOX STACEY;;HANES KEVIN LEE;;HARDING CHRISTOPHER;;RONES CRAIG,,https://lens.org/175-908-251-044-064,Patent Application,no,0,0,13,13,0,H04L41/022;;H04L41/0816;;H04L67/1095;;G06F16/40;;G16Z99/00;;G06F17/00;;G06F30/18;;H04L41/0816;;H04L41/12;;H04L41/022;;H04L67/1095,G06Q10/00;;G06F17/00;;G06F17/30;;G06F19/00;;G06Q50/00,G4A AUXB          UXB;;G4A AUXX          UXB,0,0,,,,DISCONTINUED
75,AT,T1,AT E19631 T1,177-672-314-628-900,1986-05-15,1986,AT 83300191 T,1983-01-14,EP 83300191 A;;US 34489582 A,1982-02-01,VERFAHREN ZUR HERSTELLUNG VON (3S)-3-(((2-AMINO-4-THIAZOLYL)-((1-CARBOXY-1-ME HYLETHOXY)-IMINO)ACETYL)-AMINO)-2-OXO-1-AZETIDINSULFONS|URE UND 4- SUBSTITUIERTEN DERIVATEN.,"Disclosed herein is a process for preparing a compound having the formula <IMAGE> which comprises coupling a compound having the formula <IMAGE> or a salt thereof, with a compound having the formula <IMAGE> to obtain a compound having the formula <IMAGE> reacting that compound with 2-aminooxy-2-methylpropanoic acid, or a salt thereof, to obtain a compound having the formula <IMAGE> and, if R is an amino protecting group, deprotecting that compound to yield the desired product; wherein R is hydrogen or an amino protecting group; R1 is hydrogen, methyl or ethyl; M(+) is an inorganic cation or a substituted ammonium ion; and M1(+) is hydrogen, an inorganic cation or a substituted ammonium ion.",SQUIBB & SONS INC,CIMARUSTI CHRISTOPHER M;;FOX RITA T;;FRITZ ALAN W;;KOSTER WILLIAM H;;MONIOT JEROME L,,https://lens.org/177-672-314-628-900,Granted Patent,no,0,0,10,10,0,C07D277/587;;C07D417/12;;Y02P20/55;;C07D277/587;;C07D417/12;;Y02P20/55,C07D205/08;;C07D205/085;;C07D277/20;;C07D417/12,,0,0,,,,DISCONTINUED
76,US,A1,US 2022/0141177 A1,070-613-526-616-266,2022-05-05,2022,US 202117517009 A,2021-11-02,US 202117517009 A;;US 202063108754 P,2020-11-02,REMOTE CONTROLLER SOURCE ADDRESS VERIFICATION AND RETENTION FOR ACCESS DEVICES,Systems and methods for source address verification and/or retention for access devices.,ARRIS ENTPR LLC,BEAN JANET T;;ANAND IMMANUEL E;;FOX CHRISTOPHER W;;BARAN DAVID F;;EMMENDORFER MICHAEL J,ARRIS ENTERPRISES LLC (2021-11-04),https://lens.org/070-613-526-616-266,Patent Application,yes,0,0,3,3,0,H04L45/021;;H04L61/5014;;H04L45/021;;H04L61/5014;;H04L45/66;;H04L45/655,H04L61/5014;;H04L45/021,,0,0,,,,ACTIVE
77,IE,A1,IE 20060400 A1,116-379-103-378-619,2007-01-24,2007,IE 20060400 A,2006-05-19,US 14122905 A,2005-05-31,System and method for information handling system custom application ordering and installation,Replacement of legacy information handling systems at a deployment site is automatically managed in cooperation with an information handling system manufacture site by coordinating the building of replacement information handling systems with appropriate configurations. An asset discovery tool interfaces with the legacy information handling systems through a deployment site network to discover the configurations of the legacy systems and communicates the legacy configurations to the manufacture site. An asset translation engine translates the legacy configurations to replacement configurations for building the replacement information handling systems. The ordering of replacement systems and the translation to the replacement configuration is managed by rules defined through an order tool of the deployment site and may include applications packaged at the deployment site and communicated to the manufacture site for installation on the replacement systems.,DELL PRODUCTS LP,RONES CRAIG;;FOX STACEY;;HARDING CHRISTOPHER;;COX TIM W;;HANES KEVIN LEE;;RALEY JEFFERSON WATTS,,https://lens.org/116-379-103-378-619,Patent Application,no,0,0,13,13,0,H04L41/022;;H04L41/0816;;H04L67/1095;;G06F16/40;;G16Z99/00;;G06F17/00;;G06F30/18;;H04L41/0816;;H04L41/12;;H04L41/022;;H04L67/1095,G06F17/30;;G06F19/00;;G06Q10/00,,0,0,,,,DISCONTINUED
78,US,A1,US 2009/0298125 A1,120-343-347-373-873,2009-12-03,2009,US 50537409 A,2009-07-17,US 50537409 A;;US 26674705 A;;US 6732305 A;;US 91717904 A;;US 54603304 P;;US 49438203 P,2003-08-11,HALOHYDRIN DEHALOGENASES AND RELATED POLYNUCLEOTIDES,"The present invention relates to novel halohydrin dehalogenase polypeptides and the polynucleotides that encode them. These polypeptides are useful in the production of 4-substituted-3-butyric acid derivatives and vicinal cyano, hydroxyl substituted carboxylic acid esters. The invention also provides related vectors, host cells and methods.",CODEXIS INC,DAVIS S CHRISTOPHER;;FOX RICHARD J;;HUISMAN GJALT W;;GAVRILOVIC VESNA;;MUNDORFF EMILY C;;NEWMAN LISA M,,https://lens.org/120-343-347-373-873,Patent Application,yes,16,1,9,29,2848,C12N9/14;;C12N9/14;;C12N9/88;;C12N9/88,C12P21/06;;C07H21/04;;C12N1/19;;C12N1/21;;C12N9/00;;C12N9/04;;C12N9/14;;C12N9/88;;C12N15/60;;C12N15/63;;C12N15/74;;C12Q1/68,435/69.1;;435/183;;536/23.2;;435/320.1;;435/254.2,0,0,,,,ACTIVE
79,US,B2,US 7588928 B2,155-337-987-747-553,2009-09-15,2009,US 26674705 A,2005-11-02,US 26674705 A;;US 6732305 A;;US 91717904 A;;US 54603304 P;;US 49438203 P,2003-08-11,Halohydrin dehalogenases and related polynucleotides,"The present invention relates to novel halohydrin dehalogenase polypeptides and the polynucleotides that encode them. These polypeptides are useful in the production of 4-substituted-3-butyric acid derivatives and vicinal cyano, hydroxyl substituted carboxylic acid esters. The invention also provides related vectors, host cells and methods.",CODEXIS INC,DAVIS S CHRISTOPHER;;FOX RICHARD JOHN;;HUISMAN GJALT W;;GAVRILOVIC VESNA;;MUNDORFF EMILY C;;NEWMAN LISA MARIE,CODEXIS INC (2005-12-10),https://lens.org/155-337-987-747-553,Granted Patent,yes,24,9,9,29,2848,C12N9/14;;C12N9/14;;C12N9/88;;C12N9/88,C12N9/88;;C07H21/04;;C12N1/21;;C12N9/04;;C12N9/14;;C12N15/60;;C12N15/74;;C12Q1/68,435/232,22,15,088-273-242-424-372;;017-976-846-535-343;;052-328-795-035-042;;179-801-653-878-016;;133-245-607-243-913;;043-043-968-709-186;;061-583-917-506-24X;;008-782-851-804-219;;017-390-715-015-286;;001-514-332-046-617;;005-222-568-120-407;;025-769-853-797-657;;012-706-634-231-645;;038-382-938-657-069;;038-043-510-052-572,10.1016/s0040-4020(97)00843-0;;10.1016/s0141-0229(97)00255-x;;10.1016/s1381-1177(97)00034-9;;10.1016/s0957-4166(98)00003-2;;10.1016/s0957-4166(99)00308-0;;10.1016/0040-4039(94)88167-7;;1656964;;10.1016/s0006-291x(05)81264-1;;10.1016/s0040-4020(01)89297-8;;10094681;;10.1128/jb.181.7.2050-2058.1999;;pmc93616;;9169427;;10.1074/jbc.272.23.14650;;1846134;;10.1128/jb.173.1.124-129.1991;;pmc207165;;10.1093/emboj/cdg479;;pmc204463;;14517233;;10.3109/10242429508998161;;10.1007/bf00170187;;10.1016/s0958-1669(99)80066-4;;10449315,"Archer, 1997, ""Epoxide Hydrolases as Asymmetric Catalysts,"" Tetrahedron, Elsevier Science, 53(46):15617-15662.;;Assis et al., 1998, ""Synthesis of Chiral Epihalohydrins Using Haloalcohol Dehalogenase A from Arthrobacter erithii H10a,"" Enzyme Microb. Technol. 22:545-551.;;Kasai et al., 1998, ""Chiral C3 Epoxides and Halohydrins: Their Preparation and Synthetic Application,"" J. Molec. Cat. B: Enzymatic, 4:237-252.;;Lewis et al., 1999, ""Cloning and Nucleotide Sequence of the Haloalcohol Dehalogenase B Gene from Agrobacterium tumefaciens,"" Database Accession No. Q9WWB6, XP002152213.;;Lewis, M., 1999, ""Agrobacterium tumefaciens Haloalcohol Dehalogenase B Gene, complete CDs,"" Database EMBL Online! XP002305665 retrieved from EBI accession No. EM-PRO:AF149769, Database Accession No. AF149769.;;Lutje Spelberg et al., 1998, ""Enantioselectivity of a Recombinant Epoxide Hydrolase from Agrobacterium radiobacter,"" Tetrahedron: Asymmetry, Elsevier Science, 9(3):459-466.;;Lutje Spelberg et al., 1999, ""A Tandem Enzyme Reaction to Produce Optically Active Halohydrins, Epoxides and Diols,"" Tetrahedron: Asymmetry, 10:2863-2870.;;Mischitz et al., 1994 ""Asymmetric Opening of an Epoxide by Azide Catalyzed by an Immobilized Enzyme Preparation from Rhodococcus sp.,"" Tetrahedron Letters, 35(1):81-84.;;Nakamura et al., 1991, ""A New Catalytic Function of Halohydrin Hydrogen-Halide-Lyase, Synthesis of beta-Hydroxynitriles from Epoxides and Cyanide,"" Biochem Biophys Res Commun., 180(1):124-30.;;Nakamura et al., 1994, ""A New Enzymatic Synthesis of (R)-gamma-Chloro-beta-Hydroxybutyronitrile,"" Tetrahedron, Elsevier Science, 50(41):11821-11826.;;Office Action from U.S. Appl. No. 10/917,179, dated Aug. 6, 2007.;;Office Action from U.S. Appl. No. 11/067,323, dated Aug. 8, 2007.;;PCT International Search Report from PCT/US06/05487 dated Sep. 25, 2008.;;PCT International Search Report from PCT/US04/26654 dated Nov. 29, 2004.;;Poelarends et al., 1999, ""Degradation of 1,2-Dibromoethane by Mycobacterium sp. Strain GP1,"" J. Bacteriol., 181(7):2050-2058.;;Rink et al., Jun. 1997, ""Primary Structure and Catalytic Mechanism of the Epoxide Hydrolase from Agrobacterium radiobacter ADI,"" J. Biol. Chem., 272(23):14650-14657.;;SEQ ID NO: 2 Comparison to Accession No. AAW69435 in JP1020981 A1.;;Van Den Wijngaard et al., 1991, ""Purification and Characterization of Haloalcohol Dehalogenase from Arthrobacter sp. Strain AD2,"" J. Bacteriol., 173(1):124-129.;;de Jong, R.M. et al., ""Structure and mechanism of a bacterial haloalcohol dehalogenase: a new variation of the short-chain dehydrogenase/reductase fold without an NAD(P)H binding site,"" The EMBO Journal 22(19):4933-4944 (2003) XP-002305279.;;Hallinan, K. O. et al., Yeast catalysed reduction of alpha-keto esters (2): optimization of the stereospecific reduction by Zygosaccharomyces rouxll, Biocatalysis and Biotransformation 12:179-191 (1995).;;Nagasawa, T. et al., ""Purification and characterization of halohydrin hydrogen-halide lyase from a recombinant Escherichia coli containing the gene from a Corynebacterium sp.,"" Applied Microbiology. and Biotechnology 36:478-482 (1992).;;Swanson, P. E. ""Dehalogenases applied to industrial-scale biocatalysis,"" Current Opinion in Biotechnology 10:365-369, (1999).",ACTIVE
80,US,B2,US 8252554 B2,010-964-858-978-173,2012-08-28,2012,US 50537409 A,2009-07-17,US 50537409 A;;US 26674705 A;;US 6732305 A;;US 91717904 A;;US 54603304 P;;US 49438203 P,2003-08-11,Halohydrin dehalogenases and related polynucleotides,"The present invention relates to novel halohydrin dehalogenase polypeptides and the polynucleotides that encode them. These polypeptides are useful in the production of 4-substituted-3-butyric acid derivatives and vicinal cyano, hydroxyl substituted carboxylic acid esters. The invention also provides related vectors, host cells and methods.",DAVIS S CHRISTOPHER;;NEWMAN LISA MARIE;;GAVRILOVIC VESNA;;HUISMAN GJALT W;;FOX RICHARD JOHN;;MUNDORFF EMILY C;;CODEXIS INC,DAVIS S CHRISTOPHER;;NEWMAN LISA MARIE;;GAVRILOVIC VESNA;;HUISMAN GJALT W;;FOX RICHARD JOHN;;MUNDORFF EMILY C,,https://lens.org/010-964-858-978-173,Granted Patent,yes,25,1,9,29,2848,C12N9/14;;C12N9/14;;C12N9/88;;C12N9/88,C12P21/06;;C07H21/04;;C12N1/21;;C12N9/00;;C12N9/04;;C12N9/14;;C12N9/88;;C12N15/60;;C12N15/74;;C12Q1/68,435/69.1;;435/254.2;;435/320.1;;435/183;;536/23.2,32,21,088-273-242-424-372;;017-976-846-535-343;;025-769-853-797-657;;012-706-634-231-645;;052-328-795-035-042;;179-801-653-878-016;;133-245-607-243-913;;052-549-921-761-790;;166-958-105-502-652;;043-043-968-709-186;;038-382-938-657-069;;061-583-917-506-24X;;008-782-851-804-219;;047-978-243-986-580;;017-390-715-015-286;;001-514-332-046-617;;038-043-510-052-572;;054-399-907-114-548;;135-456-794-183-356;;005-222-568-120-407;;124-335-592-847-062,10.1016/s0040-4020(97)00843-0;;10.1016/s0141-0229(97)00255-x;;10.1093/emboj/cdg479;;pmc204463;;14517233;;10.3109/10242429508998161;;10.1016/s1381-1177(97)00034-9;;10.1016/s0957-4166(98)00003-2;;10.1016/s0957-4166(99)00308-0;;10.1021/ol0067540;;11429866;;10.1016/s0957-4166(02)00222-7;;10.1016/0040-4039(94)88167-7;;10.1007/bf00170187;;1656964;;10.1016/s0006-291x(05)81264-1;;10.1016/s0040-4020(01)89297-8;;10.1128/aem.60.4.1297-1301.1994;;8017917;;pmc201473;;10094681;;10.1128/jb.181.7.2050-2058.1999;;pmc93616;;9169427;;10.1074/jbc.272.23.14650;;10.1016/s0958-1669(99)80066-4;;10449315;;14636074;;10.1021/bi034941a;;10.1016/s0141-0229(01)00488-4;;1846134;;10.1128/jb.173.1.124-129.1991;;pmc207165;;11489858;;10.1128/jb.183.17.5058-5066.2001;;pmc95381,"Archer 1997, ""Epoxide Hydrolases as Asymmetric Catalysts,"" Tetrahedron, Elsevier Science, 53(46):15617-15662.;;Assis et al., 1998, ""Synthesis of Chiral Epihalohydrins Using Haloalcohol Dehalogenase A from Arthrobacter Erithii H10a,"" Emyme Microb. Technol. 22:545-551.;;De Jong et al., 2003, ""Structure and Mechanism of a Bacterial Haloalcohol Dehalogenase: A New Variation of the Short-Chain Dehydrogenase/Reductase Fold Without an NAD(P)H Binding Site,"" EMBO Journal, 22(19):4933-4944, XP002305279, ISSN: 0261-4189.;;Hallinan et al., 1995, ""Yeast Catalysed Reduction of beta-keto Esters (2): Optimisation of the Stereospecific Reduction by Zygosaccharomyces rouxii,"" Biocatal. Biotransform. 12:179-191.;;Kasai et al., 1998, ""Chiral C3 Epoxides and Halohydrins: Their Preparation and Synthetic Application,"" J Molec. Cat. B: Enzymatic, 4:237-252.;;Lewis et al., 1999, ""Cloning and Nucleotide Sequence of the Haloalcohol Dehalogenase B Gene from Agrobacterium Tumefaciens,"" Database Accession No. Q9WWB6, XP002152213.;;Lewis, 1999, ""Agrobacterium tumefaciens Haloalcohol Dehalogenase B Gene, Complete CDS,"" Database EMBL Online!, XP002305665, retrieved from EBI accession No. EM-PRO: AF149769, database accession No. AF149769.;;Lutje Spelberg et al., 1998, ""Enantioselectivity of a Recombinant Epoxide Hydrolase from Agrobacterium radiobacter,"" Tetrahedron: Asymmetry, Elsevier Science, 9(3):459-466.;;Lutje Spelberg et al., 1999, ""A Tandem Enzyme Reaction to Produce Optically Active Halohydrins, Epoxides and Diols,"" Tetrahedron: Asymmetry, 10:2863-2870.;;Lutje Spelberg, et al., 2000, ""Highly Enantioselective and Regioselective Biocatalytic Azidolysis of Aromatic Epoxides,"" Org. Lett., 3(1):41-43.;;Lutje Spelberg, et al., 2002, ""Exploration of the Biocatalytic Potential of a Halohydrin Dehalogenase using Chromogenic Substrates,"" Tetrahedron: Asymmetry, 13:1083-1089.;;Mischitz et al., 1994 ""Asymmetric Opening of an Epoxide by Azide Catalyzed by an Immobilized Enzyme Preparation from Rhodococcus sp.,"" Tetrahedron Letters, 35(l):81-84.;;Nagasawa, et al., 1992, ""Purification and Characterization of Halohydrin Hydrogen-halide Lyase from a Recombinant Escherichia coli Containing the Gene from a Corynebacterium sp.,"" Appl. Microbiol. Biotechnol., 36:478-482.;;Nakamura et al., 1991, ""A New Catalytic Function of Halohydrin Hydrogen-Halide-Lyase, Synthesis of beta-Hydroxynitriles from Epoxides and Cyanide,"" Biochem Biophys Res Commun., 180(1):124-30.;;Nakamura et al., 1994, ""A New Enzymatic Synthesis of (R)-gamma-Chloro-beta-Hydroxybutyronitrile,"" Tetrahedron, Elsevier Science, 50(41):11821-11826.;;Nakamura, et al., 1994, ""Characterization of a Novel Enantioselective Halohydrin Hydrogen-Halide-Lyase,"" Appl. Environ. Microbiol., 60(4):1297-1301.;;Office Action from U.S. Appl. No. 10/917,179 dated Aug. 6, 2007.;;Office Action from U.S. Appl. No. 11/067,323 dated Aug. 8, 2007.;;Office Action from U.S. Appl. No. 11/266,747 dated Aug. 8, 2007.;;Office Action from U.S. Appl. No. 11/266,747 dated May 15, 2008.;;PCT International Search Report from PCT/US06/05487 dated Sep. 25, 2008.;;PCT International Search Report from PCT/US04/26654 dated Nov. 29,2004.;;Poelarends et al:, 1999, ""Degradation of 1,2-Dibromoethane by Mycobacterium sp. Strain GPI,"" J. Bacteriol., 181(7):2050-2058.;;Rink et al., Jun 1997, ""Primary Structure and Catalytic Mechanism of the Epoxide Hydrolase from Agrobacterium radiobacter ADI,"" J. Biol. Chem., 272(23):14650-14657.;;SEQ ID No: 2 Comparison to Accession No. AAW69435 in JP1020981 A1 , 1999.;;Swanson, P. E., 1999, ""Dehalogenases Applied to Industrial-Scale Biocatalysis,"" Curr. Opin. Biotechnol., 10:365-369.;;Tang et al., 2003, ""Steady-State Kinetics and Tryptophan Fluorescence Properties of Halohydrin Dehalogenase from Agrobacterium radiobacter. Roles of W139 and W249 in the Active Site and Halide-Induced Conformational Change,"" Biochemistry, 42(47):14057-14065, XP002305278, ISSNL 0006-2960.;;Tang et al., 2002, ""Improved Stability of Halohydrin Dehalogenase from Agrobacterium radiobacter AD1 by Replacement of Cysteine Residues,"" Enzyme Microb. Technol., 30:251-258.;;Van Den Wijngaard et al., 1991, ""Purification and Characterization of Haloalcohol Dehalogenase from Arthrobacter sp. Strain AD2,"" J. Bacteriol., 173(1):124-129.;;Van Hylckama et al., 2001, ""Halohydrin Dehalogenases are Structurally and Mechanistically Related to Short-Chain Dehydrogenases/Reductases,"" Journal of Bacteriology, 183(17):5058-5066, XP002305277, ISSN: 0021-9193.;;Supplementary European Search Report for EP06735244.3 dated Jul. 9, 2009.;;Singapore Search Report for SG200808477-4 dated Apr. 13, 2010.",ACTIVE
81,CA,C,CA 2418186 C,026-833-629-098-413,2007-08-14,2007,CA 2418186 A,2003-01-31,US 6110002 A,2002-02-01,ESP PUMP FOR GASSY WELLS,"Well equipment well fluid more efficiently from a gassy well. A conduit is hung and sealed inside a string of casing, forcing the gas and well fluid to flow into the conduit. A gas separator and a series of flow controls and valves are mounted into and run with the conduit. A pump assembly is hung and sealed into the conduit for pumping well fluid to the surface. T he pump assembly is lowered and retrieved from the conduit on tubing. The pump may be located below the motor, or above the motor.",BAKER HUGHES INC,LOUDERMILK DEWEY MICHAEL;;FOX MICHAEL J;;BEBAK KENNETH T;;KNIGHT JEFFREY W;;VOSS DAVID A;;SHAW CHRISTOPHER K,,https://lens.org/026-833-629-098-413,Granted Patent,no,0,0,4,4,0,E21B43/128;;E21B43/38;;E21B43/128;;E21B43/38,E21B43/38;;E21B43/16,,0,0,,,,EXPIRED
82,CA,A1,CA 2418186 A1,063-467-311-483-818,2003-08-01,2003,CA 2418186 A,2003-01-31,US 6110002 A,2002-02-01,ESP PUMP FOR GASSY WELLS,"Well equipment well fluid more efficiently from a gassy well. A conduit is hung and sealed inside a string of casing, forcing the gas and well fluid to flow into the conduit. A gas separator and a series of flow controls and valves are mounted into and run with the conduit. A pump assembly is hung and sealed into the conduit for pumping well fluid to the surface. T he pump assembly is lowered and retrieved from the conduit on tubing. The pump may be located below the motor, or above the motor.",BAKER HUGHES INC,BEBAK KENNETH T;;SHAW CHRISTOPHER K;;VOSS DAVID A;;LOUDERMILK DEWEY MICHAEL;;KNIGHT JEFFREY W;;FOX MICHAEL J,,https://lens.org/063-467-311-483-818,Patent Application,no,0,0,4,4,0,E21B43/128;;E21B43/38;;E21B43/128;;E21B43/38,E21B43/38,,0,0,,,,EXPIRED
83,US,B2,US 6668925 B2,062-028-653-294-725,2003-12-30,2003,US 6110002 A,2002-02-01,US 6110002 A,2002-02-01,ESP pump for gassy wells,"
    Well equipment transporting well fluid from a gassy well. A conduit is hung and sealed inside a string of casing, forcing the gas and well fluid to flow into the conduit. A gas separator and a series of flow controls and valves are mounted into and run with the conduit. A pump assembly is hung and sealed into the conduit for pumping well fluid to the surface. The pump assembly is lowered and retrieved from the conduit on tubing. The pump may be located below the motor, or above the motor. 
",BAKER HUGHES INC,SHAW CHRISTOPHER K;;VOSS DAVID A;;KNIGHT JEFFREY W;;FOX MICHAEL J;;LOUDERMILK DEWEY MICHAEL;;BEBAK KENNETH T,BAKER HUGHES INCORPORATED (2002-01-28),https://lens.org/062-028-653-294-725,Granted Patent,yes,23,44,4,4,0,E21B43/128;;E21B43/38;;E21B43/128;;E21B43/38,E21B43/38,166/265;;166/105.5;;166/106;;166/370,3,0,,,"Inventor: Neuroth et al, Method and Apparatus to Remove Coiled Tubing Deployed Equipment in High Sand Applications.;;Tubular Junction for Tubing Pump, This application claims the benefits of provisional application S.N. 60/107,919 filed Nov. 10, 1998.;;Thru-Tubing Retrievable Packer Product No. 330-01; product information; Baker Hughes; Mar. 1996.",EXPIRED
84,US,A1,US 2003/0145989 A1,151-910-365-216-065,2003-08-07,2003,US 6110002 A,2002-02-01,US 6110002 A,2002-02-01,ESP pump for gassy wells,"
   Well equipment well fluid more efficiently from a gassy well. A conduit is hung and sealed inside a string of casing, forcing the gas and well fluid to flow into the conduit. A gas separator and a series of flow controls and valves are mounted into and run with the conduit. A pump assembly is hung and sealed into the conduit for pumping well fluid to the surface. The pump assembly is lowered and retrieved from the conduit on tubing. The pump may be located below the motor, or above the motor. 
",SHAW CHRISTOPHER K.;;VOSS DAVID A.;;KNIGHT JEFFREY W.;;FOX MICHAEL J.;;LOUDERMILK DEWEY MICHAEL;;BEBAK KENNETH T.,SHAW CHRISTOPHER K;;VOSS DAVID A;;KNIGHT JEFFREY W;;FOX MICHAEL J;;LOUDERMILK DEWEY MICHAEL;;BEBAK KENNETH T,BAKER HUGHES INCORPORATED (2002-01-28),https://lens.org/151-910-365-216-065,Patent Application,yes,0,24,4,4,0,E21B43/128;;E21B43/38;;E21B43/128;;E21B43/38,E21B43/38,166/265;;166/105.5;;166/105.6,0,0,,,,EXPIRED
85,US,S,US D0859486 S,123-884-532-456-292,2019-09-10,2019,US 201529540725 F,2015-09-27,US 201529540725 F,2015-09-27,Confocal microscope,,CALIBER IMAGING & DIAGNOSTICS INC,CRAMB ALLISON L;;DISTASIO CHRISTOPHER C;;FOX WILLIAM J;;ALEXANDER BENNY;;RIDGE STEVEN;;ROBERTO ANTHONY J;;PORTER TYLER W,CALIBER IMAGING & DIAGNOSTICS INC (2019-06-17),https://lens.org/123-884-532-456-292,Design Right,no,9,0,1,1,0,,,1606;;D16/131,4,1,084-763-915-270-66X,10.1093/benz/9780199773787.article.b00119265,"Scanning Stages with Integrated Measuring System, Märzhäuser Wetzlar GmbH Co. KG, http://www.marzhauser.com/en/products/microscope-stages/motorized-microscope-stages/scanplus-series.html, Sep. 7, 2015.;;VivaScope(R) 1500/3000, MAVIG GmbH, 2011.;;Stereo Microscope Boom Stands, Catalog #BS-3, Diagnostic Instruments, Inc., at least as early as Sep. 25, 2015.;;Dual Linear Ball Bearing Arm, Old School Industries, Inc., www.osi-incorp.com, printed Sep. 25, 2015.",ACTIVE
86,US,S,US D0843429 S,000-187-476-400-425,2019-03-19,2019,US 201629584240 F,2016-11-12,US 201629584240 F,2016-11-12,Confocal microscope,,CALIBER IMAGING & DIAGNOSTICS INC,CRAMB ALLISON L;;DISTASIO CHRISTOPHER C;;FOX WILLIAM J;;ALEXANDER BENNY;;RIDGE STEVEN;;ROBERTO ANTHONY J;;PORTER TYLER W,CALIBER IMAGING & DIAGNOSTICS INC (2017-04-20),https://lens.org/000-187-476-400-425,Design Right,no,10,4,2,2,0,,,1606;;D16/131,7,1,084-763-915-270-66X,10.1093/benz/9780199773787.article.b00119265,"VivaScope(R) 1500/3000, MAVIG GmbH, 2011.;;Design U.S. Appl. No. 29/540,725, filed Sep. 27, 2015 with Filing Receipt.;;Scanning Stage SCANplus IM, Marzhauser Wetzlar Gmbh & Co. KG, Mar. 2016.;;Velmex Rotary Tables, Velmex, Inc., at least as early as Nov. 6, 2016.;;Motorized BiSlide Systems, Velmex, Inc., http://www.velmexcom/Products/BiSlide/BiSlide_Motorized.html, printed Nov. 6, 2016.;;Precision Rotation Stage Model UTR80, Newport Corp., http://www.newport.com/p/UTR80, printed Nov. 7, 2016.;;Vexta 2-Phase Stepping Motor, http://www.skycraftsurplus.com/vexta2-phasesteppingmotor18degstep.aspx, printed Nov. 9, 2016.",ACTIVE
87,US,A1,US 2023/0097102 A1,025-787-339-377-86X,2023-03-30,2023,US 202218075618 A,2022-12-06,US 202218075618 A;;US 202117390731 A;;US 202063059745 P;;US 202063123827 P,2020-07-31,LINEAR LIGHTING DEVICE,A linear lighting device may include an elongated housing that defines a cavity. The linear lighting device may include plurality of emitter printed circuit boards configured to be received within the cavity. Each of the plurality of emitter printed circuit boards may include a plurality of emitter modules mounted thereto. Each of the plurality of emitter printed circuit boards may include a control circuit configured to control the plurality of emitter modules mounted to the respective emitter printed circuit board based on receipt of one or more messages. The linear lighting device may include a total internal reflection lens for each of the plurality of emitter printed circuit boards. The total internal reflection lens may be configured to diffuse light emitted by the emitter modules of the plurality of emitter printed circuit boards.,LUTRON TECH CO LLC,BOCOCK RYAN M;;DONG FANGXU;;FOX ARI L;;GREEN CHRISTOPHER M;;OGDEN JR PETER W;;PHILLIPS STEPHEN;;REDUS JONATHAN R;;SHUKLA JAYKRISHNA A,,https://lens.org/025-787-339-377-86X,Patent Application,yes,2,0,9,9,0,H05B45/10;;H05B47/19;;H05B47/18;;H05B47/199;;F21S4/28;;H05B47/18;;F21V5/007;;F21V7/0091;;F21V7/04;;F21V23/06,H05B47/18;;F21S4/28;;F21V5/00;;F21V7/00;;F21V7/04;;F21V23/06,,0,0,,,,ACTIVE
88,MX,A,MX 2022016414 A,106-077-181-168-119,2023-03-06,2023,MX 2022016414 A,2021-07-30,US 202063059745 P;;US 202063123827 P;;US 2021/0044058 W,2020-07-31,LINEAR LIGHTING DEVICE.,A linear lighting device may include an elongated housing that defines a cavity. The linear lighting device may include plurality of emitter printed circuit boards configured to be received within the cavity. Each of the plurality of emitter printed circuit boards may include a plurality of emitter modules mounted thereto. Each of the plurality of emitter printed circuit boards may include a control circuit configured to control the plurality of emitter modules mounted to the respective emitter printed circuit board based on receipt of one or more messages. The linear lighting device may include a total internal reflection lens for each of the plurality of emitter printed circuit boards. The total internal reflection lens may be configured to diffuse light emitted by the emitter modules of the plurality of emitter printed circuit boards.,LUTRON TECH CO LLC,GREEN CHRISTOPHER M;;PHILLIPS STEPHEN;;SHUKLA JAYKRISHNA A;;OGDEN JR PETER W;;DONG FANGXU;;BOCOCK RYAN M;;FOX ARI L;;REDUS JONATHAN R,,https://lens.org/106-077-181-168-119,Patent Application,no,0,0,9,9,0,H05B45/10;;H05B47/19;;H05B47/18;;H05B47/199;;F21S4/28;;H05B47/18;;F21V5/007;;F21V7/0091;;F21V7/04;;F21V23/06,H05B45/10;;F21K9/278;;F21K9/68;;H05B47/18;;H05B47/19,,0,0,,,,PENDING
89,EP,A1,EP 4190126 A1,121-593-737-317-269,2023-06-07,2023,EP 21758923 A,2021-07-30,US 202063059745 P;;US 202063123827 P;;US 2021/0044058 W,2020-07-31,LINEAR LIGHTING DEVICE,,LUTRON TECH CO LLC,BOCOCK RYAN M;;DONG FANGXU;;FOX ARI L;;GREEN CHRISTOPHER M;;OGDEN JR PETER W;;PHILLIPS STEPHEN;;REDUS JONATHAN R;;SHUKLA JAYKRISHNA A,,https://lens.org/121-593-737-317-269,Patent Application,yes,0,0,9,9,0,H05B45/10;;H05B47/19;;H05B47/18;;H05B47/199;;F21S4/28;;H05B47/18;;F21V5/007;;F21V7/0091;;F21V7/04;;F21V23/06,F21K9/278;;H05B45/10;;F21K9/68;;H05B47/18;;H05B47/19,,0,0,,,,PENDING
90,CA,A1,CA 3181065 A1,045-354-831-356-659,2022-02-03,2022,CA 3181065 A,2021-07-30,US 202063059745 P;;US 202063123827 P;;US 2021/0044058 W,2020-07-31,LINEAR LIGHTING DEVICE,A linear lighting device may include an elongated housing that defines a cavity. The linear lighting device may include plurality of emitter printed circuit boards configured to be received within the cavity. Each of the plurality of emitter printed circuit boards may include a plurality of emitter modules mounted thereto. Each of the plurality of emitter printed circuit boards may include a control circuit configured to control the plurality of emitter modules mounted to the respective emitter printed circuit board based on receipt of one or more messages. The linear lighting device may include a total internal reflection lens for each of the plurality of emitter printed circuit boards. The total internal reflection lens may be configured to diffuse light emitted by the emitter modules of the plurality of emitter printed circuit boards,LUTRON TECH CO LLC,BOCOCK RYAN M;;DONG FANGXU;;FOX ARI L;;GREEN CHRISTOPHER M;;OGDEN JR PETER W;;PHILLIPS STEPHEN;;REDUS JONATHAN R;;SHUKLA JAYKRISHNA A,,https://lens.org/045-354-831-356-659,Patent Application,no,0,0,9,9,0,H05B45/10;;H05B47/19;;H05B47/18;;H05B47/199;;F21S4/28;;H05B47/18;;F21V5/007;;F21V7/0091;;F21V7/04;;F21V23/06,H05B45/10;;F21K9/278;;F21K9/68;;H05B47/18;;H05B47/19,,0,0,,,,PENDING
91,US,B2,US 11570874 B2,095-878-945-058-271,2023-01-31,2023,US 202117390731 A,2021-07-30,US 202117390731 A;;US 202063059745 P;;US 202063123827 P,2020-07-31,Linear lighting device,A linear lighting device may include an elongated housing that defines a cavity. The linear lighting device may include plurality of emitter printed circuit boards configured to be received within the cavity. Each of the plurality of emitter printed circuit boards may include a plurality of emitter modules mounted thereto. Each of the plurality of emitter printed circuit boards may include a control circuit configured to control the plurality of emitter modules mounted to the respective emitter printed circuit board based on receipt of one or more messages. The linear lighting device may include a total internal reflection lens for each of the plurality of emitter printed circuit boards. The total internal reflection lens may be configured to diffuse light emitted by the emitter modules of the plurality of emitter printed circuit boards.,LUTRON TECH CO LLC,BOCOCK RYAN M;;DONG FANGXU;;FOX ARI L;;GREEN CHRISTOPHER M;;OGDEN JR PETER W;;PHILLIPS STEPHEN;;REDUS JONATHAN R;;SHUKLA JAYKRISHNA A,LUTRON TECHNOLOGY COMPANY LLC (2021-09-29),https://lens.org/095-878-945-058-271,Granted Patent,yes,13,2,9,9,0,H05B45/10;;H05B47/19;;H05B47/18;;H05B47/199;;F21S4/28;;H05B47/18;;F21V5/007;;F21V7/0091;;F21V7/04;;F21V23/06,H05B47/10;;F21S4/28;;F21V5/00;;F21V7/00;;F21V7/04;;F21V23/06;;H05B47/18,,0,0,,,,ACTIVE
92,US,A1,US 2022/0039243 A1,092-320-318-028-493,2022-02-03,2022,US 202117390731 A,2021-07-30,US 202117390731 A;;US 202063059745 P;;US 202063123827 P,2020-07-31,LINEAR LIGHTING DEVICE,A linear lighting device may include an elongated housing that defines a cavity. The linear lighting device may include plurality of emitter printed circuit boards configured to be received within the cavity. Each of the plurality of emitter printed circuit boards may include a plurality of emitter modules mounted thereto. Each of the plurality of emitter printed circuit boards may include a control circuit configured to control the plurality of emitter modules mounted to the respective emitter printed circuit board based on receipt of one or more messages. The linear lighting device may include a total internal reflection lens for each of the plurality of emitter printed circuit boards. The total internal reflection lens may be configured to diffuse light emitted by the emitter modules of the plurality of emitter printed circuit boards.,LUTRON TECH CO LLC,BOCOCK RYAN M;;DONG FANGXU;;FOX ARI L;;GREEN CHRISTOPHER M;;OGDEN JR PETER W;;PHILLIPS STEPHEN;;REDUS JONATHAN R;;SHUKLA JAYKRISHNA A,LUTRON TECHNOLOGY COMPANY LLC (2021-09-29),https://lens.org/092-320-318-028-493,Patent Application,yes,0,7,9,9,0,H05B45/10;;H05B47/19;;H05B47/18;;H05B47/199;;F21S4/28;;H05B47/18;;F21V5/007;;F21V7/0091;;F21V7/04;;F21V23/06,H05B47/18;;F21S4/28;;F21V5/00;;F21V7/00;;F21V7/04;;F21V23/06,,0,0,,,,ACTIVE
93,US,B2,US 11917739 B2,055-941-840-599-07X,2024-02-27,2024,US 202218075618 A,2022-12-06,US 202218075618 A;;US 202117390731 A;;US 202063059745 P;;US 202063123827 P,2020-07-31,Linear lighting device,A linear lighting device may include an elongated housing that defines a cavity. The linear lighting device may include plurality of emitter printed circuit boards configured to be received within the cavity. Each of the plurality of emitter printed circuit boards may include a plurality of emitter modules mounted thereto. Each of the plurality of emitter printed circuit boards may include a control circuit configured to control the plurality of emitter modules mounted to the respective emitter printed circuit board based on receipt of one or more messages. The linear lighting device may include a total internal reflection lens for each of the plurality of emitter printed circuit boards. The total internal reflection lens may be configured to diffuse light emitted by the emitter modules of the plurality of emitter printed circuit boards.,LUTRON TECH CO LLC,BOCOCK RYAN M;;DONG FANGXU;;FOX ARI L;;GREEN CHRISTOPHER M;;OGDEN JR PETER W;;PHILLIPS STEPHEN;;REDUS JONATHAN R;;SHUKLA JAYKRISHNA A,,https://lens.org/055-941-840-599-07X,Granted Patent,yes,14,0,9,9,0,H05B45/10;;H05B47/19;;H05B47/18;;H05B47/199;;F21S4/28;;H05B47/18;;F21V5/007;;F21V7/0091;;F21V7/04;;F21V23/06,H05B47/18;;F21S4/28;;F21V5/00;;F21V7/00;;F21V7/04;;F21V23/06,,0,0,,,,ACTIVE
94,US,A1,US 2022/0398231 A1,132-928-450-447-85X,2022-12-15,2022,US 202117347164 A,2021-06-14,US 202117347164 A,2021-06-14,GENERATING DERIVED DIMENSIONS TO MODIFY DATA COLLECTION SCHEMAS WITHOUT ADDITIONAL DATA INGESTION,"The present disclosure relates to systems, non-transitory computer-readable media, and methods for generating derived dimensions within ingested data collections. In particular, in one or more embodiments, the disclosed systems generate derived dimensions that modify or correct one or more organizational schemas of an ingested data collection when querying the ingested data collection. For example, the disclosed systems receive a user-defined definition, and generates a fallback expression based on the user-defined definition and aligned to the schema of a particular ingested data collection. In at least one embodiment, the disclosed systems generate the derived dimension by identifying and modifying one or more existing dimensions in the schema based on the fallback expression when reading data from the ingested data collection.",ADOBE INC,LUBY CHRISTOPHER;;WILCOX DAVID;;FOX ERIC;;LAWSON JEFFERY;;SMITH KYLE W;;GOULD MATTHEW;;RIMER MICHAEL;;PURSER NATHAN A;;PAULSEN TREVOR;;GEORGE WILLIAM BRANDON,ADOBE INC (2021-06-10),https://lens.org/132-928-450-447-85X,Patent Application,yes,2,0,1,1,0,G06Q30/0201;;G06F16/215;;G06F16/2423;;G06F16/285;;G06F16/283;;G06F16/2291,G06F16/22;;G06F16/215;;G06F16/242;;G06F16/28,,3,0,,,"Educba, ""Spell Check in Excel"", https://web.archive.org/web/20210127112242/https://www.educba.com/excel-spell-check/ (Year: 2021);;Chris Facer, ""What is Data Filtering"", DISPLAYR, https://web.archive.org/web/20201127082609/https://www.displayr.com/what-is-data-filtering/ (Year: 2020);;Diana, ""AutoCorrect in Word"", www.myrenocomputertutor.com, https://web.archive.org/web/20230924213945/http://www.myrenocomputertutor.com/autocorrect-in-word/ (Year: 2021)",PENDING
95,AR,A1,AR 112469 A1,018-654-239-474-74X,2019-10-30,2019,AR P180102270 A,2018-08-09,US 201762543307 P,2017-08-09,MODULADORES DEL FACTOR DE INICIACIÓN EUCARIÓTICO 2B,"La presente se refiere en general a moduladores de factor de iniciación eucariótico 2B, o a una sal, estereoisómero, mezcla de estereoisómeros o profármaco farmacéuticamente aceptable de los mismos, y a métodos de preparación y uso de los mismos Reivindicación 1: Un compuesto de la fórmula (1) o una sal farmacéuticamente aceptable, un análogo isotópicamente enriquecido, un estereoisómero, una mezcla de estereoisómeros o un profármaco de este, en el que: L es un heteroalquileno opcionalmente sustituido con uno a seis R¹⁰ o L es heterociclilo opcionalmente sustituido o heteroarilo opcionalmente sustituido, siempre que cuando L sea heterociclilo opcionalmente sustituido y se encuentre enlazado al cicloalquilo puenteado mediante un átomo anular de nitrógeno, un átomo de carbono en L adyacente al punto de unión no se encuentre sustituido con =O ó =S; x es 1 ó 2; z es 0 ó 1, siempre que cuando z sea 0 y X¹ sea O, R³ no sea alquilo; X¹ es O, NR⁹ o un enlace; R¹ es hidrógeno, alquilo C₁₋₁₂, alquenilo C₂₋₁₂, alquinilo C₂₋₁₂, cicloalquilo C₃₋₁₀ o heterociclilo, cada uno de los cuales, sin ser hidrógeno, se encuentra opcionalmente sustituido con uno o más halo, oxo, acetilo, amino, hidroxilo o alquilo C₁₋₁₂ o R¹ y R⁵ juntos forman un anillo heterociclilo; R² es hidrógeno, alquilo C₁₋₁₂, alquenilo C₂₋₁₂, alquinilo C₂₋₁₂, alcoxi C₁₋₁₂, cicloalquilo C₃₋₁₀, cicloalcoxi C₃₋₁₀, heterociclilo, arilo o heteroarilo, cada uno de los cuales, sin ser hidrógeno, se encuentra opcionalmente sustituido con uno o más R¹¹, siempre que cuando L sea un heteroalquileno, R² sea cicloalquilo C₃₋₁₀, heterociclilo, arilo o heteroarilo, cada uno opcionalmente sustituido con uno o más R¹¹; R³ es hidrógeno, alquilo C₁₋₁₂, alquenilo C₂₋₁₂, alquinilo C₂₋₁₂, cicloalquilo C₃₋₁₀, heterociclilo, arilo o heteroarilo, cada uno de los cuales, sin ser hidrógeno, se encuentra opcionalmente sustituido con uno o más R¹¹; cada uno de R⁴ y R⁵ es independientemente hidrógeno, alquilo C₁₋₁₂, alquenilo C₂₋₁₂ o alquinilo C₂₋₁₂, cada uno de los cuales, sin ser hidrógeno, se encuentra opcionalmente sustituido de forma independiente con uno o más halo, oxo, acetilo, amino o hidroxilo; o R³ y R⁴, junto con los átomos a los que se encuentran enlazados, se unen para formar un cicloalquilo C₃₋₁₀ o heterociclilo, cada uno de los cuales se encuentra opcionalmente sustituido con uno o más R¹¹; o R⁴ y R⁵, junto con los átomos a los que se encuentran enlazados, se unen para formar un cicloalquilo C₃₋₁₀, heterociclilo o heteroarilo, cada uno de los cuales se encuentra opcionalmente sustituido con uno o más R¹¹; cada R⁶, R⁷ y R⁸ es independientemente hidrógeno, alquilo C₁₋₁₂, alquenilo C₂₋₁₂, alquinilo C₂₋₁₂, cicloalquilo C₃₋₁₀, heterociclilo, arilo, heteroarilo, -C(O)R²⁰, -C(O)OR²⁰, -C(O)NR²⁰R²¹, -S(O)₁₋₂R²⁰ o -S(O)₁₋₂NR²⁰, donde cada alquilo, alquenilo, alquinilo, cicloalquilo, heterociclilo, arilo y heteroarilo de R⁶, R⁷ y R⁸ se encuentra opcionalmente sustituido de forma independiente con uno o más R¹²; o dos de R⁶, R⁷ y R⁸ se toman en conjunto con los átomos a los que están enlazados para formar heterociclilo opcionalmente sustituido de forma independiente por uno o más halo, oxo o alquilo C₁₋₁₂ opcionalmente sustituido de forma independiente por uno o más oxo, halo, hidroxilo o amino; R⁹ es hidrógeno, alquilo C₁₋₁₂, alquenilo C₂₋₁₂, alquinilo C₂₋₁₂, cicloalquilo C₃₋₁₀ o heterociclilo, cada uno de los cuales, sin ser hidrógeno, se encuentra opcionalmente sustituido con uno o más halo, oxo, acetilo, amino, hidroxilo o alquilo C₁₋₁₂; cada R¹⁰ es independientemente halo, alquilo C₁₋₁₂ o haloalquilo C₁₋₁₂; y es 1, 2, 3, 4, 5, 6, 7 u 8; cada R¹¹ es independientemente halo, ciano, nitro, oxo, -OR⁶, -SR⁶, -SF₅, -NR⁶R⁷, alquilo C₁₋₁₂, alquenilo C₂₋₁₂, alquinilo C₂₋₁₂, cicloalquilo C₃₋₁₀, heterociclilo, arilo, heteroarilo, -C(O)R⁶, -C(O)OR⁶, -OC(O)OR⁶, -OC(O)R⁶, -C(O)NR⁶R⁷, -OC(O)NR⁶R⁷, -NR⁶C(O)NR⁷R⁸, -S(O)₁₋₂R⁶, -S(O)₁₋₂NR⁶, NR⁶S(O)₁₋₂R⁷, -NR⁶S(O)₁₋₂NR⁷R⁸, -NR⁶C(O)R⁷ o -NR⁶C(O)OR⁷, donde cada alquilo, alquenilo, alquinilo, cicloalquilo, heterociclilo, arilo y heteroarilo de R¹¹ se encuentra opcionalmente sustituido de forma independiente con uno o más R¹²; cada R¹² es independientemente halo, ciano, nitro, oxo, -OR³⁰, -SR³⁰, -SF₅, -NR³⁰R³¹, alquilo C₁₋₁₂, alquenilo C₂₋₁₂, alquinilo C₂₋₁₂, cicloalquilo C₃₋₁₀, heterociclilo, arilo, heteroarilo, -C(O)R³⁰, -C(O)OR³⁰, -OC(O)OR³⁰, -OC(O)R³⁰, -C(O)NR³⁰R³¹, -OC(O)NR³⁰R³¹, -NR³⁰C(O)NR³⁰R³¹, -S(O)₁₋₂R³⁰, -S(O)₁₋₂NR³⁰, -NR³⁰S(O)₁₋₂R³¹, -NR³⁰S(O)₁₋₂NR³⁰R³¹, -NR³⁰C(O)R³¹ o -NR³⁰C(=O)OR³¹, donde cada alquilo, alquenilo, alquinilo, cicloalquilo, heterociclilo, arilo y heteroarilo de R¹² se encuentra opcionalmente sustituido de forma independiente con uno o más halo o alquilo C₁₋₁₂ opcionalmente sustituido de forma independiente por uno o más oxo, halo, hidroxilo o amino; cada R²⁰ y R²¹ es independientemente hidrógeno o alquilo C₁₋₁₂ opcionalmente sustituido de forma independiente con uno o más oxo, halo, hidroxilo o amino; o R²⁰ y R²¹ se toman en conjunto con los átomos a los que están enlazados para formar heterociclilo opcionalmente sustituido de forma independiente por uno o más halo o alquilo C₁₋₁₂ opcionalmente sustituido de forma independiente por uno o más oxo, halo, hidroxilo o amino; y cada R³⁰ y R³¹ es independientemente hidrógeno o alquilo C₁₋₁₂ opcionalmente sustituido de forma independiente con uno o más oxo, halo, hidroxilo o amino; o R³⁰ y R³¹ se toman en conjunto con los átomos a los que están enlazados para formar heterociclilo opcionalmente sustituido de forma independiente por uno o más halo o alquilo C₁₋₁₂ opcionalmente sustituido de forma independiente por uno o más oxo, halo, hidroxilo o amino.",DENALI THERAPEUTICS INC,REMARCHUCK TRAVIS;;HALE CHRISTOPHER;;DE VICENTE FIDALGO JAVIER;;SWEENEY ZACHARY K;;OSIPOV MAKSIM;;LEXA KATRINA W;;FOX BRIAN;;FENG JIANWEN A;;ESTRADA ANTHONY A;;CRAIG II ROBERT A,,https://lens.org/018-654-239-474-74X,Patent Application,no,0,0,1,31,0,,C07D231/12;;A61K31/41;;A61K31/4192;;A61K31/4196;;A61K31/42;;A61P25/00;;A61P25/16;;A61P25/28;;C07D233/36;;C07D233/42;;C07D233/64;;C07D249/04;;C07D249/06;;C07D249/08;;C07D257/04;;C07D261/04;;C07D261/08;;C07D263/32;;C07D263/38;;C07D263/56;;C07D271/06;;C07D271/10;;C07D291/04;;C07D401/12;;C07D403/04;;C07D403/12;;C07D413/04;;C07D413/06;;C07D413/12;;C07D417/04;;C07D417/12;;C07D471/04;;C07D487/04;;C07D491/048,,0,0,,,,PENDING
96,TW,A,TW 201920115 A,065-720-187-906-471,2019-06-01,2019,TW 107127864 A,2018-08-09,US 201762543307 P;;US 201762553728 P;;US 201762608504 P,2017-08-09,"Compounds, compositions and methods","The present disclosure relates generally to eukaryotic initiation factor 2B modulators, or a pharmaceutically acceptable salt, stereoisomer, mixture of stereoisomers or prodrug thereof, and methods of making and using thereof.",DENALI THERAPEUTICS INC,CRAIG ROBERT A;;ESTRADA ANTHONY A;;FENG JIANWEN A;;FOX BRIAN M;;LEXA KATRINA W;;OSIPOV MAKSIM;;SWEENEY ZACHARY K;;DE VICENTE FIDALGO JAVIER;;HALE CHRISTOPHER;;REMARCHUK TRAVIS,,https://lens.org/065-720-187-906-471,Patent of Addition,no,0,0,29,31,0,C07C271/24;;C07C235/14;;C07C2602/38;;A61P25/16;;C07D263/56;;C07D403/12;;C07D231/12;;C07D233/36;;C07D233/42;;C07D233/64;;C07D401/12;;C07D403/04;;C07D413/04;;C07D413/06;;C07D413/12;;C07D417/04;;C07D417/12;;C07D249/04;;C07D249/06;;C07D249/08;;C07D471/04;;C07D257/04;;C07D261/04;;C07D261/08;;C07D487/04;;C07D263/32;;C07D263/38;;C07D491/048;;C07D271/06;;C07D271/10;;C07D207/27;;C07D291/04;;A61P25/28;;C07F7/1804;;C07C235/14;;C07D491/048;;C07D233/42;;C07D417/04;;C07D487/04;;C07D271/10;;C07C2602/38;;C07D401/12;;C07D231/12;;C07D271/06;;C07D403/04;;C07D471/04;;A61P25/16;;C07D249/08;;C07D413/04;;C07D233/61;;C07D249/04;;C07D263/38;;C07D291/04;;C07D257/04;;C07D263/56;;C07C271/24;;C07D207/27;;C07D417/12;;C07D233/64;;C07D263/32;;C07D261/08;;C07D261/04;;C07D249/06;;C07D233/36;;C07D413/06;;C07D413/12;;A61P25/28;;C07D403/12;;C07F7/1804;;C07C235/22;;C07D411/04;;A61K31/4245;;C07D411/04;;A61K31/4245;;A61P25/16;;A61P25/28;;C07D207/27;;C07D271/06;;C07D271/10;;C07D231/12;;C07D233/36;;C07D233/42;;C07D233/64;;C07D249/04;;C07D249/06;;C07D249/08;;C07D257/04;;C07D261/04;;C07D261/08;;C07D263/32;;C07D263/38;;C07D263/56;;C07D291/04;;C07D401/12;;C07D403/04;;C07D403/12;;C07D413/04;;C07D413/06;;C07D413/12;;C07D417/04;;C07D417/12;;C07D471/04;;C07D487/04;;C07D491/048;;C07F7/1804;;C07C235/14;;C07C271/24;;C07C2602/38;;C07C235/22;;C07D207/27;;C07D233/36;;C07D233/42;;C07D233/61;;C07D233/64;;C07D249/04;;C07D249/08;;C07D257/04;;C07D261/04;;C07D261/08;;C07D263/32;;C07D263/38;;C07D263/56;;C07D271/06;;C07D271/10;;C07D291/04;;C07D401/12;;C07D403/04;;C07D403/12;;C07D413/04;;C07D413/06;;C07D413/12;;C07D417/04;;C07D471/04;;C07D487/04;;C07D491/048;;A61K31/415;;A61K31/4245;;A61K31/421;;A61K31/4164,A61K31/41;;C07D233/56;;A61K31/4192;;A61K31/4196;;A61K31/42;;C07D249/06;;C07D249/08;;C07D257/06;;C07D261/08;;C07D263/14;;C07D263/32;;C07D263/58;;C07D271/06;;C07D271/10;;C07D413/04;;C07D413/12;;C07D417/12;;C07D471/04;;C07D487/04;;C07D491/048,,0,0,,,,PENDING
97,WO,A1,WO 2019/032743 A1,140-031-504-560-609,2019-02-14,2019,US 2018/0045868 W,2018-08-08,US 201762543307 P;;US 201762553728 P;;US 201762608504 P,2017-08-09,"COMPOUNDS, COMPOSITIONS AND METHODS","The present disclosure relates generally to eukaryotic initiation factor 2B modulators, or a pharmaceutically acceptable salt, stereoisomer, mixture of stereoisomers or prodrug thereof, and methods of making and using thereof.",DENALI THERAPEUTICS INC,CRAIG ROBERT A;;ESTRADA ANTHONY A;;FENG JIANWEN A;;FOX BRIAN;;HALE CHRISTOPHER R H;;LEXA KATRINA W;;OSIPOV MAKSIM;;REMARCHUCK TRAVIS;;SWEENEY ZACHARY K;;DE VICENTE FIDALGO JAVIER,,https://lens.org/140-031-504-560-609,Patent Application,yes,3,21,29,31,0,C07C271/24;;C07C235/14;;C07C2602/38;;A61P25/16;;C07D263/56;;C07D403/12;;C07D231/12;;C07D233/36;;C07D233/42;;C07D233/64;;C07D401/12;;C07D403/04;;C07D413/04;;C07D413/06;;C07D413/12;;C07D417/04;;C07D417/12;;C07D249/04;;C07D249/06;;C07D249/08;;C07D471/04;;C07D257/04;;C07D261/04;;C07D261/08;;C07D487/04;;C07D263/32;;C07D263/38;;C07D491/048;;C07D271/06;;C07D271/10;;C07D207/27;;C07D291/04;;A61P25/28;;C07F7/1804;;C07C235/14;;C07D491/048;;C07D233/42;;C07D417/04;;C07D487/04;;C07D271/10;;C07C2602/38;;C07D401/12;;C07D231/12;;C07D271/06;;C07D403/04;;C07D471/04;;A61P25/16;;C07D249/08;;C07D413/04;;C07D233/61;;C07D249/04;;C07D263/38;;C07D291/04;;C07D257/04;;C07D263/56;;C07C271/24;;C07D207/27;;C07D417/12;;C07D233/64;;C07D263/32;;C07D261/08;;C07D261/04;;C07D249/06;;C07D233/36;;C07D413/06;;C07D413/12;;A61P25/28;;C07D403/12;;C07F7/1804;;C07C235/22;;C07D411/04;;A61K31/4245;;C07D411/04;;A61K31/4245;;A61P25/16;;A61P25/28;;C07D207/27;;C07D271/06;;C07D271/10;;C07D231/12;;C07D233/36;;C07D233/42;;C07D233/64;;C07D249/04;;C07D249/06;;C07D249/08;;C07D257/04;;C07D261/04;;C07D261/08;;C07D263/32;;C07D263/38;;C07D263/56;;C07D291/04;;C07D401/12;;C07D403/04;;C07D403/12;;C07D413/04;;C07D413/06;;C07D413/12;;C07D417/04;;C07D417/12;;C07D471/04;;C07D487/04;;C07D491/048;;C07F7/1804;;C07C235/14;;C07C271/24;;C07C2602/38;;C07C235/22;;C07D207/27;;C07D233/36;;C07D233/42;;C07D233/61;;C07D233/64;;C07D249/04;;C07D249/08;;C07D257/04;;C07D261/04;;C07D261/08;;C07D263/32;;C07D263/38;;C07D263/56;;C07D271/06;;C07D271/10;;C07D291/04;;C07D401/12;;C07D403/04;;C07D403/12;;C07D413/04;;C07D413/06;;C07D413/12;;C07D417/04;;C07D471/04;;C07D487/04;;C07D491/048;;A61K31/415;;A61K31/4245;;A61K31/421;;A61K31/4164,C07C211/38;;C07C217/52;;C07C233/05,,1,0,,,See also references of EP 3665156A4,PENDING
98,CN,A,CN 111094233 A,054-186-022-457-018,2020-05-01,2020,CN 201880055607 A,2018-08-08,US 201762543307 P;;US 201762553728 P;;US 201762608504 P;;US 2018/0045868 W,2017-08-09,"COMPOUNDS, COMPOSITIONS AND METHODS","The present disclosure relates generally to eukaryotic initiation factor 2B modulators, or a pharmaceutically acceptable salt, stereoisomer, mixture of stereoisomers or prodrug thereof, and methods ofmaking and using thereof.",DENALI THERAPEUTICS INC,CRAIG ROBERT A;;ESTRADA ANTHONY A;;FENG JIANWEN A;;FOX BRIAN;;HALE CHRISTOPHER R H;;LEXA KATRINA W;;OSIPOV MAKSIM;;REMARCHUCK TRAVIS;;SWEENEY ZACHARY K;;DE VICENTE FIDALGO JAVIER,,https://lens.org/054-186-022-457-018,Patent Application,no,4,0,29,31,0,C07C271/24;;C07C235/14;;C07C2602/38;;A61P25/16;;C07D263/56;;C07D403/12;;C07D231/12;;C07D233/36;;C07D233/42;;C07D233/64;;C07D401/12;;C07D403/04;;C07D413/04;;C07D413/06;;C07D413/12;;C07D417/04;;C07D417/12;;C07D249/04;;C07D249/06;;C07D249/08;;C07D471/04;;C07D257/04;;C07D261/04;;C07D261/08;;C07D487/04;;C07D263/32;;C07D263/38;;C07D491/048;;C07D271/06;;C07D271/10;;C07D207/27;;C07D291/04;;A61P25/28;;C07F7/1804;;C07C235/14;;C07D491/048;;C07D233/42;;C07D417/04;;C07D487/04;;C07D271/10;;C07C2602/38;;C07D401/12;;C07D231/12;;C07D271/06;;C07D403/04;;C07D471/04;;A61P25/16;;C07D249/08;;C07D413/04;;C07D233/61;;C07D249/04;;C07D263/38;;C07D291/04;;C07D257/04;;C07D263/56;;C07C271/24;;C07D207/27;;C07D417/12;;C07D233/64;;C07D263/32;;C07D261/08;;C07D261/04;;C07D249/06;;C07D233/36;;C07D413/06;;C07D413/12;;A61P25/28;;C07D403/12;;C07F7/1804;;C07C235/22;;C07D411/04;;A61K31/4245;;C07D411/04;;A61K31/4245;;A61P25/16;;A61P25/28;;C07D207/27;;C07D271/06;;C07D271/10;;C07D231/12;;C07D233/36;;C07D233/42;;C07D233/64;;C07D249/04;;C07D249/06;;C07D249/08;;C07D257/04;;C07D261/04;;C07D261/08;;C07D263/32;;C07D263/38;;C07D263/56;;C07D291/04;;C07D401/12;;C07D403/04;;C07D403/12;;C07D413/04;;C07D413/06;;C07D413/12;;C07D417/04;;C07D417/12;;C07D471/04;;C07D487/04;;C07D491/048;;C07F7/1804;;C07C235/14;;C07C271/24;;C07C2602/38;;C07C235/22;;C07D207/27;;C07D233/36;;C07D233/42;;C07D233/61;;C07D233/64;;C07D249/04;;C07D249/08;;C07D257/04;;C07D261/04;;C07D261/08;;C07D263/32;;C07D263/38;;C07D263/56;;C07D271/06;;C07D271/10;;C07D291/04;;C07D401/12;;C07D403/04;;C07D403/12;;C07D413/04;;C07D413/06;;C07D413/12;;C07D417/04;;C07D471/04;;C07D487/04;;C07D491/048;;A61K31/415;;A61K31/4245;;A61K31/421;;A61K31/4164,C07C211/38;;C07C217/52;;C07C233/05,,0,0,,,,PENDING
99,SG,A,SG 11202000532S A,011-459-674-968-455,2020-02-27,2020,SG 11202000532S A,2018-08-08,US 201762543307 P;;US 201762553728 P;;US 201762608504 P;;US 2018/0045868 W,2017-08-09,"COMPOUNDS, COMPOSITIONS AND METHODS",,DENALI THERAPEUTICS INC,CRAIG ROBERT A;;ESTRADA ANTHONY A;;FENG JIANWEN A;;FOX BRIAN;;HALE CHRISTOPHER R H;;LEXA KATRINA W;;OSIPOV MAKSIM;;REMARCHUK TRAVIS;;SWEENEY ZACHARY K;;DE VICENTE FIDALGO JAVIER,,https://lens.org/011-459-674-968-455,Unknown,no,0,0,29,31,0,C07C271/24;;C07C235/14;;C07C2602/38;;A61P25/16;;C07D263/56;;C07D403/12;;C07D231/12;;C07D233/36;;C07D233/42;;C07D233/64;;C07D401/12;;C07D403/04;;C07D413/04;;C07D413/06;;C07D413/12;;C07D417/04;;C07D417/12;;C07D249/04;;C07D249/06;;C07D249/08;;C07D471/04;;C07D257/04;;C07D261/04;;C07D261/08;;C07D487/04;;C07D263/32;;C07D263/38;;C07D491/048;;C07D271/06;;C07D271/10;;C07D207/27;;C07D291/04;;A61P25/28;;C07F7/1804;;C07C235/14;;C07D491/048;;C07D233/42;;C07D417/04;;C07D487/04;;C07D271/10;;C07C2602/38;;C07D401/12;;C07D231/12;;C07D271/06;;C07D403/04;;C07D471/04;;A61P25/16;;C07D249/08;;C07D413/04;;C07D233/61;;C07D249/04;;C07D263/38;;C07D291/04;;C07D257/04;;C07D263/56;;C07C271/24;;C07D207/27;;C07D417/12;;C07D233/64;;C07D263/32;;C07D261/08;;C07D261/04;;C07D249/06;;C07D233/36;;C07D413/06;;C07D413/12;;A61P25/28;;C07D403/12;;C07F7/1804;;C07C235/22;;C07D411/04;;A61K31/4245;;C07D411/04;;A61K31/4245;;A61P25/16;;A61P25/28;;C07D207/27;;C07D271/06;;C07D271/10;;C07D231/12;;C07D233/36;;C07D233/42;;C07D233/64;;C07D249/04;;C07D249/06;;C07D249/08;;C07D257/04;;C07D261/04;;C07D261/08;;C07D263/32;;C07D263/38;;C07D263/56;;C07D291/04;;C07D401/12;;C07D403/04;;C07D403/12;;C07D413/04;;C07D413/06;;C07D413/12;;C07D417/04;;C07D417/12;;C07D471/04;;C07D487/04;;C07D491/048;;C07F7/1804;;C07C235/14;;C07C271/24;;C07C2602/38;;C07C235/22;;C07D207/27;;C07D233/36;;C07D233/42;;C07D233/61;;C07D233/64;;C07D249/04;;C07D249/08;;C07D257/04;;C07D261/04;;C07D261/08;;C07D263/32;;C07D263/38;;C07D263/56;;C07D271/06;;C07D271/10;;C07D291/04;;C07D401/12;;C07D403/04;;C07D403/12;;C07D413/04;;C07D413/06;;C07D413/12;;C07D417/04;;C07D471/04;;C07D487/04;;C07D491/048;;A61K31/415;;A61K31/4245;;A61K31/421;;A61K31/4164,C07C211/38;;C07C217/52;;C07C233/05,,0,0,,,,PENDING
100,CO,A2,CO 2020001220 A2,049-742-881-446-45X,2020-02-18,2020,CO 2020001220 A,2020-02-03,US 2018/0045868 W;;US 201762543307 P;;US 201762553728 P;;US 201762608504 P,2017-08-09,"Compuestos, composiciones y métodos","La presente descripción hace referencia en términos generales a moduladores del factor de iniciación eucariota 2B o una sal farmacéuticamente aceptable, un estereoisómero, una mezcla de estereoisómeros o un profármaco de estos y a métodos para realizarlos y utilizarlos.",DENALI THERAPEUTICS INC,CRAIG ROBERT A II;;FENG JIANWEN A;;ESTRADA ANTHONY A;;DE VICENTE FIDALGO JAVIER;;FOX BRIAN;;LEXA KATRINA W;;HALE CHRISTOPHER R H;;OSIPOV MAKSIM;;REMARCHUK TRAVIS;;SWEENEY ZACHARY K,,https://lens.org/049-742-881-446-45X,Patent Application,no,0,0,29,31,0,C07C271/24;;C07C235/14;;C07C2602/38;;A61P25/16;;C07D263/56;;C07D403/12;;C07D231/12;;C07D233/36;;C07D233/42;;C07D233/64;;C07D401/12;;C07D403/04;;C07D413/04;;C07D413/06;;C07D413/12;;C07D417/04;;C07D417/12;;C07D249/04;;C07D249/06;;C07D249/08;;C07D471/04;;C07D257/04;;C07D261/04;;C07D261/08;;C07D487/04;;C07D263/32;;C07D263/38;;C07D491/048;;C07D271/06;;C07D271/10;;C07D207/27;;C07D291/04;;A61P25/28;;C07F7/1804;;C07C235/14;;C07D491/048;;C07D233/42;;C07D417/04;;C07D487/04;;C07D271/10;;C07C2602/38;;C07D401/12;;C07D231/12;;C07D271/06;;C07D403/04;;C07D471/04;;A61P25/16;;C07D249/08;;C07D413/04;;C07D233/61;;C07D249/04;;C07D263/38;;C07D291/04;;C07D257/04;;C07D263/56;;C07C271/24;;C07D207/27;;C07D417/12;;C07D233/64;;C07D263/32;;C07D261/08;;C07D261/04;;C07D249/06;;C07D233/36;;C07D413/06;;C07D413/12;;A61P25/28;;C07D403/12;;C07F7/1804;;C07C235/22;;C07D411/04;;A61K31/4245;;C07D411/04;;A61K31/4245;;A61P25/16;;A61P25/28;;C07D207/27;;C07D271/06;;C07D271/10;;C07D231/12;;C07D233/36;;C07D233/42;;C07D233/64;;C07D249/04;;C07D249/06;;C07D249/08;;C07D257/04;;C07D261/04;;C07D261/08;;C07D263/32;;C07D263/38;;C07D263/56;;C07D291/04;;C07D401/12;;C07D403/04;;C07D403/12;;C07D413/04;;C07D413/06;;C07D413/12;;C07D417/04;;C07D417/12;;C07D471/04;;C07D487/04;;C07D491/048;;C07F7/1804;;C07C235/14;;C07C271/24;;C07C2602/38;;C07C235/22;;C07D207/27;;C07D233/36;;C07D233/42;;C07D233/61;;C07D233/64;;C07D249/04;;C07D249/08;;C07D257/04;;C07D261/04;;C07D261/08;;C07D263/32;;C07D263/38;;C07D263/56;;C07D271/06;;C07D271/10;;C07D291/04;;C07D401/12;;C07D403/04;;C07D403/12;;C07D413/04;;C07D413/06;;C07D413/12;;C07D417/04;;C07D471/04;;C07D487/04;;C07D491/048;;A61K31/415;;A61K31/4245;;A61K31/421;;A61K31/4164,C07C211/38;;C07C217/52;;C07C233/05,,0,0,,,,PENDING
101,EP,A1,EP 3665156 A1,102-548-294-564-102,2020-06-17,2020,EP 18844666 A,2018-08-08,US 201762543307 P;;US 201762553728 P;;US 201762608504 P;;US 2018/0045868 W,2017-08-09,"COMPOUNDS, COMPOSITIONS AND METHODS",,DENALI THERAPEUTICS INC,CRAIG ROBERT A II;;ESTRADA ANTHONY A;;FENG JIANWEN A;;FOX BRIAN;;HALE CHRISTOPHER R H;;LEXA KATRINA W;;OSIPOV MAKSIM;;REMARCHUK TRAVIS;;SWEENEY ZACHARY K;;DE VICENTE FIDALGO JAVIER,,https://lens.org/102-548-294-564-102,Patent Application,yes,0,0,29,31,0,C07C271/24;;C07C235/14;;C07C2602/38;;A61P25/16;;C07D263/56;;C07D403/12;;C07D231/12;;C07D233/36;;C07D233/42;;C07D233/64;;C07D401/12;;C07D403/04;;C07D413/04;;C07D413/06;;C07D413/12;;C07D417/04;;C07D417/12;;C07D249/04;;C07D249/06;;C07D249/08;;C07D471/04;;C07D257/04;;C07D261/04;;C07D261/08;;C07D487/04;;C07D263/32;;C07D263/38;;C07D491/048;;C07D271/06;;C07D271/10;;C07D207/27;;C07D291/04;;A61P25/28;;C07F7/1804;;C07C235/14;;C07D491/048;;C07D233/42;;C07D417/04;;C07D487/04;;C07D271/10;;C07C2602/38;;C07D401/12;;C07D231/12;;C07D271/06;;C07D403/04;;C07D471/04;;A61P25/16;;C07D249/08;;C07D413/04;;C07D233/61;;C07D249/04;;C07D263/38;;C07D291/04;;C07D257/04;;C07D263/56;;C07C271/24;;C07D207/27;;C07D417/12;;C07D233/64;;C07D263/32;;C07D261/08;;C07D261/04;;C07D249/06;;C07D233/36;;C07D413/06;;C07D413/12;;A61P25/28;;C07D403/12;;C07F7/1804;;C07C235/22;;C07D411/04;;A61K31/4245;;C07D411/04;;A61K31/4245;;A61P25/16;;A61P25/28;;C07D207/27;;C07D271/06;;C07D271/10;;C07D231/12;;C07D233/36;;C07D233/42;;C07D233/64;;C07D249/04;;C07D249/06;;C07D249/08;;C07D257/04;;C07D261/04;;C07D261/08;;C07D263/32;;C07D263/38;;C07D263/56;;C07D291/04;;C07D401/12;;C07D403/04;;C07D403/12;;C07D413/04;;C07D413/06;;C07D413/12;;C07D417/04;;C07D417/12;;C07D471/04;;C07D487/04;;C07D491/048;;C07F7/1804;;C07C235/14;;C07C271/24;;C07C2602/38;;C07C235/22;;C07D207/27;;C07D233/36;;C07D233/42;;C07D233/61;;C07D233/64;;C07D249/04;;C07D249/08;;C07D257/04;;C07D261/04;;C07D261/08;;C07D263/32;;C07D263/38;;C07D263/56;;C07D271/06;;C07D271/10;;C07D291/04;;C07D401/12;;C07D403/04;;C07D403/12;;C07D413/04;;C07D413/06;;C07D413/12;;C07D417/04;;C07D471/04;;C07D487/04;;C07D491/048;;A61K31/415;;A61K31/4245;;A61K31/421;;A61K31/4164,C07C211/38;;C07C217/52;;C07C233/05,,0,0,,,,PENDING
102,EP,A4,EP 3665156 A4,026-835-558-318-552,2021-04-28,2021,EP 18844666 A,2018-08-08,US 201762543307 P;;US 201762553728 P;;US 201762608504 P;;US 2018/0045868 W,2017-08-09,"COMPOUNDS, COMPOSITIONS AND METHODS",,DENALI THERAPEUTICS INC,CRAIG ROBERT A II;;ESTRADA ANTHONY A;;FENG JIANWEN A;;FOX BRIAN;;HALE CHRISTOPHER R H;;LEXA KATRINA W;;OSIPOV MAKSIM;;REMARCHUK TRAVIS;;SWEENEY ZACHARY K;;DE VICENTE FIDALGO JAVIER,,https://lens.org/026-835-558-318-552,Search Report,no,4,0,29,31,0,C07C271/24;;C07C235/14;;C07C2602/38;;A61P25/16;;C07D263/56;;C07D403/12;;C07D231/12;;C07D233/36;;C07D233/42;;C07D233/64;;C07D401/12;;C07D403/04;;C07D413/04;;C07D413/06;;C07D413/12;;C07D417/04;;C07D417/12;;C07D249/04;;C07D249/06;;C07D249/08;;C07D471/04;;C07D257/04;;C07D261/04;;C07D261/08;;C07D487/04;;C07D263/32;;C07D263/38;;C07D491/048;;C07D271/06;;C07D271/10;;C07D207/27;;C07D291/04;;A61P25/28;;C07F7/1804;;C07C235/14;;C07D491/048;;C07D233/42;;C07D417/04;;C07D487/04;;C07D271/10;;C07C2602/38;;C07D401/12;;C07D231/12;;C07D271/06;;C07D403/04;;C07D471/04;;A61P25/16;;C07D249/08;;C07D413/04;;C07D233/61;;C07D249/04;;C07D263/38;;C07D291/04;;C07D257/04;;C07D263/56;;C07C271/24;;C07D207/27;;C07D417/12;;C07D233/64;;C07D263/32;;C07D261/08;;C07D261/04;;C07D249/06;;C07D233/36;;C07D413/06;;C07D413/12;;A61P25/28;;C07D403/12;;C07F7/1804;;C07C235/22;;C07D411/04;;A61K31/4245;;C07D411/04;;A61K31/4245;;A61P25/16;;A61P25/28;;C07D207/27;;C07D271/06;;C07D271/10;;C07D231/12;;C07D233/36;;C07D233/42;;C07D233/64;;C07D249/04;;C07D249/06;;C07D249/08;;C07D257/04;;C07D261/04;;C07D261/08;;C07D263/32;;C07D263/38;;C07D263/56;;C07D291/04;;C07D401/12;;C07D403/04;;C07D403/12;;C07D413/04;;C07D413/06;;C07D413/12;;C07D417/04;;C07D417/12;;C07D471/04;;C07D487/04;;C07D491/048;;C07F7/1804;;C07C235/14;;C07C271/24;;C07C2602/38;;C07C235/22;;C07D207/27;;C07D233/36;;C07D233/42;;C07D233/61;;C07D233/64;;C07D249/04;;C07D249/08;;C07D257/04;;C07D261/04;;C07D261/08;;C07D263/32;;C07D263/38;;C07D263/56;;C07D271/06;;C07D271/10;;C07D291/04;;C07D401/12;;C07D403/04;;C07D403/12;;C07D413/04;;C07D413/06;;C07D413/12;;C07D417/04;;C07D471/04;;C07D487/04;;C07D491/048;;A61K31/415;;A61K31/4245;;A61K31/421;;A61K31/4164,C07D271/10;;A61K31/4245;;A61P25/28;;C07C211/38;;C07C217/52;;C07C233/05;;C07D471/04;;C07F7/18,,1,0,,,See also references of WO 2019032743A1,PENDING
103,CL,A1,CL 2020000299 A1,007-599-397-317-776,2020-07-24,2020,CL 2020000299 A,2020-02-03,US 201762543307 P;;US 201762553728 P;;US 201762608504 P,2017-08-09,"Compuestos, composiciones y métodos.","LA PRESENTE DESCRIPCIÓN HACE REFERENCIA EN TÉRMINOS GENERALES A MODULADORES DEL FACTOR DE INICIACIÓN EUCARIOTA 2B O UNA SAL FARMACÉUTICAMENTE ACEPTABLE, UN ESTEREOISÓMERO, UNA MEZCLA DE ESTEREOISÓMEROS O UN PROFÁRMACO DE ESTOS Y A MÉTODOS PARA REALIZARLOS Y UTILIZARLOS.",DENALI THERAPEUTICS INC,FENG JIANWEN A;;FOX BRIAN;;CRAIG ROBERT A II;;ESTRADA ANTHONY A;;HALE CHRISTOPHER R H;;LEXA KATRINA W;;OSIPOV MAKSIM;;REMARCHUK TRAVIS;;SWEENEY ZACHARY K;;DE VICENTE FIDALGO JAVIER,,https://lens.org/007-599-397-317-776,Patent Application,no,0,0,29,31,0,C07C271/24;;C07C235/14;;C07C2602/38;;A61P25/16;;C07D263/56;;C07D403/12;;C07D231/12;;C07D233/36;;C07D233/42;;C07D233/64;;C07D401/12;;C07D403/04;;C07D413/04;;C07D413/06;;C07D413/12;;C07D417/04;;C07D417/12;;C07D249/04;;C07D249/06;;C07D249/08;;C07D471/04;;C07D257/04;;C07D261/04;;C07D261/08;;C07D487/04;;C07D263/32;;C07D263/38;;C07D491/048;;C07D271/06;;C07D271/10;;C07D207/27;;C07D291/04;;A61P25/28;;C07F7/1804;;C07C235/14;;C07D491/048;;C07D233/42;;C07D417/04;;C07D487/04;;C07D271/10;;C07C2602/38;;C07D401/12;;C07D231/12;;C07D271/06;;C07D403/04;;C07D471/04;;A61P25/16;;C07D249/08;;C07D413/04;;C07D233/61;;C07D249/04;;C07D263/38;;C07D291/04;;C07D257/04;;C07D263/56;;C07C271/24;;C07D207/27;;C07D417/12;;C07D233/64;;C07D263/32;;C07D261/08;;C07D261/04;;C07D249/06;;C07D233/36;;C07D413/06;;C07D413/12;;A61P25/28;;C07D403/12;;C07F7/1804;;C07C235/22;;C07D411/04;;A61K31/4245;;C07D411/04;;A61K31/4245;;A61P25/16;;A61P25/28;;C07D207/27;;C07D271/06;;C07D271/10;;C07D231/12;;C07D233/36;;C07D233/42;;C07D233/64;;C07D249/04;;C07D249/06;;C07D249/08;;C07D257/04;;C07D261/04;;C07D261/08;;C07D263/32;;C07D263/38;;C07D263/56;;C07D291/04;;C07D401/12;;C07D403/04;;C07D403/12;;C07D413/04;;C07D413/06;;C07D413/12;;C07D417/04;;C07D417/12;;C07D471/04;;C07D487/04;;C07D491/048;;C07F7/1804;;C07C235/14;;C07C271/24;;C07C2602/38;;C07C235/22;;C07D207/27;;C07D233/36;;C07D233/42;;C07D233/61;;C07D233/64;;C07D249/04;;C07D249/08;;C07D257/04;;C07D261/04;;C07D261/08;;C07D263/32;;C07D263/38;;C07D263/56;;C07D271/06;;C07D271/10;;C07D291/04;;C07D401/12;;C07D403/04;;C07D403/12;;C07D413/04;;C07D413/06;;C07D413/12;;C07D417/04;;C07D471/04;;C07D487/04;;C07D491/048;;A61K31/415;;A61K31/4245;;A61K31/421;;A61K31/4164,C07C211/38;;C07C217/52;;C07C233/05,,0,0,,,,PENDING
104,AU,A1,AU 2023/201775 A1,079-479-899-935-094,2023-04-20,2023,AU 2023/201775 A,2023-03-22,AU 2023/201775 A;;AU 2018/313850 A;;US 201762608504 P;;US 201762543307 P;;US 201762553728 P;;US 2018/0045868 W,2017-08-09,"Compounds, compositions and methods","The present disclosure relates generally to eukaryotic initiation factor 2B modulators, or a pharmaceutically acceptable salt, stereoisomer, mixture of stereoisomers or prodrug thereof, and methods of making and using thereof.",DENALI THERAPEUTICS INC,CRAIG II ROBERT A;;ESTRADA ANTHONY A;;FENG JIANWEN A;;FOX BRIAN;;HALE CHRISTOPHER R H;;LEXA KATRINA W;;OSIPOV MAKSIM;;REMARCHUK TRAVIS;;SWEENEY ZACHARY K;;DE VICENTE FIDALGO JAVIER,,https://lens.org/079-479-899-935-094,Patent Application,no,0,0,29,31,0,C07C271/24;;C07C235/14;;C07C2602/38;;A61P25/16;;C07D263/56;;C07D403/12;;C07D231/12;;C07D233/36;;C07D233/42;;C07D233/64;;C07D401/12;;C07D403/04;;C07D413/04;;C07D413/06;;C07D413/12;;C07D417/04;;C07D417/12;;C07D249/04;;C07D249/06;;C07D249/08;;C07D471/04;;C07D257/04;;C07D261/04;;C07D261/08;;C07D487/04;;C07D263/32;;C07D263/38;;C07D491/048;;C07D271/06;;C07D271/10;;C07D207/27;;C07D291/04;;A61P25/28;;C07F7/1804;;C07C235/14;;C07D491/048;;C07D233/42;;C07D417/04;;C07D487/04;;C07D271/10;;C07C2602/38;;C07D401/12;;C07D231/12;;C07D271/06;;C07D403/04;;C07D471/04;;A61P25/16;;C07D249/08;;C07D413/04;;C07D233/61;;C07D249/04;;C07D263/38;;C07D291/04;;C07D257/04;;C07D263/56;;C07C271/24;;C07D207/27;;C07D417/12;;C07D233/64;;C07D263/32;;C07D261/08;;C07D261/04;;C07D249/06;;C07D233/36;;C07D413/06;;C07D413/12;;A61P25/28;;C07D403/12;;C07F7/1804;;C07C235/22;;C07D411/04;;A61K31/4245;;C07D411/04;;A61K31/4245;;A61P25/16;;A61P25/28;;C07D207/27;;C07D271/06;;C07D271/10;;C07D231/12;;C07D233/36;;C07D233/42;;C07D233/64;;C07D249/04;;C07D249/06;;C07D249/08;;C07D257/04;;C07D261/04;;C07D261/08;;C07D263/32;;C07D263/38;;C07D263/56;;C07D291/04;;C07D401/12;;C07D403/04;;C07D403/12;;C07D413/04;;C07D413/06;;C07D413/12;;C07D417/04;;C07D417/12;;C07D471/04;;C07D487/04;;C07D491/048;;C07F7/1804;;C07C235/14;;C07C271/24;;C07C2602/38;;C07C235/22;;C07D207/27;;C07D233/36;;C07D233/42;;C07D233/61;;C07D233/64;;C07D249/04;;C07D249/08;;C07D257/04;;C07D261/04;;C07D261/08;;C07D263/32;;C07D263/38;;C07D263/56;;C07D271/06;;C07D271/10;;C07D291/04;;C07D401/12;;C07D403/04;;C07D403/12;;C07D413/04;;C07D413/06;;C07D413/12;;C07D417/04;;C07D471/04;;C07D487/04;;C07D491/048;;A61K31/415;;A61K31/4245;;A61K31/421;;A61K31/4164,C07C211/38;;C07C217/52;;C07C233/05,,0,0,,,,PENDING
105,CA,A1,CA 3071024 A1,082-341-691-227-36X,2019-02-14,2019,CA 3071024 A,2018-08-08,US 201762543307 P;;US 201762553728 P;;US 201762608504 P;;US 2018/0045868 W,2017-08-09,"COMPOUNDS, COMPOSITIONS AND METHODS","The present disclosure relates generally to eukaryotic initiation factor 2B modulators, or a pharmaceutically acceptable salt, stereoisomer, mixture of stereoisomers or prodrug thereof, and methods of making and using thereof.",DENALI THERAPEUTICS INC,CRAIG ROBERT A;;ESTRADA ANTHONY A;;FENG JIANWEN A;;FOX BRIAN M;;HALE CHRISTOPHER R H;;LEXA KATRINA W;;OSIPOV MAKSIM;;REMARCHUK TRAVIS;;SWEENEY ZACHARY K;;DE VICENTE FIDALGO JAVIER,,https://lens.org/082-341-691-227-36X,Patent Application,no,0,1,29,31,0,C07C271/24;;C07C235/14;;C07C2602/38;;A61P25/16;;C07D263/56;;C07D403/12;;C07D231/12;;C07D233/36;;C07D233/42;;C07D233/64;;C07D401/12;;C07D403/04;;C07D413/04;;C07D413/06;;C07D413/12;;C07D417/04;;C07D417/12;;C07D249/04;;C07D249/06;;C07D249/08;;C07D471/04;;C07D257/04;;C07D261/04;;C07D261/08;;C07D487/04;;C07D263/32;;C07D263/38;;C07D491/048;;C07D271/06;;C07D271/10;;C07D207/27;;C07D291/04;;A61P25/28;;C07F7/1804;;C07C235/14;;C07D491/048;;C07D233/42;;C07D417/04;;C07D487/04;;C07D271/10;;C07C2602/38;;C07D401/12;;C07D231/12;;C07D271/06;;C07D403/04;;C07D471/04;;A61P25/16;;C07D249/08;;C07D413/04;;C07D233/61;;C07D249/04;;C07D263/38;;C07D291/04;;C07D257/04;;C07D263/56;;C07C271/24;;C07D207/27;;C07D417/12;;C07D233/64;;C07D263/32;;C07D261/08;;C07D261/04;;C07D249/06;;C07D233/36;;C07D413/06;;C07D413/12;;A61P25/28;;C07D403/12;;C07F7/1804;;C07C235/22;;C07D411/04;;A61K31/4245;;C07D411/04;;A61K31/4245;;A61P25/16;;A61P25/28;;C07D207/27;;C07D271/06;;C07D271/10;;C07D231/12;;C07D233/36;;C07D233/42;;C07D233/64;;C07D249/04;;C07D249/06;;C07D249/08;;C07D257/04;;C07D261/04;;C07D261/08;;C07D263/32;;C07D263/38;;C07D263/56;;C07D291/04;;C07D401/12;;C07D403/04;;C07D403/12;;C07D413/04;;C07D413/06;;C07D413/12;;C07D417/04;;C07D417/12;;C07D471/04;;C07D487/04;;C07D491/048;;C07F7/1804;;C07C235/14;;C07C271/24;;C07C2602/38;;C07C235/22;;C07D207/27;;C07D233/36;;C07D233/42;;C07D233/61;;C07D233/64;;C07D249/04;;C07D249/08;;C07D257/04;;C07D261/04;;C07D261/08;;C07D263/32;;C07D263/38;;C07D263/56;;C07D271/06;;C07D271/10;;C07D291/04;;C07D401/12;;C07D403/04;;C07D403/12;;C07D413/04;;C07D413/06;;C07D413/12;;C07D417/04;;C07D471/04;;C07D487/04;;C07D491/048;;A61K31/415;;A61K31/4245;;A61K31/421;;A61K31/4164,C07C211/38;;C07C217/52;;C07C233/05,,0,0,,,,PENDING
106,KR,A,KR 20200037830 A,028-978-339-656-640,2020-04-09,2020,KR 20207005952 A,2018-08-08,US 201762543307 P;;US 201762553728 P;;US 201762608504 P;;US 2018/0045868 W,2017-08-09,"화합물, 조성물 및 방법","본 개시내용은 진핵생물 개시인자 2B 조절제, 또는 이의 약제학적으로 허용 가능한 염, 입체이성질체, 또는 입체이성질체의 또는 프로드러그의 혼합물, 및 이의 제조 및 사용 방법에 관한 것이다.",DENALI THERAPEUTICS INC,CRAIG ROBERT A II;;ESTRADA ANTHONY A;;FENG JIANWEN A;;FOX BRIAN;;HALE CHRISTOPHER R H;;LEXA KATRINA W;;OSIPOV MAKSIM;;REMARCHUK TRAVIS;;SWEENEY ZACHARY K;;DE VICENTE FIDALGO JAVIER,,https://lens.org/028-978-339-656-640,Patent Application,no,0,0,29,31,0,C07C271/24;;C07C235/14;;C07C2602/38;;A61P25/16;;C07D263/56;;C07D403/12;;C07D231/12;;C07D233/36;;C07D233/42;;C07D233/64;;C07D401/12;;C07D403/04;;C07D413/04;;C07D413/06;;C07D413/12;;C07D417/04;;C07D417/12;;C07D249/04;;C07D249/06;;C07D249/08;;C07D471/04;;C07D257/04;;C07D261/04;;C07D261/08;;C07D487/04;;C07D263/32;;C07D263/38;;C07D491/048;;C07D271/06;;C07D271/10;;C07D207/27;;C07D291/04;;A61P25/28;;C07F7/1804;;C07C235/14;;C07D491/048;;C07D233/42;;C07D417/04;;C07D487/04;;C07D271/10;;C07C2602/38;;C07D401/12;;C07D231/12;;C07D271/06;;C07D403/04;;C07D471/04;;A61P25/16;;C07D249/08;;C07D413/04;;C07D233/61;;C07D249/04;;C07D263/38;;C07D291/04;;C07D257/04;;C07D263/56;;C07C271/24;;C07D207/27;;C07D417/12;;C07D233/64;;C07D263/32;;C07D261/08;;C07D261/04;;C07D249/06;;C07D233/36;;C07D413/06;;C07D413/12;;A61P25/28;;C07D403/12;;C07F7/1804;;C07C235/22;;C07D411/04;;A61K31/4245;;C07D411/04;;A61K31/4245;;A61P25/16;;A61P25/28;;C07D207/27;;C07D271/06;;C07D271/10;;C07D231/12;;C07D233/36;;C07D233/42;;C07D233/64;;C07D249/04;;C07D249/06;;C07D249/08;;C07D257/04;;C07D261/04;;C07D261/08;;C07D263/32;;C07D263/38;;C07D263/56;;C07D291/04;;C07D401/12;;C07D403/04;;C07D403/12;;C07D413/04;;C07D413/06;;C07D413/12;;C07D417/04;;C07D417/12;;C07D471/04;;C07D487/04;;C07D491/048;;C07F7/1804;;C07C235/14;;C07C271/24;;C07C2602/38;;C07C235/22;;C07D207/27;;C07D233/36;;C07D233/42;;C07D233/61;;C07D233/64;;C07D249/04;;C07D249/08;;C07D257/04;;C07D261/04;;C07D261/08;;C07D263/32;;C07D263/38;;C07D263/56;;C07D271/06;;C07D271/10;;C07D291/04;;C07D401/12;;C07D403/04;;C07D403/12;;C07D413/04;;C07D413/06;;C07D413/12;;C07D417/04;;C07D471/04;;C07D487/04;;C07D491/048;;A61K31/415;;A61K31/4245;;A61K31/421;;A61K31/4164,C07D411/04;;A61K31/4245;;A61P25/16;;A61P25/28;;C07D207/27;;C07D231/12;;C07D233/36;;C07D233/42;;C07D233/64;;C07D271/06;;C07D271/10,,0,0,,,,DISCONTINUED
107,AU,A1,AU 2018/313850 A1,187-499-280-388-764,2020-02-06,2020,AU 2018/313850 A,2018-08-08,US 201762608504 P;;US 201762543307 P;;US 201762553728 P;;US 2018/0045868 W,2017-08-09,"Compounds, compositions and methods","The present disclosure relates generally to eukaryotic initiation factor 2B modulators, or a pharmaceutically acceptable salt, stereoisomer, mixture of stereoisomers or prodrug thereof, and methods of making and using thereof.",DENALI THERAPEUTICS INC,CRAIG II ROBERT A;;ESTRADA ANTHONY A;;FENG JIANWEN A;;FOX BRIAN;;HALE CHRISTOPHER R H;;LEXA KATRINA W;;OSIPOV MAKSIM;;REMARCHUK TRAVIS;;SWEENEY ZACHARY K;;DE VICENTE FIDALGO JAVIER,,https://lens.org/187-499-280-388-764,Patent Application,no,0,0,29,31,0,C07C271/24;;C07C235/14;;C07C2602/38;;A61P25/16;;C07D263/56;;C07D403/12;;C07D231/12;;C07D233/36;;C07D233/42;;C07D233/64;;C07D401/12;;C07D403/04;;C07D413/04;;C07D413/06;;C07D413/12;;C07D417/04;;C07D417/12;;C07D249/04;;C07D249/06;;C07D249/08;;C07D471/04;;C07D257/04;;C07D261/04;;C07D261/08;;C07D487/04;;C07D263/32;;C07D263/38;;C07D491/048;;C07D271/06;;C07D271/10;;C07D207/27;;C07D291/04;;A61P25/28;;C07F7/1804;;C07C235/14;;C07D491/048;;C07D233/42;;C07D417/04;;C07D487/04;;C07D271/10;;C07C2602/38;;C07D401/12;;C07D231/12;;C07D271/06;;C07D403/04;;C07D471/04;;A61P25/16;;C07D249/08;;C07D413/04;;C07D233/61;;C07D249/04;;C07D263/38;;C07D291/04;;C07D257/04;;C07D263/56;;C07C271/24;;C07D207/27;;C07D417/12;;C07D233/64;;C07D263/32;;C07D261/08;;C07D261/04;;C07D249/06;;C07D233/36;;C07D413/06;;C07D413/12;;A61P25/28;;C07D403/12;;C07F7/1804;;C07C235/22;;C07D411/04;;A61K31/4245;;C07D411/04;;A61K31/4245;;A61P25/16;;A61P25/28;;C07D207/27;;C07D271/06;;C07D271/10;;C07D231/12;;C07D233/36;;C07D233/42;;C07D233/64;;C07D249/04;;C07D249/06;;C07D249/08;;C07D257/04;;C07D261/04;;C07D261/08;;C07D263/32;;C07D263/38;;C07D263/56;;C07D291/04;;C07D401/12;;C07D403/04;;C07D403/12;;C07D413/04;;C07D413/06;;C07D413/12;;C07D417/04;;C07D417/12;;C07D471/04;;C07D487/04;;C07D491/048;;C07F7/1804;;C07C235/14;;C07C271/24;;C07C2602/38;;C07C235/22;;C07D207/27;;C07D233/36;;C07D233/42;;C07D233/61;;C07D233/64;;C07D249/04;;C07D249/08;;C07D257/04;;C07D261/04;;C07D261/08;;C07D263/32;;C07D263/38;;C07D263/56;;C07D271/06;;C07D271/10;;C07D291/04;;C07D401/12;;C07D403/04;;C07D403/12;;C07D413/04;;C07D413/06;;C07D413/12;;C07D417/04;;C07D471/04;;C07D487/04;;C07D491/048;;A61K31/415;;A61K31/4245;;A61K31/421;;A61K31/4164,C07C211/38;;C07C217/52;;C07C233/05,,0,0,,,,ACTIVE
108,MA,A,MA 49858 A,020-129-719-726-770,2021-04-28,2021,MA 49858 A,2018-08-08,US 201762543307 P;;US 201762553728 P;;US 201762608504 P,2017-08-09,"COMPOSÉS, COMPOSITIONS ET PROCÉDÉS",,DENALI THERAPEUTICS INC,CRAIG ROBERT A II;;DE VICENTE FIDALGO JAVIER;;ESTRADA ANTHONY A;;FENG JIANWEN A;;FOX BRIAN;;HALE CHRISTOPHER R H;;LEXA KATRINA W;;OSIPOV MAKSIM;;REMARCHUK TRAVIS;;SWEENEY ZACHARY K,,https://lens.org/020-129-719-726-770,Unknown,no,0,0,29,31,0,C07C271/24;;C07C235/14;;C07C2602/38;;A61P25/16;;C07D263/56;;C07D403/12;;C07D231/12;;C07D233/36;;C07D233/42;;C07D233/64;;C07D401/12;;C07D403/04;;C07D413/04;;C07D413/06;;C07D413/12;;C07D417/04;;C07D417/12;;C07D249/04;;C07D249/06;;C07D249/08;;C07D471/04;;C07D257/04;;C07D261/04;;C07D261/08;;C07D487/04;;C07D263/32;;C07D263/38;;C07D491/048;;C07D271/06;;C07D271/10;;C07D207/27;;C07D291/04;;A61P25/28;;C07F7/1804;;C07C235/14;;C07D491/048;;C07D233/42;;C07D417/04;;C07D487/04;;C07D271/10;;C07C2602/38;;C07D401/12;;C07D231/12;;C07D271/06;;C07D403/04;;C07D471/04;;A61P25/16;;C07D249/08;;C07D413/04;;C07D233/61;;C07D249/04;;C07D263/38;;C07D291/04;;C07D257/04;;C07D263/56;;C07C271/24;;C07D207/27;;C07D417/12;;C07D233/64;;C07D263/32;;C07D261/08;;C07D261/04;;C07D249/06;;C07D233/36;;C07D413/06;;C07D413/12;;A61P25/28;;C07D403/12;;C07F7/1804;;C07C235/22;;C07D411/04;;A61K31/4245;;C07D411/04;;A61K31/4245;;A61P25/16;;A61P25/28;;C07D207/27;;C07D271/06;;C07D271/10;;C07D231/12;;C07D233/36;;C07D233/42;;C07D233/64;;C07D249/04;;C07D249/06;;C07D249/08;;C07D257/04;;C07D261/04;;C07D261/08;;C07D263/32;;C07D263/38;;C07D263/56;;C07D291/04;;C07D401/12;;C07D403/04;;C07D403/12;;C07D413/04;;C07D413/06;;C07D413/12;;C07D417/04;;C07D417/12;;C07D471/04;;C07D487/04;;C07D491/048;;C07F7/1804;;C07C235/14;;C07C271/24;;C07C2602/38;;C07C235/22;;C07D207/27;;C07D233/36;;C07D233/42;;C07D233/61;;C07D233/64;;C07D249/04;;C07D249/08;;C07D257/04;;C07D261/04;;C07D261/08;;C07D263/32;;C07D263/38;;C07D263/56;;C07D271/06;;C07D271/10;;C07D291/04;;C07D401/12;;C07D403/04;;C07D403/12;;C07D413/04;;C07D413/06;;C07D413/12;;C07D417/04;;C07D471/04;;C07D487/04;;C07D491/048;;A61K31/415;;A61K31/4245;;A61K31/421;;A61K31/4164,A61K31/4245;;A61P25/28;;C07C211/38;;C07C217/52;;C07C233/05;;C07D271/10;;C07D471/04;;C07F7/18,,0,0,,,,PENDING
109,PH,A1,PH 12020550028 A1,018-461-190-598-301,2021-02-08,2021,PH 12020550028 A,2020-01-16,US 201762553728 P;;US 201762608504 P;;US 201762543307 P;;US 2018/0045868 W,2017-08-09,"COMPOUNDS, COMPOSITIONS AND METHODS","The present disclosure relates generally to eukaryotic initiation factor 2B modulators, or a pharmaceutically acceptable salt, stereoisomer, mixture of stereoisomers or prodrug thereof, and methods of making and using thereof.",DENALI THERAPEUTICS INC,CRAIG ROBERT A II;;ESTRADA ANTHONY A;;FENG JIANWEN A;;FOX BRIAN;;HALE CHRISTOPHER R H;;LEXA KATRINA W;;OSIPOV MAKSIM;;REMARCHUK TRAVIS;;SWEENEY ZACHARY K;;DE VICENTE FIDALGO JAVIER,,https://lens.org/018-461-190-598-301,Patent Application,no,0,0,29,31,0,C07C271/24;;C07C235/14;;C07C2602/38;;A61P25/16;;C07D263/56;;C07D403/12;;C07D231/12;;C07D233/36;;C07D233/42;;C07D233/64;;C07D401/12;;C07D403/04;;C07D413/04;;C07D413/06;;C07D413/12;;C07D417/04;;C07D417/12;;C07D249/04;;C07D249/06;;C07D249/08;;C07D471/04;;C07D257/04;;C07D261/04;;C07D261/08;;C07D487/04;;C07D263/32;;C07D263/38;;C07D491/048;;C07D271/06;;C07D271/10;;C07D207/27;;C07D291/04;;A61P25/28;;C07F7/1804;;C07C235/14;;C07D491/048;;C07D233/42;;C07D417/04;;C07D487/04;;C07D271/10;;C07C2602/38;;C07D401/12;;C07D231/12;;C07D271/06;;C07D403/04;;C07D471/04;;A61P25/16;;C07D249/08;;C07D413/04;;C07D233/61;;C07D249/04;;C07D263/38;;C07D291/04;;C07D257/04;;C07D263/56;;C07C271/24;;C07D207/27;;C07D417/12;;C07D233/64;;C07D263/32;;C07D261/08;;C07D261/04;;C07D249/06;;C07D233/36;;C07D413/06;;C07D413/12;;A61P25/28;;C07D403/12;;C07F7/1804;;C07C235/22;;C07D411/04;;A61K31/4245;;C07D411/04;;A61K31/4245;;A61P25/16;;A61P25/28;;C07D207/27;;C07D271/06;;C07D271/10;;C07D231/12;;C07D233/36;;C07D233/42;;C07D233/64;;C07D249/04;;C07D249/06;;C07D249/08;;C07D257/04;;C07D261/04;;C07D261/08;;C07D263/32;;C07D263/38;;C07D263/56;;C07D291/04;;C07D401/12;;C07D403/04;;C07D403/12;;C07D413/04;;C07D413/06;;C07D413/12;;C07D417/04;;C07D417/12;;C07D471/04;;C07D487/04;;C07D491/048;;C07F7/1804;;C07C235/14;;C07C271/24;;C07C2602/38;;C07C235/22;;C07D207/27;;C07D233/36;;C07D233/42;;C07D233/61;;C07D233/64;;C07D249/04;;C07D249/08;;C07D257/04;;C07D261/04;;C07D261/08;;C07D263/32;;C07D263/38;;C07D263/56;;C07D271/06;;C07D271/10;;C07D291/04;;C07D401/12;;C07D403/04;;C07D403/12;;C07D413/04;;C07D413/06;;C07D413/12;;C07D417/04;;C07D471/04;;C07D487/04;;C07D491/048;;A61K31/415;;A61K31/4245;;A61K31/421;;A61K31/4164,C07C217/52;;C07C211/38;;C07C233/05,,0,0,,,,PENDING
110,AU,B2,AU 2018/313850 B2,186-439-184-612-497,2022-12-22,2022,AU 2018/313850 A,2018-08-08,US 201762608504 P;;US 201762543307 P;;US 201762553728 P;;US 2018/0045868 W,2017-08-09,"Compounds, compositions and methods","The present disclosure relates generally to eukaryotic initiation factor 2B modulators, or a pharmaceutically acceptable salt, stereoisomer, mixture of stereoisomers or prodrug thereof, and methods of making and using thereof.",DENALI THERAPEUTICS INC,CRAIG II ROBERT A;;ESTRADA ANTHONY A;;FENG JIANWEN A;;FOX BRIAN;;HALE CHRISTOPHER R H;;LEXA KATRINA W;;OSIPOV MAKSIM;;REMARCHUK TRAVIS;;SWEENEY ZACHARY K;;DE VICENTE FIDALGO JAVIER,,https://lens.org/186-439-184-612-497,Granted Patent,no,1,0,29,31,0,C07C271/24;;C07C235/14;;C07C2602/38;;A61P25/16;;C07D263/56;;C07D403/12;;C07D231/12;;C07D233/36;;C07D233/42;;C07D233/64;;C07D401/12;;C07D403/04;;C07D413/04;;C07D413/06;;C07D413/12;;C07D417/04;;C07D417/12;;C07D249/04;;C07D249/06;;C07D249/08;;C07D471/04;;C07D257/04;;C07D261/04;;C07D261/08;;C07D487/04;;C07D263/32;;C07D263/38;;C07D491/048;;C07D271/06;;C07D271/10;;C07D207/27;;C07D291/04;;A61P25/28;;C07F7/1804;;C07C235/14;;C07D491/048;;C07D233/42;;C07D417/04;;C07D487/04;;C07D271/10;;C07C2602/38;;C07D401/12;;C07D231/12;;C07D271/06;;C07D403/04;;C07D471/04;;A61P25/16;;C07D249/08;;C07D413/04;;C07D233/61;;C07D249/04;;C07D263/38;;C07D291/04;;C07D257/04;;C07D263/56;;C07C271/24;;C07D207/27;;C07D417/12;;C07D233/64;;C07D263/32;;C07D261/08;;C07D261/04;;C07D249/06;;C07D233/36;;C07D413/06;;C07D413/12;;A61P25/28;;C07D403/12;;C07F7/1804;;C07C235/22;;C07D411/04;;A61K31/4245;;C07D411/04;;A61K31/4245;;A61P25/16;;A61P25/28;;C07D207/27;;C07D271/06;;C07D271/10;;C07D231/12;;C07D233/36;;C07D233/42;;C07D233/64;;C07D249/04;;C07D249/06;;C07D249/08;;C07D257/04;;C07D261/04;;C07D261/08;;C07D263/32;;C07D263/38;;C07D263/56;;C07D291/04;;C07D401/12;;C07D403/04;;C07D403/12;;C07D413/04;;C07D413/06;;C07D413/12;;C07D417/04;;C07D417/12;;C07D471/04;;C07D487/04;;C07D491/048;;C07F7/1804;;C07C235/14;;C07C271/24;;C07C2602/38;;C07C235/22;;C07D207/27;;C07D233/36;;C07D233/42;;C07D233/61;;C07D233/64;;C07D249/04;;C07D249/08;;C07D257/04;;C07D261/04;;C07D261/08;;C07D263/32;;C07D263/38;;C07D263/56;;C07D271/06;;C07D271/10;;C07D291/04;;C07D401/12;;C07D403/04;;C07D403/12;;C07D413/04;;C07D413/06;;C07D413/12;;C07D417/04;;C07D471/04;;C07D487/04;;C07D491/048;;A61K31/415;;A61K31/4245;;A61K31/421;;A61K31/4164,C07C211/38;;C07C217/52;;C07C233/05,,0,0,,,,ACTIVE
111,CR,A,CR 20200054 A,051-540-593-449-417,2020-03-21,2020,CR 20200054 A,2018-08-08,US 201762543307 P;;US 201762553728 P;;US 201762608504 P;;US 2018/0045868 W,2017-08-09,"COMPOUNDS, COMPOSITIONS AND METHODS","The present disclosure relates generally to eukaryotic initiation factor 2B modulators, or a pharmaceutically acceptable salt, stereoisomer, mixture of stereoisomers or prodrug thereof, and methods of making and using thereof.",DENALI THERAPEUTICS INC,REMARCHUK TRAVIS;;FENG JIANWEN A;;LEXA KATRINA W;;OSIPOV MAKSIM;;FOX BRIAN;;CRAIG ROBERT A II;;DE VICENTE FIDALGO JAVIER;;SWEENEY ZACHARY K;;ESTRADA ANTHONY A;;HALE CHRISTOPHER R H,,https://lens.org/051-540-593-449-417,Patent Application,no,0,0,29,31,0,C07C271/24;;C07C235/14;;C07C2602/38;;A61P25/16;;C07D263/56;;C07D403/12;;C07D231/12;;C07D233/36;;C07D233/42;;C07D233/64;;C07D401/12;;C07D403/04;;C07D413/04;;C07D413/06;;C07D413/12;;C07D417/04;;C07D417/12;;C07D249/04;;C07D249/06;;C07D249/08;;C07D471/04;;C07D257/04;;C07D261/04;;C07D261/08;;C07D487/04;;C07D263/32;;C07D263/38;;C07D491/048;;C07D271/06;;C07D271/10;;C07D207/27;;C07D291/04;;A61P25/28;;C07F7/1804;;C07C235/14;;C07D491/048;;C07D233/42;;C07D417/04;;C07D487/04;;C07D271/10;;C07C2602/38;;C07D401/12;;C07D231/12;;C07D271/06;;C07D403/04;;C07D471/04;;A61P25/16;;C07D249/08;;C07D413/04;;C07D233/61;;C07D249/04;;C07D263/38;;C07D291/04;;C07D257/04;;C07D263/56;;C07C271/24;;C07D207/27;;C07D417/12;;C07D233/64;;C07D263/32;;C07D261/08;;C07D261/04;;C07D249/06;;C07D233/36;;C07D413/06;;C07D413/12;;A61P25/28;;C07D403/12;;C07F7/1804;;C07C235/22;;C07D411/04;;A61K31/4245;;C07D411/04;;A61K31/4245;;A61P25/16;;A61P25/28;;C07D207/27;;C07D271/06;;C07D271/10;;C07D231/12;;C07D233/36;;C07D233/42;;C07D233/64;;C07D249/04;;C07D249/06;;C07D249/08;;C07D257/04;;C07D261/04;;C07D261/08;;C07D263/32;;C07D263/38;;C07D263/56;;C07D291/04;;C07D401/12;;C07D403/04;;C07D403/12;;C07D413/04;;C07D413/06;;C07D413/12;;C07D417/04;;C07D417/12;;C07D471/04;;C07D487/04;;C07D491/048;;C07F7/1804;;C07C235/14;;C07C271/24;;C07C2602/38;;C07C235/22;;C07D207/27;;C07D233/36;;C07D233/42;;C07D233/61;;C07D233/64;;C07D249/04;;C07D249/08;;C07D257/04;;C07D261/04;;C07D261/08;;C07D263/32;;C07D263/38;;C07D263/56;;C07D271/06;;C07D271/10;;C07D291/04;;C07D401/12;;C07D403/04;;C07D403/12;;C07D413/04;;C07D413/06;;C07D413/12;;C07D417/04;;C07D471/04;;C07D487/04;;C07D491/048;;A61K31/415;;A61K31/4245;;A61K31/421;;A61K31/4164,C07C211/38;;C07C217/52;;C07C233/05,,0,0,,,,PENDING
112,MX,A,MX 2020001352 A,097-745-090-819-269,2020-03-20,2020,MX 2020001352 A,2018-08-08,US 201762543307 P;;US 201762553728 P;;US 201762608504 P;;US 2018/0045868 W,2017-08-09,"COMPOUNDS, COMPOSITIONS AND METHODS.","The present disclosure relates generally to eukaryotic initiation factor 2B modulators, or a pharmaceutically acceptable salt, stereoisomer, mixture of stereoisomers or prodrug thereof, and methods of making and using thereof.",DENALI THERAPEUTICS INC,JIANWEN A FENG;;MAKSIM OSIPOV;;BRIAN FOX;;ZACHARY K SWEENEY;;JAVIER DE VICENTE FIDALGO;;ROBERT A II CRAIG;;ANTONHY A ESTRADA;;CHRISTOPHER R H HALE;;KATRINA W LEXA;;TRAVIS REMARCHUK,,https://lens.org/097-745-090-819-269,Patent Application,no,0,0,29,31,0,C07C271/24;;C07C235/14;;C07C2602/38;;A61P25/16;;C07D263/56;;C07D403/12;;C07D231/12;;C07D233/36;;C07D233/42;;C07D233/64;;C07D401/12;;C07D403/04;;C07D413/04;;C07D413/06;;C07D413/12;;C07D417/04;;C07D417/12;;C07D249/04;;C07D249/06;;C07D249/08;;C07D471/04;;C07D257/04;;C07D261/04;;C07D261/08;;C07D487/04;;C07D263/32;;C07D263/38;;C07D491/048;;C07D271/06;;C07D271/10;;C07D207/27;;C07D291/04;;A61P25/28;;C07F7/1804;;C07C235/14;;C07D491/048;;C07D233/42;;C07D417/04;;C07D487/04;;C07D271/10;;C07C2602/38;;C07D401/12;;C07D231/12;;C07D271/06;;C07D403/04;;C07D471/04;;A61P25/16;;C07D249/08;;C07D413/04;;C07D233/61;;C07D249/04;;C07D263/38;;C07D291/04;;C07D257/04;;C07D263/56;;C07C271/24;;C07D207/27;;C07D417/12;;C07D233/64;;C07D263/32;;C07D261/08;;C07D261/04;;C07D249/06;;C07D233/36;;C07D413/06;;C07D413/12;;A61P25/28;;C07D403/12;;C07F7/1804;;C07C235/22;;C07D411/04;;A61K31/4245;;C07D411/04;;A61K31/4245;;A61P25/16;;A61P25/28;;C07D207/27;;C07D271/06;;C07D271/10;;C07D231/12;;C07D233/36;;C07D233/42;;C07D233/64;;C07D249/04;;C07D249/06;;C07D249/08;;C07D257/04;;C07D261/04;;C07D261/08;;C07D263/32;;C07D263/38;;C07D263/56;;C07D291/04;;C07D401/12;;C07D403/04;;C07D403/12;;C07D413/04;;C07D413/06;;C07D413/12;;C07D417/04;;C07D417/12;;C07D471/04;;C07D487/04;;C07D491/048;;C07F7/1804;;C07C235/14;;C07C271/24;;C07C2602/38;;C07C235/22;;C07D207/27;;C07D233/36;;C07D233/42;;C07D233/61;;C07D233/64;;C07D249/04;;C07D249/08;;C07D257/04;;C07D261/04;;C07D261/08;;C07D263/32;;C07D263/38;;C07D263/56;;C07D271/06;;C07D271/10;;C07D291/04;;C07D401/12;;C07D403/04;;C07D403/12;;C07D413/04;;C07D413/06;;C07D413/12;;C07D417/04;;C07D471/04;;C07D487/04;;C07D491/048;;A61K31/415;;A61K31/4245;;A61K31/421;;A61K31/4164,A61P25/16;;A61K31/41;;A61K31/4164;;A61K31/4245;;A61K31/428;;A61K31/437;;A61K31/4439;;A61K31/454;;A61K31/4709;;A61K31/4725;;A61K31/498;;A61K31/502;;A61K31/517;;A61K31/519;;A61K31/5377;;A61P25/28;;C07C211/38;;C07C217/52;;C07C233/05,,0,0,,,,PENDING
113,US,A1,US 2022/0411433 A1,082-840-881-842-589,2022-12-29,2022,US 202117531039 A,2021-11-19,US 202117531039 A;;US 202016637718 A;;US 2018/0045868 W;;US 201762608504 P;;US 201762553728 P;;US 201762543307 P,2017-08-09,"Modulators of eukaryotic initiation factor 2B, compositions and methods","The present disclosure relates generally to eukaryotic initiation factor 2B modulators, or a pharmaceutically acceptable salt, stereoisomer, mixture of stereoisomers or prodrug thereof, and methods of making and using thereof.",DENALI THERAPEUTICS INC,CRAIG II ROBERT A;;DE VICENTE FIDALGO JAVIER;;ESTRADA ANTHONY A;;FENG JIANWEN A;;FOX BRIAN M;;HALE CHRISTOPHER R H;;LEXA KATRINA W;;OSIPOV MAKSIM;;REMARCHUK TRAVIS;;SWEENEY ZACHARY K,DENALI THERAPEUTICS INC (2020-03-04),https://lens.org/082-840-881-842-589,Patent Application,yes,0,0,29,31,0,C07C271/24;;C07C235/14;;C07C2602/38;;A61P25/16;;C07D263/56;;C07D403/12;;C07D231/12;;C07D233/36;;C07D233/42;;C07D233/64;;C07D401/12;;C07D403/04;;C07D413/04;;C07D413/06;;C07D413/12;;C07D417/04;;C07D417/12;;C07D249/04;;C07D249/06;;C07D249/08;;C07D471/04;;C07D257/04;;C07D261/04;;C07D261/08;;C07D487/04;;C07D263/32;;C07D263/38;;C07D491/048;;C07D271/06;;C07D271/10;;C07D207/27;;C07D291/04;;A61P25/28;;C07F7/1804;;C07C235/14;;C07D491/048;;C07D233/42;;C07D417/04;;C07D487/04;;C07D271/10;;C07C2602/38;;C07D401/12;;C07D231/12;;C07D271/06;;C07D403/04;;C07D471/04;;A61P25/16;;C07D249/08;;C07D413/04;;C07D233/61;;C07D249/04;;C07D263/38;;C07D291/04;;C07D257/04;;C07D263/56;;C07C271/24;;C07D207/27;;C07D417/12;;C07D233/64;;C07D263/32;;C07D261/08;;C07D261/04;;C07D249/06;;C07D233/36;;C07D413/06;;C07D413/12;;A61P25/28;;C07D403/12;;C07F7/1804;;C07C235/22;;C07D411/04;;A61K31/4245;;C07D411/04;;A61K31/4245;;A61P25/16;;A61P25/28;;C07D207/27;;C07D271/06;;C07D271/10;;C07D231/12;;C07D233/36;;C07D233/42;;C07D233/64;;C07D249/04;;C07D249/06;;C07D249/08;;C07D257/04;;C07D261/04;;C07D261/08;;C07D263/32;;C07D263/38;;C07D263/56;;C07D291/04;;C07D401/12;;C07D403/04;;C07D403/12;;C07D413/04;;C07D413/06;;C07D413/12;;C07D417/04;;C07D417/12;;C07D471/04;;C07D487/04;;C07D491/048;;C07F7/1804;;C07C235/14;;C07C271/24;;C07C2602/38;;C07C235/22;;C07D207/27;;C07D233/36;;C07D233/42;;C07D233/61;;C07D233/64;;C07D249/04;;C07D249/08;;C07D257/04;;C07D261/04;;C07D261/08;;C07D263/32;;C07D263/38;;C07D263/56;;C07D271/06;;C07D271/10;;C07D291/04;;C07D401/12;;C07D403/04;;C07D403/12;;C07D413/04;;C07D413/06;;C07D413/12;;C07D417/04;;C07D471/04;;C07D487/04;;C07D491/048;;A61K31/415;;A61K31/4245;;A61K31/421;;A61K31/4164,C07D491/048;;C07C235/22;;C07D207/27;;C07D233/36;;C07D233/42;;C07D233/61;;C07D233/64;;C07D249/04;;C07D249/08;;C07D257/04;;C07D261/04;;C07D261/08;;C07D263/32;;C07D263/38;;C07D263/56;;C07D271/06;;C07D271/10;;C07D291/04;;C07D401/12;;C07D403/04;;C07D403/12;;C07D413/04;;C07D413/06;;C07D413/12;;C07D417/04;;C07D471/04;;C07D487/04,,0,0,,,,ACTIVE
114,US,B2,US 11236100 B2,057-512-657-435-939,2022-02-01,2022,US 201816637718 A,2018-08-08,US 201816637718 A;;US 201762608504 P;;US 201762553728 P;;US 201762543307 P;;US 2018/0045868 W,2017-08-09,"Modulators of eukaryotic initiation factor 2B, compositions and methods","The present disclosure relates generally to eukaryotic initiation factor 2B modulators, or a pharmaceutically acceptable salt, stereoisomer, mixture of stereoisomers or prodrug thereof, and methods of making and using thereof.",DENALI THERAPEUTICS INC,CRAIG II ROBERT A;;DE VICENTE FIDALGO JAVIER;;ESTRADA ANTHONY A;;FENG JIANWEN A;;FOX BRIAN M;;HALE CHRISTOPHER R H;;LEXA KATRINA W;;OSIPOV MAKSIM;;REMARCHUK TRAVIS;;SWEENEY ZACHARY K,DENALI THERAPEUTICS INC (2020-03-04),https://lens.org/057-512-657-435-939,Granted Patent,yes,72,1,29,31,0,C07C271/24;;C07C235/14;;C07C2602/38;;A61P25/16;;C07D263/56;;C07D403/12;;C07D231/12;;C07D233/36;;C07D233/42;;C07D233/64;;C07D401/12;;C07D403/04;;C07D413/04;;C07D413/06;;C07D413/12;;C07D417/04;;C07D417/12;;C07D249/04;;C07D249/06;;C07D249/08;;C07D471/04;;C07D257/04;;C07D261/04;;C07D261/08;;C07D487/04;;C07D263/32;;C07D263/38;;C07D491/048;;C07D271/06;;C07D271/10;;C07D207/27;;C07D291/04;;A61P25/28;;C07F7/1804;;C07C235/14;;C07D491/048;;C07D233/42;;C07D417/04;;C07D487/04;;C07D271/10;;C07C2602/38;;C07D401/12;;C07D231/12;;C07D271/06;;C07D403/04;;C07D471/04;;A61P25/16;;C07D249/08;;C07D413/04;;C07D233/61;;C07D249/04;;C07D263/38;;C07D291/04;;C07D257/04;;C07D263/56;;C07C271/24;;C07D207/27;;C07D417/12;;C07D233/64;;C07D263/32;;C07D261/08;;C07D261/04;;C07D249/06;;C07D233/36;;C07D413/06;;C07D413/12;;A61P25/28;;C07D403/12;;C07F7/1804;;C07C235/22;;C07D411/04;;A61K31/4245;;C07D411/04;;A61K31/4245;;A61P25/16;;A61P25/28;;C07D207/27;;C07D271/06;;C07D271/10;;C07D231/12;;C07D233/36;;C07D233/42;;C07D233/64;;C07D249/04;;C07D249/06;;C07D249/08;;C07D257/04;;C07D261/04;;C07D261/08;;C07D263/32;;C07D263/38;;C07D263/56;;C07D291/04;;C07D401/12;;C07D403/04;;C07D403/12;;C07D413/04;;C07D413/06;;C07D413/12;;C07D417/04;;C07D417/12;;C07D471/04;;C07D487/04;;C07D491/048;;C07F7/1804;;C07C235/14;;C07C271/24;;C07C2602/38;;C07C235/22;;C07D207/27;;C07D233/36;;C07D233/42;;C07D233/61;;C07D233/64;;C07D249/04;;C07D249/08;;C07D257/04;;C07D261/04;;C07D261/08;;C07D263/32;;C07D263/38;;C07D263/56;;C07D271/06;;C07D271/10;;C07D291/04;;C07D401/12;;C07D403/04;;C07D403/12;;C07D413/04;;C07D413/06;;C07D413/12;;C07D417/04;;C07D471/04;;C07D487/04;;C07D491/048;;A61K31/415;;A61K31/4245;;A61K31/421;;A61K31/4164,C07C211/38;;C07D491/048;;C07C217/52;;C07C233/05;;C07C235/22;;C07D207/27;;C07D233/36;;C07D233/42;;C07D233/61;;C07D233/64;;C07D249/04;;C07D249/08;;C07D257/04;;C07D261/04;;C07D261/08;;C07D263/32;;C07D263/38;;C07D263/56;;C07D271/06;;C07D271/10;;C07D291/04;;C07D401/12;;C07D403/04;;C07D403/12;;C07D413/04;;C07D413/06;;C07D413/12;;C07D417/04;;C07D471/04;;C07D487/04,,24,6,015-112-044-385-653;;061-743-007-964-049;;063-943-507-206-585;;042-001-051-196-743;;025-663-563-734-521;;075-644-661-171-726,10.1002/cmdc.201500483;;26789650;;26901872;;10.1038/nature16991;;10.1038/ng.2853;;24336168;;pmc3934366;;pmc4538794;;10.1126/science.aaa6986;;25858979;;pmc3667625;;10.7554/elife.00498;;23741617;;pmc4426669;;10.7554/elife.07314;;25875391;;10.7554/elife.07314.016,"Extended European Search Report for European Application No. 18844666.0 dated Mar. 26, 2021. 10 pages.;;Extended European Search Report for European Application No. 18850713.1 dated Mar. 30, 2021. 6 pages.;;Hearn et al., Structure-Activity Studies of Bis-O-Arylglycolamides: Inhibitors of the Integrated Stress Response. ChemMedChem 2016, vol. 11, pp. 870-880.;;International Search Report and Written Opinion for International Application No. PCT/US2018/045868 dated Nov. 26, 2018. 9 pages.;;International Search Report and Written Opinion for International Application No. PCT/US2018/049197 dated Feb. 5, 2019. 12 pages.;;International Search Report and Written Opinion for International Application No. PCT/US2019/023739 dated Jul. 11, 2019. 16 pages.;;International Search Report and Written Opinion for International Application No. PCT/US2020/017985 dated Apr. 23, 2020. 15 pages.;;International Search Report and Written Opinion for International Application No. PCT/US2020/018007 dated Apr. 21, 2020. 11 pages.;;International Search Report and Written Opinion for International Application No. PCT/US2020/021534 dated May 1, 2020. 15 pages.;;JOSHI MANALI; KULKARNI ABHIJEET; PAL JAYANTA K.: ""Small molecule modulators of eukaryotic initiation factor 2α kinases, the key regulators of protein synth"", BIOCHIMIE, MASSON, PARIS, FR, vol. 95, no. 11, 11 August 2013 (2013-08-11), FR , pages 1980 - 1990, XP028731042, ISSN: 0300-9084, DOI: 10.1016/j.biochi.2013.07.030;;Kashiwagi et al., Crystal structure of eukaryotic translation initiation factor 2B. Nature 2016, vol. 531, pp. 122-125.;;Kim et al., Therapeutic modulation of eIF2a phosphorylation rescues TDP-43 toxicity in amyotrophic lateral sclerosis disease models. Nature Genetics 2014, vol. 46, No. 2, pp. 152-160.;;PubChem CID 13756165, 3,4-dihydro-2H-chromen-2-yl-(4-phenylpiperidin-1-yl)methanone, Feb. 8, 2007, 7 pages, retrieved from the internet: pubchem.ncbi.nlm.nih.gov/compound/13756165 on Sep. 17, 2020.;;PubChem CID 65333682, 4-[2-(oxan-3-yl)-1,3-thiazol-4-yl]benzonitrile, Oct. 23, 2012, 8 pages, retrieved from the internet: pubchem.ncbi.nlm.nih.gov/compound/65333682 on Sep. 17, 2020.;;PubChem CID 68023613, N-[5-Methoxy-6-(methoxymethyl)oxan-3-yl]heptanamide, Nov. 30, 2012, 12 pages, retrieved from the internet: pubchem.ncbi.nlm.nih.gov/compound/68023613 on Oct. 16, 2018.;;PubChem CID 68310749, [(2S,5R)-5-Aminooxan-2-yl]-morpholin-4-ylmethanone, Nov. 30, 2012, 10 pages, retrieved from the internet: pubchem.ncbi.nlm.nih.gov/compound/68310749 on Sep. 17, 2020.;;PubChem CID 79039022, N-[(4-hydroxyoxan-4-yl)methyl]-3-phenoxypropanamide, Oct. 19, 2014, 8 pages, retrieved from the internet: pubchem.ncbi.nlm.nih.gov/compound/79039022 on Sep. 17, 2020.;;PubChem CID 828546, N-Cyclohexyl-1,2,3,4-tetrahydroisoquinoline-2-carboxamide, Jul. 9, 2005, 10 pages, retrieved from the internet: pubchem.ncbi.nlm.nih.gov/compound/828546#section=BioAssay-Results on Sep. 17, 2020.;;PubChem CID 91786719, N-[(3R,4S)-4-(2-amino-2-oxoethoxy)oxan-3-yl]-4-phenoxybutanamide, Jun. 3, 2015, 9 pages, retrieved from the internet: pubchem.ncbi.nlm.nih.gov/compound/91786719 on Sep. 17, 2020.;;RN 1449697-58-8, registry database compound, (2013). 1 page.;;Sekine et al., Mutations in a translation initiation factor identify the target of a memory-enhancing compound. Science 2015, vol. 348, issue 6238, pp. 1027-1030.;;Sidrauski et al., Pharmacological brake-release of mRNA translation enhances cognitive memory. eLife 2013;2:e00498 doi: 10.7554/eLife.00498. 22 pages.;;Sidrauski et al., Pharmacological dimerization and activation of the exchange factor eIF2B antagonizes the integrated stress response. eLife 2015;4:e07314, doi: 10.7554/eLife.07314. 27 pages.;;Chemical Abstracts Registry No. 1135218-61-9, indexed in the Registry file on STN CAS Online Apr. 16, 2009. (Year: 2009).",ACTIVE
115,US,B2,US 11851440 B2,083-852-175-906-439,2023-12-26,2023,US 202117531039 A,2021-11-19,US 202117531039 A;;US 202016637718 A;;US 2018/0045868 W;;US 201762608504 P;;US 201762553728 P;;US 201762543307 P,2017-08-09,"Modulators of eukaryotic initiation factor 2B, compositions and methods","The present disclosure relates generally to eukaryotic initiation factor 2B modulators, or a pharmaceutically acceptable salt, stereoisomer, mixture of stereoisomers or prodrug thereof, and methods of making and using thereof.",DENALI THERAPEUTICS INC,CRAIG II ROBERT A;;DE VICENTE FIDALGO JAVIER;;ESTRADA ANTHONY A;;FENG JIANWEN A;;FOX BRIAN M;;HALE CHRISTOPHER R H;;LEXA KATRINA W;;OSIPOV MAKSIM;;REMARCHUK TRAVIS;;SWEENEY ZACHARY K,DENALI THERAPEUTICS INC (2020-03-04),https://lens.org/083-852-175-906-439,Granted Patent,yes,86,0,29,31,0,C07C271/24;;C07C235/14;;C07C2602/38;;A61P25/16;;C07D263/56;;C07D403/12;;C07D231/12;;C07D233/36;;C07D233/42;;C07D233/64;;C07D401/12;;C07D403/04;;C07D413/04;;C07D413/06;;C07D413/12;;C07D417/04;;C07D417/12;;C07D249/04;;C07D249/06;;C07D249/08;;C07D471/04;;C07D257/04;;C07D261/04;;C07D261/08;;C07D487/04;;C07D263/32;;C07D263/38;;C07D491/048;;C07D271/06;;C07D271/10;;C07D207/27;;C07D291/04;;A61P25/28;;C07F7/1804;;C07C235/14;;C07D491/048;;C07D233/42;;C07D417/04;;C07D487/04;;C07D271/10;;C07C2602/38;;C07D401/12;;C07D231/12;;C07D271/06;;C07D403/04;;C07D471/04;;A61P25/16;;C07D249/08;;C07D413/04;;C07D233/61;;C07D249/04;;C07D263/38;;C07D291/04;;C07D257/04;;C07D263/56;;C07C271/24;;C07D207/27;;C07D417/12;;C07D233/64;;C07D263/32;;C07D261/08;;C07D261/04;;C07D249/06;;C07D233/36;;C07D413/06;;C07D413/12;;A61P25/28;;C07D403/12;;C07F7/1804;;C07C235/22;;C07D411/04;;A61K31/4245;;C07D411/04;;A61K31/4245;;A61P25/16;;A61P25/28;;C07D207/27;;C07D271/06;;C07D271/10;;C07D231/12;;C07D233/36;;C07D233/42;;C07D233/64;;C07D249/04;;C07D249/06;;C07D249/08;;C07D257/04;;C07D261/04;;C07D261/08;;C07D263/32;;C07D263/38;;C07D263/56;;C07D291/04;;C07D401/12;;C07D403/04;;C07D403/12;;C07D413/04;;C07D413/06;;C07D413/12;;C07D417/04;;C07D417/12;;C07D471/04;;C07D487/04;;C07D491/048;;C07F7/1804;;C07C235/14;;C07C271/24;;C07C2602/38;;C07C235/22;;C07D207/27;;C07D233/36;;C07D233/42;;C07D233/61;;C07D233/64;;C07D249/04;;C07D249/08;;C07D257/04;;C07D261/04;;C07D261/08;;C07D263/32;;C07D263/38;;C07D263/56;;C07D271/06;;C07D271/10;;C07D291/04;;C07D401/12;;C07D403/04;;C07D403/12;;C07D413/04;;C07D413/06;;C07D413/12;;C07D417/04;;C07D471/04;;C07D487/04;;C07D491/048;;A61K31/415;;A61K31/4245;;A61K31/421;;A61K31/4164,A61K31/4245;;A61K31/415;;A61K31/4164;;A61K31/421;;C07C235/22;;C07D207/27;;C07D233/36;;C07D233/42;;C07D233/61;;C07D233/64;;C07D249/04;;C07D249/08;;C07D257/04;;C07D261/04;;C07D261/08;;C07D263/32;;C07D263/38;;C07D263/56;;C07D271/06;;C07D271/10;;C07D291/04;;C07D401/12;;C07D403/04;;C07D403/12;;C07D413/04;;C07D413/06;;C07D413/12;;C07D417/04;;C07D471/04;;C07D487/04;;C07D491/048,,27,0,,,"Chemical Abstracts Registry No. 1135218-61-9, indexed in the Registry file on STN CAS Online Apr. 16, 2009. (Year: 2009).;;Extended European Search Report for European Application No. 18850713.1 dated Mar. 30, 2021. 6 pages.;;Extended European Search Report for European Application No. 18844666.0 dated Mar. 26, 2021. 10 pages.;;Hearn et al., Structure-Activity Studies of Bis-O-Arylglycolamides: Inhibitors of the Integrated Stress Response. ChemMedChem 2016, vol. 11, pp. 870-880.;;International Search Report and Written Opinion for International Application No. PCT/US2018/045868 dated Nov. 26, 2018. 9 pages.;;International Search Report and Written Opinion for International Application No. PCT/US2018/049197 dated Feb. 5, 2019. 12 pages.;;International Search Report and Written Opinion for International Application No. PCT/US2019/023739 dated Jul. 11, 2019. 16 pages.;;International Search Report and Written Opinion for International Application No. PCT/US2020/017985 dated Apr. 23, 2020. 15 pages.;;International Search Report and Written Opinion for International Application No. PCT/US2020/018007 dated Apr. 21, 2020. 11 pages.;;International Search Report and Written Opinion for International Application No. PCT/US2020/021534 dated May 1, 2020. 15 pages.;;Joshi et al., Small molecule modulators of eukaryotic initiation factor 2a kinases, the key regulators of protein synthesis. Biochimie 2013, vol. 95, pp. 1980-1990, XP028731042.;;Kashiwagi et al., Crystal structure of eukaryotic translation initiation factor 2B. Nature 2016, vol. 531, pp. 122-125.;;Kim et al., Therapeutic modulation of elF2a phosphorylation rescues TDP-43 toxicity in amyotrophic lateral sclerosis disease models. Nature Genetics 2014, vol. 46, No. 2, pp. 152-160.;;PubChem CID 13756165, 3,4-dihydro-2H-chromen-2-yl-(4-phenylpiperidin-1-yl)methanone, Feb. 8, 2007, 7 pages, retrieved from the internet: pubchem.ncbi.nlm.nih.gov/compound/13756165 on Sep. 17, 2020.;;PubChem CID 65333682, 4-[2-(oxan-3-yl)-1,3-thiazol-4-yl]benzonitrile, Oct. 23, 2012, 8 pages, retrieved from the internet: pubchem.ncbi.nlm.nih.gov/compound/65333682 on Sep. 17, 2020.;;PubChem CID 68023613, N-[5-Methoxy-6-(methoxymethyl)oxan-3-yl]heptanamide, Nov. 30, 2012, 12 pages, retrieved from the internet: pubchem.ncbi.nlm.nih.gov/compound/68023613 on Oct. 16, 2018.;;PubChem CID 68310749, [(2S,5R)-5-Aminooxan-2-yl]-morpholin-4-ylmethanone, Nov. 30, 2012, 10 pages, retrieved from the internet: pubchem.ncbi.nlm.nih.gov/compound/68310749 on Sep. 17, 2020.;;PubChem CID 79039022, N-[(4-hydroxyoxan-4-yl)methyl]-3-phenoxypropanamide, Oct. 19, 2014, 8 pages, retrieved from the internet: pubchem.ncbi.nlm.nih.gov/compound/79039022 on Sep. 17, 2020.;;PubChem CID 828546, N-Cyclohexyl-1,2,3,4-tetrahydroisoquinoline-2-carboxamide, Jul. 9, 2005, 10 pages, retrieved from the internet: pubchem.ncbi.nlm.nih.gov/compound/828546#section=BioAssay-Results on Sep. 17, 2020.;;PubChem CID 91786719, N-[(3R,4S)-4-(2-amino-2-oxoethoxy)oxan-3-yl]-4-phenoxybutanamide, Jun. 3, 2015, 9 pages, retrieved from the internet: pubchem.ncbi.nlm.nih.gov/compound/91786719 on Sep. 17, 2020.;;RN 1449697-58-8, registry database compound, (2013). 1 page.;;Sekine et al., Mutations in a translation initiation factor identify the target of a memory-enhancing compound. Science 2015, vol. 348, issue 6238, pp. 1027-1030.;;Sidrauski et al., Pharmacological brake-release of mRNA translation enhances cognitive memory. eLife 2013;2:e00498 doi: 10.7554/eLife.00498. 22 pages.;;Sidrauski et al., Pharmacological dimerization and activation of the exchange factor elF2B antagonizes the integrated stress response. eLife 2015;4:e07314, doi: 10.7554/eLife.07314. 27 pages.;;Registry (STN) [online], Oct. 3, 2012, [retrieval date: Jul. 25, 2022], CAS Registration No. 1398569-33-9. 1 page.;;Registrydatabasecompounds, 2021, listing of registry database compounds. 17 pages.;;Bessodes et al., Synthesis of unsaturated 4′-azido pyranosyl thymines as potential antiviral and anti-HIV agents, J. Chem. Soc. Perkin Trans. 1, 1990, pp. 3035-3039.",ACTIVE
116,US,A1,US 2021/0147435 A1,157-280-933-992-439,2021-05-20,2021,US 201816637718 A,2018-08-08,US 201816637718 A;;US 201762608504 P;;US 201762553728 P;;US 201762543307 P;;US 2018/0045868 W,2017-08-09,"COMPOUNDS, COMPOSITIONS AND METHODS","The present disclosure relates generally to eukaryotic initiation factor 2B modulators, or a pharmaceutically acceptable salt, stereoisomer, mixture of stereoisomers or prodrug thereof, and methods of making and using thereof.",DENALI THERAPEUTICS INC,CRAIG II ROBERT A;;DE VICENTE FIDALGO JAVIER;;ESTRADA ANTHONY A;;FENG JIANWEN A;;FOX BRIAN M;;HALE CHRISTOPHER R H;;LEXA KATRINA W;;OSIPOV MAKSIM;;REMARCHUK TRAVIS;;SWEENEY ZACHARY K,DENALI THERAPEUTICS INC (2020-03-04),https://lens.org/157-280-933-992-439,Patent Application,yes,0,3,29,31,0,C07C271/24;;C07C235/14;;C07C2602/38;;A61P25/16;;C07D263/56;;C07D403/12;;C07D231/12;;C07D233/36;;C07D233/42;;C07D233/64;;C07D401/12;;C07D403/04;;C07D413/04;;C07D413/06;;C07D413/12;;C07D417/04;;C07D417/12;;C07D249/04;;C07D249/06;;C07D249/08;;C07D471/04;;C07D257/04;;C07D261/04;;C07D261/08;;C07D487/04;;C07D263/32;;C07D263/38;;C07D491/048;;C07D271/06;;C07D271/10;;C07D207/27;;C07D291/04;;A61P25/28;;C07F7/1804;;C07C235/14;;C07D491/048;;C07D233/42;;C07D417/04;;C07D487/04;;C07D271/10;;C07C2602/38;;C07D401/12;;C07D231/12;;C07D271/06;;C07D403/04;;C07D471/04;;A61P25/16;;C07D249/08;;C07D413/04;;C07D233/61;;C07D249/04;;C07D263/38;;C07D291/04;;C07D257/04;;C07D263/56;;C07C271/24;;C07D207/27;;C07D417/12;;C07D233/64;;C07D263/32;;C07D261/08;;C07D261/04;;C07D249/06;;C07D233/36;;C07D413/06;;C07D413/12;;A61P25/28;;C07D403/12;;C07F7/1804;;C07C235/22;;C07D411/04;;A61K31/4245;;C07D411/04;;A61K31/4245;;A61P25/16;;A61P25/28;;C07D207/27;;C07D271/06;;C07D271/10;;C07D231/12;;C07D233/36;;C07D233/42;;C07D233/64;;C07D249/04;;C07D249/06;;C07D249/08;;C07D257/04;;C07D261/04;;C07D261/08;;C07D263/32;;C07D263/38;;C07D263/56;;C07D291/04;;C07D401/12;;C07D403/04;;C07D403/12;;C07D413/04;;C07D413/06;;C07D413/12;;C07D417/04;;C07D417/12;;C07D471/04;;C07D487/04;;C07D491/048;;C07F7/1804;;C07C235/14;;C07C271/24;;C07C2602/38;;C07C235/22;;C07D207/27;;C07D233/36;;C07D233/42;;C07D233/61;;C07D233/64;;C07D249/04;;C07D249/08;;C07D257/04;;C07D261/04;;C07D261/08;;C07D263/32;;C07D263/38;;C07D263/56;;C07D271/06;;C07D271/10;;C07D291/04;;C07D401/12;;C07D403/04;;C07D403/12;;C07D413/04;;C07D413/06;;C07D413/12;;C07D417/04;;C07D471/04;;C07D487/04;;C07D491/048;;A61K31/415;;A61K31/4245;;A61K31/421;;A61K31/4164,C07D491/048;;C07C235/22;;C07D207/27;;C07D233/36;;C07D233/42;;C07D233/61;;C07D233/64;;C07D249/04;;C07D249/08;;C07D257/04;;C07D261/04;;C07D261/08;;C07D263/32;;C07D263/38;;C07D263/56;;C07D271/06;;C07D271/10;;C07D291/04;;C07D401/12;;C07D403/04;;C07D403/12;;C07D413/04;;C07D413/06;;C07D413/12;;C07D417/04;;C07D471/04;;C07D487/04,,0,0,,,,ACTIVE
117,MX,A,MX 2023003989 A,037-661-978-930-993,2023-04-24,2023,MX 2023003989 A,2020-01-31,US 201762543307 P;;US 201762553728 P;;US 201762608504 P,2017-08-09,"COMPOUNDS, COMPOSITIONS AND METHODS.","The present disclosure relates generally to eukaryotic initiation factor 2B modulators, or a pharmaceutically acceptable salt, stereoisomer, mixture of stereoisomers or prodrug thereof, and methods of making and using thereof.",DENALI THERAPEUTICS INC,FENG JIANWEN A;;OSIPOV MAKSIM;;ESTRADA ANTHONY A;;FOX BRIAN;;SWEENEY ZACHARY K;;DE VICENTE FIDALGO JAVIER;;HALE CHRISTOPHER R H;;LEXA KATRINA W;;REMARCHUK TRAVIS;;I I CRAIG ROBERT A,,https://lens.org/037-661-978-930-993,Patent Application,no,0,0,29,31,0,C07C271/24;;C07C235/14;;C07C2602/38;;A61P25/16;;C07D263/56;;C07D403/12;;C07D231/12;;C07D233/36;;C07D233/42;;C07D233/64;;C07D401/12;;C07D403/04;;C07D413/04;;C07D413/06;;C07D413/12;;C07D417/04;;C07D417/12;;C07D249/04;;C07D249/06;;C07D249/08;;C07D471/04;;C07D257/04;;C07D261/04;;C07D261/08;;C07D487/04;;C07D263/32;;C07D263/38;;C07D491/048;;C07D271/06;;C07D271/10;;C07D207/27;;C07D291/04;;A61P25/28;;C07F7/1804;;C07C235/14;;C07D491/048;;C07D233/42;;C07D417/04;;C07D487/04;;C07D271/10;;C07C2602/38;;C07D401/12;;C07D231/12;;C07D271/06;;C07D403/04;;C07D471/04;;A61P25/16;;C07D249/08;;C07D413/04;;C07D233/61;;C07D249/04;;C07D263/38;;C07D291/04;;C07D257/04;;C07D263/56;;C07C271/24;;C07D207/27;;C07D417/12;;C07D233/64;;C07D263/32;;C07D261/08;;C07D261/04;;C07D249/06;;C07D233/36;;C07D413/06;;C07D413/12;;A61P25/28;;C07D403/12;;C07F7/1804;;C07C235/22;;C07D411/04;;A61K31/4245;;C07D411/04;;A61K31/4245;;A61P25/16;;A61P25/28;;C07D207/27;;C07D271/06;;C07D271/10;;C07D231/12;;C07D233/36;;C07D233/42;;C07D233/64;;C07D249/04;;C07D249/06;;C07D249/08;;C07D257/04;;C07D261/04;;C07D261/08;;C07D263/32;;C07D263/38;;C07D263/56;;C07D291/04;;C07D401/12;;C07D403/04;;C07D403/12;;C07D413/04;;C07D413/06;;C07D413/12;;C07D417/04;;C07D417/12;;C07D471/04;;C07D487/04;;C07D491/048;;C07F7/1804;;C07C235/14;;C07C271/24;;C07C2602/38;;C07C235/22;;C07D207/27;;C07D233/36;;C07D233/42;;C07D233/61;;C07D233/64;;C07D249/04;;C07D249/08;;C07D257/04;;C07D261/04;;C07D261/08;;C07D263/32;;C07D263/38;;C07D263/56;;C07D271/06;;C07D271/10;;C07D291/04;;C07D401/12;;C07D403/04;;C07D403/12;;C07D413/04;;C07D413/06;;C07D413/12;;C07D417/04;;C07D471/04;;C07D487/04;;C07D491/048;;A61K31/415;;A61K31/4245;;A61K31/421;;A61K31/4164,A61P25/16;;A61P25/28;;C07C235/14;;C07C235/22;;C07C271/24;;C07D207/27;;C07D231/12;;C07D233/36;;C07D233/42;;C07D233/61;;C07D233/64;;C07D249/04;;C07D249/06;;C07D249/08;;C07D257/04;;C07D261/04;;C07D261/08;;C07D263/32;;C07D263/38;;C07D263/56;;C07D271/06;;C07D271/10;;C07D291/04;;C07D401/12;;C07D403/04;;C07D403/12;;C07D413/04;;C07D413/06;;C07D413/12;;C07D417/04;;C07D417/12;;C07D471/04;;C07D487/04;;C07D491/048;;C07F7/18,,0,0,,,,PENDING
118,US,A1,US 2009/0192344 A1,166-618-485-052-153,2009-07-30,2009,US 1946108 A,2008-01-24,US 1946108 A,2008-01-24,SURGICAL DEVICES FOR MANIPULATING TISSUE,A surgical kit can be used to manipulate tissue within the body of a patient to create a working space within the body to allow a surgeon to easily access and work within the body using various surgical instruments. A surgical kit can include an implant comprised of a magnetic material which can be engaged with tissue within the body. The kit can further include a surgical instrument having a magnet which can be used to manipulate the implant and tissue engaged therewith. A surgical kit can include an anchor and a hanger configured to engage tissue at different locations within the body and a connection member engaged with the anchor and the hanger such that the connection member can be pulled to move the anchor toward the hanger. A surgical instrument which utilizes a vacuum provided to one or more movable members can also be used to manipulate tissue.,ETHICON ENDO SURGERY INC,BAKOS GREGORY J;;CUNNINGHAM CHRISTIE MRIE;;DOBLER KENDALL LEE;;FOX WILLIAM D;;HESS CHRISTOPHER J;;LONG GARY L;;NOBIS RUDOLPH HENRY;;SHURTLEFF CARL J;;SPIVEY JAMES T;;STEFANCHIK DAVID;;STOKES MICHAEL J;;VAKHARIA OMAR J;;VOEGELE JAMES W,ETHICON ENDO-SURGERY INC (2008-03-04),https://lens.org/166-618-485-052-153,Patent Application,yes,8,61,1,1,0,A61B17/0218;;A61B17/0401;;A61B17/30;;A61B17/3478;;A61B2017/00876;;A61B2017/0464;;A61B2017/2926;;A61B2017/306;;A61B34/73;;A61B17/0218;;A61B17/30;;A61B2017/2926;;A61B2017/00876;;A61B17/0401;;A61B2017/0464;;A61B17/3478;;A61B2017/306;;A61B34/73,A61N2/00;;A61N2/10,600/12;;600/9,0,0,,,,DISCONTINUED
119,US,A1,US 2020/0085442 A1,132-774-125-808-261,2020-03-19,2020,US 201916586082 A,2019-09-27,US 201916586082 A;;US 201514751612 A,2015-06-26,METHOD OF APPLYING AN ANNULAR ARRAY OF STAPLES TO TISSUE,"A surgical instrument includes a body, a shaft assembly, a stapling head assembly, an anvil, an anvil adjustment assembly, a trigger, and a lockout assembly. The stapling head assembly is operable to drive an annular array of staples. The anvil is configured to couple with the stapling head assembly. The anvil adjustment assembly includes a translating member, which translates relative to the body to thereby adjust the longitudinal position of the anvil relative to the stapling head assembly. The trigger is operable to actuate the stapling head assembly. The lockout assembly includes an electrically powered braking feature. A method of operating the surgical instrument includes providing the lockout assembly in a first state to permit translation of the translating member. The translating member is then translated. The lockout assembly is then transitioned to a second state to prevent further translation of the translating member.",ETHICON LLC,BEAR BRIAN W;;BOLTON MATTHEW H;;CLINGAMAN RODNEY V;;DINARDO BRIAN F;;FOX WILLIAM D;;HOUSER KEVIN L;;MEASAMER JOHN P;;MILLER CHRISTOPHER C;;OVERMYER MARK D;;SACKETT KEVIN D;;SCHEIB CHARLES J;;SCHELLIN EMILY A;;SCHWEMBERGER RICHARD F;;SHELTON IV FREDERICK E;;SMITH CRAIG S;;VAKHARIA OMAR J;;ZERKLE JASON E,CILAG GMBH INTERNATIONAL (2021-04-05),https://lens.org/132-774-125-808-261,Patent Application,yes,19,3,4,92,0,A61B2017/00039;;A61B2017/00115;;A61B2017/00367;;A61B2017/00398;;A61B2017/00407;;A61B2017/00477;;A61B2017/00734;;A61B2017/00876;;A61B2090/031;;A61B2090/0811;;A61B17/1155;;A61B2017/2923;;A61B17/1155;;A61B2017/00039;;A61B2017/00477;;H02J7/00;;A61B2090/031;;A61B2017/00115;;A61B2017/00407;;A61B2017/00876;;A61B2017/00734;;A61B2017/00398;;A61B2017/00367;;A61B2090/0811,A61B17/115;;H02J7/00,,0,0,,,,DISCONTINUED
120,US,A1,US 2016/0374672 A1,128-697-386-516-979,2016-12-29,2016,US 201514751612 A,2015-06-26,US 201514751612 A,2015-06-26,METHOD OF APPLYING AN ANNULAR ARRAY OF STAPLES TO TISSUE,"A surgical instrument includes a body, a shaft assembly, a stapling head assembly, an anvil, an anvil adjustment assembly, a trigger, and a lockout assembly. The stapling head assembly is operable to drive an annular array of staples. The anvil is configured to couple with the stapling head assembly. The anvil adjustment assembly includes a translating member, which translates relative to the body to thereby adjust the longitudinal position of the anvil relative to the stapling head assembly. The trigger is operable to actuate the stapling head assembly. The lockout assembly includes an electrically powered braking feature. A method of operating the surgical instrument includes providing the lockout assembly in a first state to permit translation of the translating member. The translating member is then translated. The lockout assembly is then transitioned to a second state to prevent further translation of the translating member.",ETHICON ENDO SURGERY LLC,BEAR BRIAN W;;BOLTON MATTHEW H;;CLINGAMAN RODNEY V;;DINARDO BRIAN F;;FOX WILLIAM D;;HOUSER KEVIN L;;MEASAMER JOHN P;;MILLER CHRISTOPHER C;;OVERMYER MARK D;;SACKETT KEVIN D;;SCHEIB CHARLES J;;SCHELLIN EMILY A;;SCHWEMBERGER RICHARD F;;SHELTON IV FREDERICK E;;SMITH CRAIG S;;VAKHARIA OMAR J;;ZERKLE JASON E,CILAG GMBH INTERNATIONAL (2021-04-05);;ITE LLC (2015-09-01);;ETHICON LLC (2016-12-30),https://lens.org/128-697-386-516-979,Patent Application,yes,6,315,4,92,0,A61B2017/00039;;A61B2017/00115;;A61B2017/00367;;A61B2017/00398;;A61B2017/00407;;A61B2017/00477;;A61B2017/00734;;A61B2017/00876;;A61B2090/031;;A61B2090/0811;;A61B17/1155;;A61B2017/2923;;A61B17/1155;;A61B2017/00039;;A61B2017/00477;;H02J7/00;;A61B2090/031;;A61B2017/00115;;A61B2017/00407;;A61B2017/00876;;A61B2017/00734;;A61B2017/00398;;A61B2017/00367;;A61B2090/0811,A61B17/115;;A61B17/068,,0,0,,,,ACTIVE
121,US,B2,US 10478189 B2,101-243-642-309-519,2019-11-19,2019,US 201514751612 A,2015-06-26,US 201514751612 A,2015-06-26,Method of applying an annular array of staples to tissue,"A surgical instrument includes a body, a shaft assembly, a stapling head assembly, an anvil, an anvil adjustment assembly, a trigger, and a lockout assembly. The stapling head assembly is operable to drive an annular array of staples. The anvil is configured to couple with the stapling head assembly. The anvil adjustment assembly includes a translating member, which translates relative to the body to thereby adjust the longitudinal position of the anvil relative to the stapling head assembly. The trigger is operable to actuate the stapling head assembly. The lockout assembly includes an electrically powered braking feature. A method of operating the surgical instrument includes providing the lockout assembly in a first state to permit translation of the translating member. The translating member is then translated. The lockout assembly is then transitioned to a second state to prevent further translation of the translating member.",ETHICON ENDO SURGERY LLC;;ETHICON LLC,BEAR BRIAN W;;BOLTON MATTHEW H;;CLINGAMAN RODNEY V;;DINARDO BRIAN F;;FOX WILLIAM D;;HOUSER KEVIN L;;MEASAMER JOHN P;;MILLER CHRISTOPHER C;;OVERMYER MARK D;;SACKETT KEVIN D;;SCHEIB CHARLES J;;SCHELLIN EMILY A;;SCHWEMBERGER RICHARD F;;SHELTON IV FREDERICK E;;SMITH CRAIG S;;VAKHARIA OMAR J;;ZERKLE JASON E,CILAG GMBH INTERNATIONAL (2021-04-05);;ITE LLC (2015-09-01);;ETHICON LLC (2016-12-30),https://lens.org/101-243-642-309-519,Granted Patent,yes,30,735,4,92,0,A61B2017/00039;;A61B2017/00115;;A61B2017/00367;;A61B2017/00398;;A61B2017/00407;;A61B2017/00477;;A61B2017/00734;;A61B2017/00876;;A61B2090/031;;A61B2090/0811;;A61B17/1155;;A61B2017/2923;;A61B17/1155;;A61B2017/00039;;A61B2017/00477;;H02J7/00;;A61B2090/031;;A61B2017/00115;;A61B2017/00407;;A61B2017/00876;;A61B2017/00734;;A61B2017/00398;;A61B2017/00367;;A61B2090/0811,A61B17/115;;A61B17/00;;A61B90/00;;H02J7/00,,0,0,,,,ACTIVE
122,US,A1,US 2023/0371954 A1,123-941-545-602-998,2023-11-23,2023,US 202318361158 A,2023-07-28,US 202318361158 A;;US 201916586082 A;;US 201514751612 A,2015-06-26,METHOD OF APPLYING AN ANNULAR ARRAY OF STAPLES TO TISSUE,"A surgical instrument includes a body, a shaft assembly, a stapling head assembly, an anvil, an anvil adjustment assembly, a trigger, and a lockout assembly. The stapling head assembly is operable to drive an annular array of staples. The anvil is configured to couple with the stapling head assembly. The anvil adjustment assembly includes a translating member, which translates relative to the body to thereby adjust the longitudinal position of the anvil relative to the stapling head assembly. The trigger is operable to actuate the stapling head assembly. The lockout assembly includes an electrically powered braking feature. A method of operating the surgical instrument includes providing the lockout assembly in a first state to permit translation of the translating member. The translating member is then translated. The lockout assembly is then transitioned to a second state to prevent further translation of the translating member.",CILAG GMBH INT,BEAR BRIAN W;;BOLTON MATTHEW H;;CLINGAMAN RODNEY V;;DINARDO BRIAN F;;FOX WILLIAM D;;HOUSER KEVIN L;;MEASAMER JOHN P;;MILLER CHRISTOPHER C;;OVERMYER MARK D;;SACKETT KEVIN D;;SCHEIB CHARLES J;;SCHELLIN EMILY A;;SCHWEMBERGER RICHARD F;;SHELTON IV FREDERICK E;;SMITH CRAIG S;;VAKHARIA OMAR J;;ZERKLE JASON E,,https://lens.org/123-941-545-602-998,Patent Application,yes,0,0,4,92,0,A61B2017/00039;;A61B2017/00115;;A61B2017/00367;;A61B2017/00398;;A61B2017/00407;;A61B2017/00477;;A61B2017/00734;;A61B2017/00876;;A61B2090/031;;A61B2090/0811;;A61B17/1155;;A61B2017/2923;;A61B17/1155;;A61B2017/00039;;A61B2017/00477;;H02J7/00;;A61B2090/031;;A61B2017/00115;;A61B2017/00407;;A61B2017/00876;;A61B2017/00734;;A61B2017/00398;;A61B2017/00367;;A61B2090/0811,H02J7/00;;A61B17/115,,0,0,,,,PENDING
123,US,A1,US 2017/0258471 A1,198-569-899-342-583,2017-09-14,2017,US 201715604787 A,2017-05-25,US 201715604787 A;;US 201314033688 A;;US 201314033751 A;;US 201514751612 A;;US 201615350513 A;;US 201615350621 A;;US 201715581546 A;;US 201715581640 A,2013-09-23,METHODS AND SYSTEMS FOR PERFORMING CIRCULAR STAPLING,"An apparatus includes a body, a shaft, a stapling head assembly, and an anvil. The body includes a motor, a first user input feature, and a second user input feature. The first user input feature is operable to activate the motor. The shaft extends distally from the body. The stapling head assembly is positioned at a distal end of the shaft. The stapling head assembly includes an anvil coupling feature, at least one annular array of staples, and a staple driver. The second user input feature is operable to drive the anvil coupling feature longitudinally. The staple driver is operable to drive the at least one annular array of staples. The motor is operable to drive the staple driver. The anvil is configured to couple with the anvil coupling feature. The anvil is further configured to deform the staples driven by the staple driver.",ETHICON LLC,DINARDO BRIAN F;;BEAR BRIAN W;;SCHEIB CHARLES J;;MILLER CHRISTOPHER C;;SMITH CRAIG S;;SCHELLIN EMILY A;;SHELTON IV FREDERICK E;;ZERKLE JASON E;;GAGEL JEFFREY C;;MEASAMER JOHN P;;ALEXANDER III JOHNNY H;;KLUENER JOSEPH T;;SACKETT KEVIN D;;HOUSER KEVIN L;;OVERMYER MARK D;;BOLTON MATTHEW H;;VAKHARIA OMAR J;;SCHWEMBERGER RICHARD F;;LEIMBACH RICHARD L;;CLINGAMAN RODNEY V;;GOODE TIMOTHY E;;FOX WILLIAM D;;STAGER WILLIAM R,CILAG GMBH INTERNATIONAL (2021-04-05);;ETHICON LLC (2017-09-08),https://lens.org/198-569-899-342-583,Patent Application,yes,10,153,6,92,0,A61B2017/00199;;A61B2017/00221;;A61B2017/00367;;A61B17/1155;;A61B2017/00398;;A61B2017/00017;;A61B2017/00477;;A61B2090/0808;;A61B2090/0811;;A61B2017/00119;;A61B2017/00734;;A61B2017/07264;;A61B2017/00115;;A61B17/1155;;A61B17/072;;A61B2017/07264;;A61B2017/07271;;A61B2017/07228;;A61B2017/00734;;A61B2017/00398;;A61B2017/00115;;A61B2017/00221;;A61B2017/00367;;A61B17/068;;A61B2017/00199,A61B17/115;;A61B17/072,,0,0,,,,ACTIVE
124,US,A1,US 2023/0285026 A1,110-721-926-476-896,2023-09-14,2023,US 202318160520 A,2023-01-27,US 202318160520 A;;US 202217826452 A;;US 202016836291 A;;US 201715604787 A;;US 201314033688 A;;US 201314033751 A;;US 201514751612 A;;US 201615350513 A;;US 201615350621 A;;US 201715581546 A;;US 201715581640 A,2013-09-23,METHODS AND SYSTEMS FOR PERFORMING SURGICAL STAPLING,"An apparatus includes a body, a shaft, a stapling head assembly, and an anvil. The body includes a motor, a first user input feature, and a second user input feature. The first user input feature is operable to activate the motor. The shaft extends distally from the body. The stapling head assembly is positioned at a distal end of the shaft. The stapling head assembly includes an anvil coupling feature, at least one annular array of staples, and a staple driver. The second user input feature is operable to drive the anvil coupling feature longitudinally. The staple driver is operable to drive the at least one annular array of staples. The motor is operable to drive the staple driver. The anvil is configured to couple with the anvil coupling feature. The anvil is further configured to deform the staples driven by the staple driver.",CILAG GMBH INT,DINARDO BRIAN F;;BEAR BRIAN W;;SCHEIB CHARLES J;;MILLER CHRISTOPHER C;;SMITH CRAIG S;;SCHELLIN EMILY A;;SHELTON FREDERICK E;;ZERKLE JASON E;;GAGEL JEFFREY C;;MEASAMER JOHN P;;ALEXANDER JOHNNY H;;KLUENER JOSEPH T;;SACKETT KEVIN D;;HOUSER KEVIN L;;OVERMYER MARK D;;BOLTON MATTHEW H;;VAKHARIA OMAR J;;SCHWEMBERGER RICHARD F;;LEIMBACH RICHARD L;;CLINGAMAN RODNEY V;;GOODE TIMOTHY E;;FOX WILLIAM D;;STAGER WILLIAM R,,https://lens.org/110-721-926-476-896,Patent Application,yes,3,0,6,92,0,A61B2017/00199;;A61B2017/00221;;A61B2017/00367;;A61B17/1155;;A61B2017/00398;;A61B2017/00017;;A61B2017/00477;;A61B2090/0808;;A61B2090/0811;;A61B2017/00119;;A61B2017/00734;;A61B2017/07264;;A61B2017/00115;;A61B17/1155;;A61B17/072;;A61B2017/07264;;A61B2017/07271;;A61B2017/07228;;A61B2017/00734;;A61B2017/00398;;A61B2017/00115;;A61B2017/00221;;A61B2017/00367;;A61B17/068;;A61B2017/00199,A61B17/115;;A61B17/068;;A61B17/072,,0,0,,,,PENDING
125,US,A1,US 2022/0401102 A1,031-408-007-611-765,2022-12-22,2022,US 202217826452 A,2022-05-27,US 202217826452 A;;US 202016836291 A;;US 201715604787 A;;US 201314033688 A;;US 201314033751 A;;US 201514751612 A;;US 201615350513 A;;US 201615350621 A;;US 201715581546 A;;US 201715581640 A,2013-09-23,METHODS AND SYSTEMS FOR PERFORMING CIRCULAR STAPLING,"An apparatus includes a body, a shaft, a stapling head assembly, and an anvil. The body includes a motor, a first user input feature, and a second user input feature. The first user input feature is operable to activate the motor. The shaft extends distally from the body. The stapling head assembly is positioned at a distal end of the shaft. The stapling head assembly includes an anvil coupling feature, at least one annular array of staples, and a staple driver. The second user input feature is operable to drive the anvil coupling feature longitudinally. The staple driver is operable to drive the at least one annular array of staples. The motor is operable to drive the staple driver. The anvil is configured to couple with the anvil coupling feature. The anvil is further configured to deform the staples driven by the staple driver.",CILAG GMBH INT,DINARDO BRIAN F;;BEAR BRIAN W;;SCHEIB CHARLES J;;MILLER CHRISTOPHER C;;SMITH CRAIG S;;SCHELLIN EMILY A;;SHELTON IV FREDERICK E;;ZERKLE JASON E;;GAGEL JEFFREY C;;MEASAMER JOHN P;;ALEXANDER III JOHNNY H;;KLUENER JOSEPH T;;SACKETT KEVIN D;;HOUSER KEVIN L;;OVERMYER MARK D;;BOLTON MATTHEW H;;VAKHARIA OMAR J;;SCHWEMBERGER RICHARD F;;LEIMBACH RICHARD L;;CLINGAMAN RODNEY V;;GOODE TIMOTHY E;;FOX WILLIAM D;;STAGER WILLIAM R,,https://lens.org/031-408-007-611-765,Patent Application,yes,5,0,6,92,0,A61B2017/00199;;A61B2017/00221;;A61B2017/00367;;A61B17/1155;;A61B2017/00398;;A61B2017/00017;;A61B2017/00477;;A61B2090/0808;;A61B2090/0811;;A61B2017/00119;;A61B2017/00734;;A61B2017/07264;;A61B2017/00115;;A61B17/1155;;A61B17/072;;A61B2017/07264;;A61B2017/07271;;A61B2017/07228;;A61B2017/00734;;A61B2017/00398;;A61B2017/00115;;A61B2017/00221;;A61B2017/00367;;A61B17/068;;A61B2017/00199,A61B17/115;;A61B17/068;;A61B17/072,,0,0,,,,PENDING
126,US,A1,US 2020/0305881 A1,072-535-971-675-653,2020-10-01,2020,US 202016836291 A,2020-03-31,US 202016836291 A;;US 201715604787 A;;US 201314033688 A;;US 201314033751 A;;US 201514751612 A;;US 201615350513 A;;US 201615350621 A;;US 201715581546 A;;US 201715581640 A,2013-09-23,METHODS AND SYSTEMS FOR PERFORMING CIRCULAR STAPLING,"An apparatus includes a body, a shaft, a stapling head assembly, and an anvil. The body includes a motor, a first user input feature, and a second user input feature. The first user input feature is operable to activate the motor. The shaft extends distally from the body. The stapling head assembly is positioned at a distal end of the shaft. The stapling head assembly includes an anvil coupling feature, at least one annular array of staples, and a staple driver. The second user input feature is operable to drive the anvil coupling feature longitudinally. The staple driver is operable to drive the at least one annular array of staples. The motor is operable to drive the staple driver. The anvil is configured to couple with the anvil coupling feature. The anvil is further configured to deform the staples driven by the staple driver.",ETHICON LLC,DINARDO BRIAN F;;BEAR BRIAN W;;SCHEIB CHARLES J;;MILLER CHRISTOPHER C;;SMITH CRAIG S;;SCHELLIN EMILY A;;SHELTON IV FREDERICK E;;ZERKLE JASON E;;GAGEL JEFFREY C;;MEASAMER JOHN P;;ALEXANDER III JOHNNY H;;KLUENER JOSEPH T;;SACKETT KEVIN D;;HOUSER KEVIN L;;OVERMYER MARK D;;BOLTON MATTHEW H;;VAKHARIA OMAR J;;SCHWEMBERGER RICHARD F;;LEIMBACH RICHARD L;;CLINGAMAN RODNEY V;;GOODE TIMOTHY E;;FOX WILLIAM D;;STAGER WILLIAM R,CILAG GMBH INTERNATIONAL (2021-04-05),https://lens.org/072-535-971-675-653,Patent Application,yes,0,3,6,92,0,A61B2017/00199;;A61B2017/00221;;A61B2017/00367;;A61B17/1155;;A61B2017/00398;;A61B2017/00017;;A61B2017/00477;;A61B2090/0808;;A61B2090/0811;;A61B2017/00119;;A61B2017/00734;;A61B2017/07264;;A61B2017/00115;;A61B17/1155;;A61B17/072;;A61B2017/07264;;A61B2017/07271;;A61B2017/07228;;A61B2017/00734;;A61B2017/00398;;A61B2017/00115;;A61B2017/00221;;A61B2017/00367;;A61B17/068;;A61B2017/00199,A61B17/115;;A61B17/068;;A61B17/072,,0,0,,,,ACTIVE
127,US,B2,US 11446036 B2,119-268-325-322-466,2022-09-20,2022,US 202016836291 A,2020-03-31,US 202016836291 A;;US 201715604787 A;;US 201314033688 A;;US 201314033751 A;;US 201514751612 A;;US 201615350513 A;;US 201615350621 A;;US 201715581546 A;;US 201715581640 A,2013-09-23,Methods and systems for performing circular stapling,"An apparatus includes a body, a shaft, a stapling head assembly, and an anvil. The body includes a motor, a first user input feature, and a second user input feature. The first user input feature is operable to activate the motor. The shaft extends distally from the body. The stapling head assembly is positioned at a distal end of the shaft. The stapling head assembly includes an anvil coupling feature, at least one annular array of staples, and a staple driver. The second user input feature is operable to drive the anvil coupling feature longitudinally. The staple driver is operable to drive the at least one annular array of staples. The motor is operable to drive the staple driver. The anvil is configured to couple with the anvil coupling feature. The anvil is further configured to deform the staples driven by the staple driver.",ETHICON LLC;;CILAG GMBH INT,DINARDO BRIAN F;;BEAR BRIAN W;;SCHEIB CHARLES J;;MILLER CHRISTOPHER C;;SMITH CRAIG S;;SCHELLIN EMILY A;;SHELTON IV FREDERICK E;;ZERKLE JASON E;;GAGEL JEFFREY C;;MEASAMER JOHN P;;ALEXANDER III JOHNNY H;;KLUENER JOSEPH T;;SACKETT KEVIN D;;HOUSER KEVIN L;;OVERMYER MARK D;;BOLTON MATTHEW H;;VAKHARIA OMAR J;;SCHWEMBERGER RICHARD F;;LEIMBACH RICHARD L;;CLINGAMAN RODNEY V;;GOODE TIMOTHY E;;FOX WILLIAM D;;STAGER WILLIAM R,CILAG GMBH INTERNATIONAL (2021-04-05),https://lens.org/119-268-325-322-466,Granted Patent,yes,213,0,6,92,0,A61B2017/00199;;A61B2017/00221;;A61B2017/00367;;A61B17/1155;;A61B2017/00398;;A61B2017/00017;;A61B2017/00477;;A61B2090/0808;;A61B2090/0811;;A61B2017/00119;;A61B2017/00734;;A61B2017/07264;;A61B2017/00115;;A61B17/1155;;A61B17/072;;A61B2017/07264;;A61B2017/07271;;A61B2017/07228;;A61B2017/00734;;A61B2017/00398;;A61B2017/00115;;A61B2017/00221;;A61B2017/00367;;A61B17/068;;A61B2017/00199,A61B17/068;;A61B17/00;;A61B17/072;;A61B17/115,,60,0,,,"Brazilian Office Action dated Feb. 14, 2020 for Application No. BR112016006289-2, 4 pgs.;;Chinese Search Report dated Dec. 19, 2017 for Application No. CN 201480052184.4, 2 pgs.;;Japanese Office Action, Notification, dated Mar. 13, 2018 for Application No. JP 2017-010286, 2 pgs.;;Japanese Office Action, Notification, dated Aug. 7, 2018 for Application No. JP 2017-010287, 2pgs.;;Japanese Office Action, Notification, dated Mar. 13, 2018 for Application No. JP 2017-023542, 2 pgs.;;Japanese Office Action, Notification, dated Mar. 13, 2018 for Application No. JP 2017-023544, 2 pgs.;;Japanese Office Action, Notification, dated Mar. 13, 2018 for Application No. JP 2017-023545, 2 pgs.;;Japanese Office Action, Notification, dated Mar. 13, 2018 for Application No. JP 2017-023652, 2 pgs.;;Japanese Office Action, Notification, dated Mar. 13, 2018 for Application No. JP 2017-023654, 2 pgs.;;Japanese Office Action, Notification, dated Mar. 13, 2018 for Application No. JP 2017-023655, 2 pgs.;;Japanese Office Action, Notification, dated Mar. 13, 2018 for Application No. JP 2017-023656, 2 pgs.;;Japanese Office Action, Notification, dated Aug. 7, 2018 for Application No. JP 2017-023649, 1 pg.;;Japanese Office Action, Notification, dated Aug. 7, 2018 for Application No. JP 2017-023651, Ipg.;;Japanese Office Action, Notification, dated Aug. 7, 2018 for Application No. JP 2017-023653, 1 pg.;;Russian Office Action, and Search Report dated May 22, 2018 for Application No. RU 2016115750, 7 pgs.;;U.S. Appl. No. 16/994,101, filed Aug. 14, 2020, by Miller et al., entitled: “Staple Forming Pocket Configurations for Circular Surgical Stapler Anvil.”;;Chinese Office Action, First Office Action, dated Dec. 29, 2017 for Application No. CN 201480052184.4, 7 pgs.;;Chinese Office Action, The Second Office Action, dated Nov. 23, 2018 for Application No. CN 201480052189.7, 4 pgs.;;Chinese Search Report, First Search, dated Feb. 24, 2018 for Application No. CN 201480052189.7, 2 pgs.;;European Search Report and Written Opinion dated Feb. 10, 2015 for Application No. EP 14185807.6, 8 pgs.;;European Exam Report dated Feb. 29, 2016 for Application No. EP 14185807.6, 5 pgs.;;European Communication, Intention to Grant, dated Mar. 30, 2017 for Application No. EP 14185807.6, 125 pgs.;;European Search Report, Partial, dated Mar. 5, 2015 for Application No. EP 14185830.8, 7 pgs.;;European Search Report and Written Opinion dated Jul. 6, 2015 for Application No. EP 14185830.8, 11 pgs.;;European Exam Report dated Aug. 9, 2016 for Application No. EP 14185830.8, 4 pgs.;;European Communication, Intention to Grant, dated May 10, 2017 for Application No. EP 14185830.8, 86 pgs.;;European Exam Report dated Oct. 6, 2017 for Application No. EP 14185830.8, 6 pgs.;;European Search Report and Written Opinion dated Apr. 18, 2018 for Application No. EP 17201266.8, 7 pgs.;;European Exam Report dated Jan. 23, 2019 for Application No. EP 17201266.8, 3 pgs.;;European Search Report and Written Opinion dated Apr. 24, 2018 for Application No. EP 17201431.8, 6 pgs.;;European Search Report and Written Opinion dated Aug. 1, 2018 for Application No. EP 18169739.2, 10 pgs.;;European Search Report and Written Opinion dated Jul. 16, 2018 for Application No. EP 18169862.2, 7 pgs.;;International Search Report and Written Opinion dated Dec. 22, 2014 for Application No. PCT/US2014/056514, 11 pgs.;;International Search Report and Written Opinion dated Apr. 1, 2015 for Application No. PCT/US2014/056525, 19 pgs.;;International Search Report and Written Opinion dated Aug. 22, 2017 for Application No. PCT/US2017/035104, 9 pgs.;;International Search Report and Written Opinion dated Sep. 4, 2017 for Application No. PCT/US2017/035117, 9pgs.;;International Search Report and Written Opinion dated Aug. 1, 2018 for Application No. PCT/US2018/028128, 16 pgs.;;International Search Report and Written Opinion dated Jul. 25, 2018 for Application No. PCT/US2018/028135, 14 pgs.;;Japanese Office Action, Notification of Reasons for Refusal, and Search Report by Registered Searching Organization dated May 8, 2018 for Application No. JP 2016-544011, 21 pgs.;;Japanese Office Action, Decision to Grant a Patent, dated Jul. 24, 2018 for Application No. JP 2016-544011, 3 pgs.;;Japanese Office Action, Notification of Reasons for Refusal, and Search Report by Registered Searching Organization dated May 8, 2018 for Application No. JP 2016-544014, 19 pgs.;;Japanese Office Action, Decision to Grant a Patent, dated Aug. 7, 2018 for Application No. JP 2016-544014, 3 pgs.;;US Design U.S. Appl. No. 29/672,408, filed Dec. 5, 2018 by Miller et al., entitled: “Surgical Stapler”.;;Indian Office Action dated Sep. 14, 2020 for Application No. IN 201617011060, 7 pgs.;;Japanese Office Action, Notice of Reasons for Refusal, dated Jun. 15, 2021 for Application No. JP 2019-524969, 5 pgs.;;Japanese Office Action, Notice of Reasons for Refusal, dated Apr. 6, 2021 for Application No. JP 2019-524876, 9 pgs.;;Russian Office Action and Search Report dated May 14, 2018 for Application No. RU 2016115744, 9 pgs.;;U.S. Pat. No. D. 830,550.;;U.S. Pat. No. D. 833,608.;;U.S. Pat. No. D. 854,152.;;U.S. Pat. No. D. 894,390.;;U.S. Pat. No. 9,907,552.;;U.S. Pat. No. 10,478,189.;;U.S. Pat. No. 10,695,068.;;U.S. Pat. No. 10,709,452.;;U.S. Pat. No. 10,729,444.;;Chinese Office Action dated Sep. 18, 2021, for Application No. 201780070473.0, 12 pages.;;Chinese Office Action dated Sep. 18, 2021, for Application No. 201780083352.X, 5 pages.;;Japanese Notification of Reasons for Refusal dated Dec. 7, 2021, for Application No. 2019-558513, 3 pages.;;Japanese Notification of Reasons for Refusal dated Dec. 21, 2021, for Application No. 2019-558606, 6 pages.",ACTIVE
128,US,B2,US 10709452 B2,134-841-361-602-695,2020-07-14,2020,US 201715604787 A,2017-05-25,US 201715604787 A;;US 201314033688 A;;US 201314033751 A;;US 201514751612 A;;US 201615350513 A;;US 201615350621 A;;US 201715581546 A;;US 201715581640 A,2013-09-23,Methods and systems for performing circular stapling,"An apparatus includes a body, a shaft, a stapling head assembly, and an anvil. The body includes a motor, a first user input feature, and a second user input feature. The first user input feature is operable to activate the motor. The shaft extends distally from the body. The stapling head assembly is positioned at a distal end of the shaft. The stapling head assembly includes an anvil coupling feature, at least one annular array of staples, and a staple driver. The second user input feature is operable to drive the anvil coupling feature longitudinally. The staple driver is operable to drive the at least one annular array of staples. The motor is operable to drive the staple driver. The anvil is configured to couple with the anvil coupling feature. The anvil is further configured to deform the staples driven by the staple driver.",ETHICON LLC,DINARDO BRIAN F;;BEAR BRIAN W;;SCHEIB CHARLES J;;MILLER CHRISTOPHER C;;SMITH CRAIG S;;SCHELLIN EMILY A;;SHELTON IV FREDERICK E;;ZERKLE JASON E;;GAGEL JEFFREY C;;MEASAMER JOHN P;;ALEXANDER III JOHNNY H;;KLUENER JOSEPH T;;SACKETT KEVIN D;;HOUSER KEVIN L;;OVERMYER MARK D;;BOLTON MATTHEW H;;VAKHARIA OMAR J;;SCHWEMBERGER RICHARD F;;LEIMBACH RICHARD L;;CLINGAMAN RODNEY V;;GOODE TIMOTHY E;;FOX WILLIAM D;;STAGER WILLIAM R,CILAG GMBH INTERNATIONAL (2021-04-05);;ETHICON LLC (2017-09-08),https://lens.org/134-841-361-602-695,Granted Patent,yes,156,29,6,92,0,A61B2017/00199;;A61B2017/00221;;A61B2017/00367;;A61B17/1155;;A61B2017/00398;;A61B2017/00017;;A61B2017/00477;;A61B2090/0808;;A61B2090/0811;;A61B2017/00119;;A61B2017/00734;;A61B2017/07264;;A61B2017/00115;;A61B17/1155;;A61B17/072;;A61B2017/07264;;A61B2017/07271;;A61B2017/07228;;A61B2017/00734;;A61B2017/00398;;A61B2017/00115;;A61B2017/00221;;A61B2017/00367;;A61B17/068;;A61B2017/00199,A61B17/68;;A61B17/00;;A61B17/068;;A61B17/072;;A61B17/115,,42,0,,,"U.S. Appl. No. 14/033,688.;;U.S. Appl. No. 14/751,612.;;U.S. Appl. No. 15/350,513.;;U.S. Appl. No. 15/350,621.;;U.S. Appl. No. 15/581,546.;;U.S. Appl. No. 15/581,640.;;U.S. Appl. No. 15/888,528.;;U.S. Appl. No. 16/109,020.;;Chinese Office Action, The First Office Action, dated Dec. 29, 2017 for Application No. CN 201480052184.4, 7 pgs.;;Chinese Office Action, The Second Office Action, dated Nov. 23, 2018 for Application No. CN 201480052189.7, 4 pgs.;;Chinese Search Report, First Search, dated Feb. 24, 2018 for Application No. CN 201480052189.7, 2 pgs.;;European Search Report and Written Opinion dated Feb. 10, 2015 for Application No. EP 14185807.6, 8 pgs.;;European Exam Report dated Feb. 29, 2016 for Application No. EP 14185807.6, 5 pgs.;;European Communication, Intention to Grant, dated Mar. 30, 2017 for Application No. EP 14185807.6, 125 pgs.;;European Search Report, Partial, dated Mar. 5, 2015 for Application No. EP 14185830.8, 7 pgs.;;European Search Report and Written Opinion dated Jul. 6, 2015 for Application No. EP 14185830.8, 11 pgs.;;European Exam Report dated Aug. 9, 2016 for Application No. EP 14185830.8, 4 pgs.;;European Communication, Intention to Grant, dated May 10, 2017 for Application No. EP 14185830.8, 86 pgs.;;European Exam Report dated Oct. 6, 2017 for Application No. EP 14185830.8, 6 pgs.;;European Search Report and Written Opinion dated Apr. 24, 2018 for Application No. EP 17201431.8, 6 pgs.;;European Search Report and Written Opinion dated Apr. 18, 2018 for Application No. EP 17201266.8, 7 pgs.;;European Exam Report dated Jan. 23, 2019 for Application No. EP 17201266.8, 3 pgs.;;European Search Report and Written Opinion dated Aug. 1, 2018 for Application No. EP 18169739.2, 10 pgs.;;European Search Report and Written Opinion dated Jul. 16, 2018 for Application No. EP 18169862.2, 7 pgs.;;International Search Report and Written Opinion dated Aug. 22, 2017 for Application No. PCT/US2017/035104, 9 pgs.;;International Search Report and Written Opinion dated Sep. 4, 2017 for Application No. PCT/US2017/035117, 9 pgs.;;International Search Report and Written Opinion dated Aug. 1, 2018 for Application No. PCT/US2018/028128, 16 pgs.;;International Search Report and Written Opinion dated Jul. 25, 2018 for Application No. PCT/US2018/028135, 14 pgs.;;Japanese Office Action, Notification of Reasons for Refusal, and Search Report by Registered Searching Organization dated May 8, 2018 for Application No. JP 2016-544011, 21 pgs.;;Japanese Office Action, Decision to Grant a Patent, dated Jul. 24, 2018 for Application No. JP 2016-544011, 3 pgs.;;Japanese Office Action, Notification of Reasons for Refusal, and Search Report by Registered Searching Organization dated May 8, 2018 for Application No. JP 2016-544014, 19 pgs.;;Japanese Office Action, Decision to Grant a Patent, dated Aug. 7, 2018 for Application No. JP 2016-544014, 3 pgs.;;International Search Report and Written Opinion dated Dec. 22, 2014 for Application No. PCT/US2014/056514, 11 pgs.;;International Search Report and Written Opinion dated Apr. 1, 2015 for Application No. PCT/US2014/056525, 19 pgs.;;U.S. Appl. No. 15/350,513, filed Nov. 14, 2016.;;U.S. Appl. No. 15/350,593, filed Nov. 14, 2016.;;U.S. Appl. No. 15/350,621, filed Nov. 14, 2016.;;U.S. Appl. No. 15/350,624, filed Nov. 14, 2016.;;U.S. Appl. No. 15/581,546, filed Apr. 28, 2017.;;U.S. Appl. No. 15/581,640, filed Apr. 28, 2017.;;Design U.S. Appl. No. 29/665,182, filed Oct. 1, 2018 by Miller et al., entitled: “Stapling Head Feature for Surgical Stapler”.;;Design U.S. Appl. No. 29/672,408, filed Dec. 5, 2018 by Miller et al., entitled: “Surgical Stapler”.",ACTIVE
